key: cord-0770884-84rdg2hf
authors: nan
title: Proceedings of Reanimation 2021, the French Intensive Care Society International Congress
date: 2021-06-29
journal: Ann Intensive Care
DOI: 10.1186/s13613-021-00862-0
sha: 30e6f2a85b9b75571e0e51a1f1fec742c1a8d64c
doc_id: 770884
cord_uid: 84rdg2hf

nan

Incidence rates of central venous catheter-and arterial catheterrelated bloodstream infections according to the type of hospital (data from the nationwide prospective SPIADI survey, 2020).

weaned and 10 decannulated during their stay. Median total duration (ICU + WC) of mechanical ventilation was 27 days. Six patients walked and 13 ate orally by the end of their WC stay. The median length of WC stay was 16 days. Two serious complications required ICU readmission (1 bleeding, 1 cannula obstruction). Ventilator-associated pneumonia was diagnosed in 4 patients in the WC. Ninety days after ICU admission, 14 patients were alive and 12 returned home. Conclusion: These two temporary WC allowed safe care of tracheotomized patients still requiring mechanical ventilation supply, with no other organ failure. This allowed ICU to accept new acute patients. This strategy is reliable when ICU beds are overwhelmed.

Hopital Foch, Suresnes, France; 12 Rationale: Critically ill obese patients may have an increased risk of difficult intubation and subsequent severe hypoxemia. We hypothesized that pre-oxygenation with noninvasive ventilation before intubation as compared with high-flow nasal cannula oxygen may decrease the risk of severe hypoxemia in obese patients. Patients and methods/materials and methods: Post hoc subgroup analysis of critically ill obese patients (body mass index ≥ 30 kg m −2 ) from a multicenter randomized controlled trial comparing preoxygenation with noninvasive ventilation and high-flow nasal oxygen before intubation of patients with acute hypoxemic respiratory failure (PaO2/FIO2 < 300 mmHg). The primary outcome was the occurrence of severe hypoxemia (pulse oximetry < 80%) during the intubation procedure according to the preoxygenation strategy. Results: Among the 313 patients included in the original trial 1 , 91 (29%) were obese with a mean body mass index of 35 ± 5 kg m −2 . Obese patients were more likely to experience an episode of severe hypoxemia during intubation procedure than non-obese patients: 34% (31/91) vs. 22% (49/222); difference, 12%; 95% CI 1 to 23%; P = 0.03. Among obese patients, 40 received preoxygenation with noninvasive ventilation and 51 with high-flow nasal oxygen. Severe hypoxemia occurred in 15 patients (37%) with noninvasive ventilation and 16 patients (31%) with high-flow nasal oxygen (difference, 6%; 95% CI −13 to 25%; P = 0.54). The lowest pulse oximetry values during intubation procedure were 87% [interquartile range, 77-93] with noninvasive ventilation and 86% [78-92] with high-flow nasal oxygen (p = 0.98). After multivariable analysis, factors independently associated with severe hypoxemia in obese patients were intubation difficulty scale > 5 points and respiratory primary failure as reason for admission. Conclusion: Obese patients with acute hypoxemic respiratory failure had an increased risk of severe hypoxemia during intubation procedure as compared to non-obese patients. However, preoxygenation with noninvasive ventilation did not reduce this risk compared with high-flow nasal oxygen.

Rationale: During cardio-pulmonary resuscitation (CPR), chest compressions (CC) tend to decrease lung volume below the functional residual capacity (FRC). This phenomenon may induce intrathoracic airway closure [1] , and possibly impact both ventilation and circulation. On the opposite, large manual bag insufflations above FRC ("thoracic distension") may excessively increase intra-thoracic pressure and thus jeopardize circulation. These two phenomena impact differently capnogram during CC. When there is no thoracic airway closure nor thoracic distension, ventilation could become a "targeted ventilation". The objective of the present study was to develop an algorithm to identify thoracic airway closure, thoracic distension and targeted ventilation based on the analysis of capnogram (CO2 patterns) recorded during CC from clinical data. Patients and methods/materials and methods: Anonymized capnograms from 122 out-of-hospital cardiac arrest (OHCA) patients obtained immediately after intubation (LIFEPACK 15, Physio-Control, WA 98052) were analyzed (RENAU registry). An algorithm was developed on Python to classify a ventilation cycle into thoracic airway closure, thoracic distension or targeted ventilation (Fig. 1) . In order to validate the algorithm, three physicians independently identified those clinical cases based on capnogram visual inspection and comparison was performed. Krippendorff's alpha score was computed to test physicians' classification agreement (between physicians and in comparison with algorithm classification). Results: Classification is illustrated on Fig. 1 . For each situation, the upper image displays a typical capnogram from clinical recordings. Lower images were obtained after numerical data were extracted with a dedicated application. Each image shows one ventilation cycle composed of expiration and insufflation. From the 122 patients included in the study, 34% of patients showed airway closure, 29% displayed thoracic distension pattern and 37% showed targeted ventilation. Krippendorff's scoring reached 0.79, suggesting excellent agreement. Conclusion: EtCO2 interpretation during CC remains challenging. Its absolute value may not be adapted during CPR as CC may complexify its interpretation. In this context, we propose an original approach to identify and interpret more accurately expired CO2 during CC. Both thoracic airway closure and thoracic distension can be identified using CO2 patterns. This study is a first step in guiding CPR using capnograms [2] .

were identified through PubMed, Web of science, and the Cochrane Central (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) . IPD were requested to corresponding authors for all identified studies. We used mixed-effect models to estimate the effect of late intubation on hospital mortality and described adjusted mortality rates over time. Results: Overall, 11 087 patients were included (24 studies), including 7705 (74%) who were intubated within 24 h of ICU admission (early intubation). Crude mortality rate was 53.2%. Adjusted survivals improved over time (OR for hospital mortality per year: 0.96[0.95-0.97]). For each elapsed day between ICU admission and intubation, mortality increased (p < 0.001). Early intubation was significantly associated with decreased mortality (OR: 0.80 [0.70-0.93]), regardless of initial oxygenation strategy Conclusion: In immunocompromised intubated patients, survival has improved over time. Time between ICU admission and intubation is a strong predictor of mortality, suggesting a detrimental effect of initial oxygenation failure. Rationale: Lung cancer accounts for the most common malignancy in patients with solid tumors requiring unplanned ICU admission. Recent therapeutic advances through immunotherapy and targeted therapy have resulted in improved survival, but may also induce new toxicities. How such changes in the landscape of lung cancer may impact on indications for ICU admissions and the eventual outcomes remains unknown. The objective of this study was to address the trends in ICUadmission patterns and prognosis of lung cancer patients with lifethreatening complications. Patients and methods/materials and methods: We conducted a retrospective monocenter study including patients with lung cancer (diagnosed before or during the ICU stay, all stages and histologic types) and requiring unplanned admission over a 12-year period (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) . Independent predictors of short-term (in-ICU) and longterm (1-year) outcome were addressed by a cause-specific multivariate Cox regression analysis. Results: 379 patients were included in the study. The number of patients dramatically increased over the study period, though likely linked to the development of the thoracic oncology department in our hospital. Non-small cell lung cancer accounted for the large majority (75%) of cancer subsets. The proportion of patients with advanced metastatic disease increased over time, as well as the number of patients under immunotherapy or targeted therapy. ICU-admissions related to medical and procedural adverse events increased over time from 4.0% in 2007-2008 to 11.6% in 2017-2018 (p = 0.02). ICU, hospital and one-year mortality rates were 32.2%, 53.3% and 68.9% and did not significantly change over the study period despite increasingly advanced malignancy. Factors independently associated with ICU mortality were a baseline Performance Status (PS) ≥ 3 and the requirements for invasive and non-invasive mechanical ventilation. One-year mortality was independently associated with advanced or metastatic cancer stage, baseline PS ≥ 3, increased acute severity at the time of ICU admission as assessed by the Simplified Acute Physiology Score 2, decisions to forgo life-sustaining therapies at the time of ICU discharge and continuation of chemotherapy or immunotherapy or both after ICU discharge (Fig. 1) .

Conclusion: Therapeutic advances in lung cancer seemingly prompted broader ICU admission policy. Despite the trend towards more advanced malignancy stages, both short-term and long-term survival rates remained stable over the study period. Continuation of chemotherapy after ICU discharge is a major prognostic factor of oneyear survival. Compliance with ethics regulations: Yes in clinical research. Fig. 1 One year-mortality in ICU-survivors according to the ability to receive oncologic treatment (landmark set at 1 month following ICU-discharge) 55.6% of the type of O2 pressure drop from the power plant O2 (42%); 37% mucosal plug obstructions. Weaning has been initiated in 61.1% of patients and 38.6% patients has mechanical ventilation withdrawal difficulties. Mortality was 58%. Conclusion: The practice of mechanical ventilation in our context comes up against technical difficulties and high morbidity and mortality, linked to the occurrence of complications and maintenance problems.

[95%CI, 12-45] of the 24 patients included and representing 40% (6/15) [95%CI, 20-64] of the patients who sustained PP ≥ 3 h. Three patients were persistent responders. Among patients who sustained PP ≥ 3 h, PaO2 increased from 73.6 mmHg (± 15.9) before, to 94.9 mmHg (± 28.3) during PP (median difference, 10 [95%CI, ; p = 0.006).No significant difference was found between PaO2 before PP and PaO2 after resupination (p = 0.53). None of the included patients experienced major complications. Back pain was reported by 10 patients (42%). At the end of the follow-up period, 5 patients required invasive mechanical ventilation. Four of them did not sustain PP ≥ 1 h and required intubation within 72 h. Conclusion: In this study on COVID-19 patients with hypoxemic respiratory failure managed outside the ICU, 63% were able to tolerate PP for more than 3 h. However, oxygenation increased during PP in only 25% and was not sustained in half of those after resupination.

Rationale: Awake PP (prone positioning) is feasible, improves oxygenation in some patients and may prevent respiratory worsening 1-2 . The main objective of the study was to evaluate the effect of PP on the outcome of spontaneously breathing COVID-19 patients with acute respiratory failure. Patients and methods/materials and methods: We designed an exposed/non-exposed bicentric retrospective matched cohort study to assess the effectiveness of PP for patients hospitalized outside Intensive Care Unit (ICU) with COVID-19 requiring oxygen. Inclusion criteria were: hypoxemic respiratory failure requiring oxygen supplementation and PCR-confirmed SARS-CoV-2. The study received approval by the appropriate IRB (n° MR 3514070520). Two treatment strategies were compared: awake PP for at least 3 h a day during 3 consecutive days (PP group) and no instruction regarding positioning or no tolerance of PP during hospitalization (no-PP group). The oxygen supplementation strategy was to initiate first oxygen therapy, second HFNC, third pressure support with non-invasive ventilation (NIV), and finally invasive mechanical ventilation (IMV).The primary outcome of the study was the "upgrading of oxygen delivery method" evaluated on day 14 (D14) and defined by reaching at least 6 L/min with a doubling of the initial oxygen flow for usual oxygen supplementation, or initiating HFNC, or initiating NIV or IMV. The secondary outcome was death at D14. Results: A total of 414 confirmed COVID-19 patients were admitted during the study period. Among the 168 patients eligible for analysis, 48 received PP for at least 3 h a day for 3 days and 120 did not. After performing a propensity score matching, 96 patients were analyzed (48 patients in each group). For the primary outcome, 15 (31.2%) patients in the PP group had an upgrading of oxygen delivery method at D14, compared with 25 (52.1%) in the no PP group (p = 0.038) with a Hazard Ratio (HR) of 2.03 (95% CI, 1.07-3.86), p = 0.003. For the secondary outcome, 4 (8.3%) patients in the PP group and 6 (12.5%) of the non-PP group died at D14 (p = 0.74). No patients in the PP-group died or required invasive mechanical ventilation within the first three days. No major adverse event was observed. Conclusion: PP for at least 3 h a day during 3 consecutive days may be associated with a clinical benefit by preventing the upgrading of oxygen delivery method on awake, non-intubated, spontaneously breathing COVID-19 patients with acute hypoxemic respiratory failure requiring oxygen supplementation.

Rationale: Awake prone position (aPP) has been proposed in COVID-19 patients with acute respiratory failure (ARF) to improve the oxygenation and thus to avoid mechanical ventilation in some cases. Therefore, we plan to investigate the physiological effects of aPP. We postulate that aPP reduces global inhomogeneity (GI) index of ventilation measured by electrical impedance tomography (EIT). Patients and methods/materials and methods: Design and setting: This is a prospective, cross-over study in a French tertiary center. Patients: We screened all patients aged > 18 years admitted in the intensive care unit with RT-PCR confirmed COVID-19 disease. We included awake spontaneously breathing patients with ARF and hypoxemia (100 < PaO2:FiO2 < 200 mmHg) requiring O2 supply. Interventions: After baseline measurements of oxygenation parameters, respiratory rate, Borg scale and 30-min EIT recordings in the supine position (SP), patients were randomized into two sequences either SP-PP, or PP-SP. At the end of each 2-h step of the sequence, measurements of oxygenation parameters, respiratory rate, Borg scale and 30-min EIT recordings were repeated. Results: Twenty patients, mean age of 60 ± 15 years, mainly male (75%) with ARF (mean PaO2:FiO2 of 135 ± 44 mmHg) were included in the study. Ten patients were randomized in the SP-PP sequence and 10 in the PP-SP sequence. Concerning GI index, we did not find any interaction between sequence and position (p = 0.053). Then, we find no significant change in GI index with comparison of each time point in the SP-PP group (baseline 74 ± 20%, end of SP 78 ± 23% and end of PP 72 ± 20%, p = 0.85) and in the PP-SP group (baseline 59 ± 14%, end of PP 59 ± 15% and end of SP 54 ± 13%, p = 0.67). PaO2/FiO2 increased at the end of PP (from 135 ± 44 at baseline to 183 ± 66 mmHg, p = 0.003), and decreased after back to SP (from 183 ± 66 mmHg at the end of PP to 130 ± 49 at the end of SP, p = 0.027). Respiratory rate decreased from 27 ± 6 at baseline to 22 ± 5 at the end of PP, (p = 0.002) and also as compared to the end of SP (23 ± 5, p = 0.003). Borg scale ranking did not differ at each time point and remained relatively low, 2.5 ± 2 at baseline, 2 ± 1.5 at end of PP and 2 ± 2 at end of SP (p = 0.647). Conclusion: Despite no reduction of inhomogeneity of ventilation, aPP was associated with improvement in respiratory parameters in COVID-19 patients with acute respiratory failure. Dyspnea assessed with Borg scale was quite low both in prone and supine positions. Compliance with ethics regulations: Yes in clinical research.

The characteristics of COVID-19-related acute respiratory distress syndrome (ARDS) regarding extravascular lung water index (EVLWi) and pulmonary vascular permeability index (PVPI) have been scarcely described, although these parameters could be related to respiratory severity and fluid management. The aim of our study is to compare EVLWi, PVPI, respiratory mechanics and hemodynamics in patients with COVID-19 vs. non-COVID-19 ARDS (Trials registration: NCT04337983). Patients and methods/materials and methods: This is an observational study conducted in three intensive care units (ICUs) from different university hospitals between March and October 2020. Sixty patients with COVID-19 ARDS monitored by transpulmonary thermodilution were consecutively included. In the non-COVID-19 group, we retrospectively selected 60 patients as in the COVID-19 group, consecutively hospitalized immediately before the first COVID-19 patient. Measurements were performed at least once a day. In all patients, we collected the transpulmonary thermodilution and mechanical ventilation variables corresponding to the maximum value of EVLWi and PVPI measured in the day. Results: Driving pressure and the respiratory system compliance was similar between COVID-19 and non-COVID-19 ARDS, at baseline as during the study period. Extravascular lung water index was higher in COVID-19 than in non-COVID-19 ARDS, both at the baseline (17 (14-21) vs. 15 (11-19) mL/kg, respectively, p = 0.03) and at the time of its maximal value during the study period (24 (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) vs. 21 (15-24) mL/kg, respectively, p = 0.01). Similar results were observed for PVPI (baseline: 3.5 (2.9-4.5) vs. 2.8 (2.2-3.7), p = 0.01; maximal values: 4.6 (3.8-5.7) vs. 4.1 (3.3-4.8), p = 0.01). In COVID-19 patients, the worst ratio between arterial oxygen partial pressure over oxygen inspired fraction was lower (81 (70-109) vs. 100 (80-124), respectively, p = 0.02) and prone positioning (50 (83%) vs. 39 (65%), p = 0.04) and ECMO (17 (28%) vs. 7 (12%), p = 0.04) were more frequently used. COVID-19 patients had lower maximal lactate level (2.0 (1.6-2.7) vs. 2.7 (2.1-4.3), p < 0.01) and lower maximal norepinephrine dose (0.51 (0.16-0.89) vs. 1 .01 (0.52-1.74), p < 0.01) than non-COVID-19 patients. Mortality was similar between two groups (57% vs. 65%, respectively, p = 0.45). Conclusion: Compared to patients with non-COVID-19 ARDS, patients with COVID-19 ARDS had similar lung mechanics, but higher EVLWi and PVPI values from the beginning of the disease. This was associated with worse oxygenation and with more prone positioning and ECMO use and is compatible with the specific lung inflammation and severe diffuse alveolar damage in COVID-19 ARDS. By contrast, patients with COVID-19 ARDS had fewer hemodynamic derangements. Mortality was not different between groups. Compliance with ethics regulations: Yes in clinical research.

Rationale: Despite a return of spontaneous circulation (ROSC), 50 to 70% of patients admitted alive to ICU after out-of-hospital cardiac arrest (OHCA) die during their ICU stay. Apart from anoxo-ischemic brain damage, many deaths result from post-resuscitation shock and multiple organ failure (MOF). So far, no study compared vasopressors in the setting of post-OHCA shock. Accordingly, we compared outcome of OHCA patients with post-resuscitation shock, according to the vasopressor used (epinephrine or norepinephrine). Patients and methods/materials and methods: We identified patients admitted after OHCA in 5 hospitals between May 2011 and May 2018. We included all consecutive adult patients with post-resuscitation shock (arterial hypotension requiring a continuous infusion of epinephrine or norepinephrine). Exclusion criteria were extracardiac cause of OHCA, refractory OHCA, treatment with extracorporeal membrane oxygenation, patients who received neither epinephrine nor norepinephrine, or patients treated with both treatments simultaneously. Primary endpoint was in-hospital allcause mortality. Secondary endpoints were cardiovascular-specific mortality (recurrent cardiac arrest or refractory shock and MOF), and unfavorable neurological status at hospital discharge (CPC 3-5). Results: Among 4918 OHCA included in the registry over the study period, 1421 were admitted in participating hospitals and developed a post-resuscitation shock. Finally, 766 patients were included, 481 (63%) treated with norepinephrine, and 285 (37%) with epinephrine. 73% of patients were male, and median age was 64 (IQR = 52-75). Median no-flow and low-flow times were 5 min and 22 min. Patients treated with epinephrine infusion had lower proportion of shockable rhythm (44% vs 57%, P < 0.001), longer lowflow time (25 vs 20 min, P < 0.0001), lower arterial pH at admission (7.17 vs 7.23, P < 0.0001). Overall, 235 patients survived to hospital discharge (31%), with favorable neurological outcome in 98% of survivors. As compared with norepinephrine, patients treated with epinephrine infusion had higher all-cause mortality (83% vs 61%, P < 0.001), higher cardiovascular-specific mortality (44% vs 11%, P < 0.001) and higher rates of unfavorable neurological outcome (85% vs 63%, P < 0.001), Fig. After multivariable adjustment for confounders (sex, age, bystander CPR, initial shockable rhythm, no-flow, low-flow, epinephrine dose during resuscitation (before ROSC), arterial pH, myocardial dysfunction, targeted temperature management, percutaneous coronary intervention), epinephrine infusion was independently associated with all-cause mortality (OR = 2.6, 95%CI = 1.4-4.7, P = 0.002), cardiovascular-specific mortality (OR = 5.5, 95%CI = 3.0-10.3, P < 0.001), and unfavorable neurological outcome (OR = 3.0, 95%CI = 1.6-5.7, P = 0.001). Similar results were found after exclusion of moribund patients (deaths < 12 h after admission), and after propensity-score analysis. Conclusion: In this population-based study, using epinephrine infusion to manage post-resuscitation shock was associated with an increased all-cause and cardiovascular-specific mortality, whatever the methodological approach. Compliance with ethics regulations: Yes in clinical research.

The post-resuscitation syndrome after out-of-hospital cardiac arrest (OHCA) results in multiple organ failure and increases both morbidity and mortality among survivors of OHCA. Acute kidney injury (AKI) occurs in 10 to 80% of patients with OHCA and is associated with long-term occurrence of chronic kidney disease as well as poor neurological outcomes and increased mortality. The previously described risk factors of AKI in patients with OHCA are not modifiable once the patient is admitted in the ICU which limits the development of interventional strategies (Reference 1). Nevertheless, the optimal mean arterial pressure (MAP) target after OHCA in terms of renal function remains to be established (Reference 2). We aimed to evaluate the effects of early MAP level on AKI incidence within the first 48 h after intensive care unit (ICU) admission in patients with OHCA Patients and methods/materials and methods: In 568 consecutive patients with OHCA, the percentage time spent below a given MAP threshold and the area below threshold (ABT), which reflects both the duration and the severity of hypotension were calculated from continuous MAP measurement. Both MAP-derived variables were calculated for different MAP thresholds (65, 75 and 85 mmHg) and time periods (within the first 6, 12 and 24 h after ICU admission). AKI was defined as stage 3 of the Acute Kidney Injury Network classification Results: Among the 568 patients included in the analysis (71% men, median age 59), 274 (48%) developed AKI within the first 48-h after ICU admission. Both ABT and percentage time were independently associated with AKI, regardless of MAP thresholds and time periods (Table 1) . Within the first 24 h, every 100 mmHg/h increase in ABT, the risk of AKI increased by 17% (OR = 1.17; 95%CI: 1.08-1.29; p < 0.01), 2% (OR = 1.02; 95%CI: 1.01-1.03; p < 0.01) and 1% (OR = 1.01; 95%CI: 1.00-1.01; p < 0.01) for MAP thresholds of 65, 75 and 85 mmHg. Every 36 min (i.e. every 10% increase in percentage time) spent under MAP thresholds of 65, 75 and 85 mmHg increased the risk of AKI by 23% (OR = 1.23; 95%CI: 1.09-1.38; p < 0.01), 13% (OR = 1.13; 95%CI: 1.05-1.21; p < 0.01) and 8% (OR = 1.08; 95%CI: 0.99-1.18; p = 0.10) Conclusion: Both severity and duration of hypotension within the first 24 h after ICU admission were independently associated with AKI for MAP thresholds ranging from 65 to 85 mmHg Rationale: SARS CoV-2-related multisystem inflammatory syndrome in children (MIS-C) has been increasingly recognized. However, the clinical features of severe cardiovascular involvement merit further accurate description. Patients and methods/materials and methods: This is an observational study conducted in a PICU in a tertiary hospital between April 1st and December 31st, 2020. Patients aged less than 18 years with SARS-CoV-2-related MIS-C and shock, according to the Centers for Disease Control and Prevention criteria were included. Demographics, clinical, biological data including inflammatory markers were collected. Results: 58 critically ill children (median age of 9 years [interquartile range (IQR) 6.9-11.7]) admitted for shock had an acute myocarditis (left ventricular ejection fraction, 44% [IQR 35-50] troponin, 217 ng/ mL [IQR 89-455]) and 15 patients exhibited a distributive component of shock. SARS-CoV-2 real-time polymerase chain reaction positive in 15 and antibody positive in 56 (96%) patients. Fever was present in all patients, as well as gastrointestinal symptoms (97%). Inflammatory markers C-reactive protein [257 mg/dL (IQR 209-339)], procalcitonin [24 ng/mL (IQR 9-55)], and serum interleukin-6 levels [131 pg/ mL (IQR 28-351)] were uniformly elevated without documented bacteria infection. At least one feature of Kawasaki disease was found in all children, but none had the typical form. Only 11 patients (19%) required invasive mechanical ventilation. Renal involvement was present in 34 patients (59%). Diastolic dysfunction was noted in 18 patients (31%) with right ventricular dysfunction in 28 (48%). 50% of patients required resuscitative fluid infusion and 42 patients (72%) needed inotropic or vasoactive drug support therapy (epinephrine, n = 15 milrinone, n = 13; dobutamine, n = 26, norepinephrine, n = 9). None of the patients required extracorporeal membrane oxygenation. Almost all children (98%) received intravenous immunoglobulin (2 g per kilogram) and 37 patients received corticosteroids. IL 1 receptor antagonist was used in three patients. All children survived and were afebrile with a full left ventricular function recovery at PICU discharge. The median length of stay in PICU was 4 days [IQR 3 -5] . Conclusion: Children with SARS-CoV-2-related MIS-C admitted at the PICU had circulatory shock including systolic and diastolic myocardial dysfunction and half of them had vasodilatory component. MIS-C with shock should be distinguished from Kawasaki disease shock syndrome, septic shock and viral myocarditis. Early recognition and aggressive management of shock and immune modulation with methyl-prednisolone and intravenous immunoglobulin are the keys of the treatment. Favourable short-term outcomes seems to be the rule. Compliance with ethics regulations: Yes in clinical research. related mortality before 1 year of age. Risk factors for SDH may be linked to the infant (male, preterm, multiple pregnancies, difficulties with feeding and crying) or the parents (i.e. psychiatric disorders, social insecurity or isolation). In 2020, French authorities ordered a large lockdown to hinder the spread of COVID-19 pandemics in France from 17 March to 10 May, then from 30 October to 15 December, immediately followed by curfew that is still underway. As parents and children had to remain isolated in their households for prolonged period, we hypothesized that this unseen social fact may affect the incidence of SBS. Patients and methods/materials and methods: We retrospectively reviewed the medical records of all patients admitted for SDH, between February 2017 and the end of January 2021, in our unit, a tertiary center where all SDH requiring Intensive Care Unit (ICU) admission and/or neurosurgical expertise are referred across the whole Ilede-France region (12.2 million inhabitants). We compared the annual hospitalization rates before (2017/02/01-2020/01/31) and during the COVID19 crisis (2020/02/01-2021/31/01) using Fisher test for proportion and log-rank test for survival analysis. We analyzed annual incidence for SBS before and during the COVID-19 crisis as well as the effect of the first (March-April 2020) and second (November-December 2020 and January 2021) lockdown on SBS rates. Results: Eighty-six patients fulfilled the criteria and were included in the analysis. From February 1st to January 31st, 24, 18 and 17 infants were, respectively, admitted in 2017- [18] [19] , and 23 infants over 2020. There was no difference in the annual prevalence before and during the COVID-19 crisis (21 vs 23, p = 0.09). However, we observed a significant difference in the SDH distribution (p = 0.005) and in the age at diagnosis (176d vs 130d, p = 0.03). Indeed, SDH prevalence was null during the first lockdown (0 vs 5, p = 0.004), whereas it dramatically increased during the second lockdown and curfew (13 vs 5.3, p = 0.03). Conclusion: COVID-19 related lockdown influenced the prevalence of SDH in the Ile-de-France region. This study provides insufficient data to precisely explain this phenomenon; however, our hypothesis is that reduced social interactions, a lack of social support, and newly arising stressors associated with the COVID-19 crisis increased the risk for SBS.

prospectively included in a physiological study; 767 non-COVID-19 ARDS from a previously published large randomized controlled trial (Express study) were used for the purpose of at least 1:2 matching. A propensity-matching based on age, severity score, oxygenation and positive end-expiratory pressure was performed using 112 COVID-19 and 273 non-COVID-19 ARDS. Results: Both groups were similar for initial oxygenation. 61.6% and 64.1% of COVID-19 and non-COVID-19 ARDS patients were still ventilated at day 7, respectively. COVID-19 patients had a higher body mass index. C RS was higher in COVID-19 than in non-COVID-19 patients at days 1 (median [IQR] , 35 [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] vs 31 [25-39] ml cmH 2 O −1 , p = 0.014) and 3 but not at day 7. C RS was correlated with PaO 2 /FiO 2 only in non-COVID-19 patients. PaO 2 /FiO 2 became lower in COVID-19 patients at days 3 and 7. VR was overall lower at day 1 in COVID-19 patients but became slightly higher at day 7. Among the 112 matched patients with COVID-19 ARDS, VR was higher in those ventilated using heat and moisture exchangers than in those using heated humidifiers. VR was higher in the 23 (21%) COVID-19 patients with a diagnosis of thromboembolic event than in those without. After adjustment on PaO 2 /FiO 2 , positive end-expiratory pressure and humidification device, C RS and VR were found not different between COVID-19 and non-COVID-19 patients at day 7. Day-28 mortality did not differ in COVID-19 and non-COVID-19 ARDS (25.9% and 29.3%, respectively, p = 0.500). Conclusion: COVID-19 ARDS initially differs from classical ARDS by a higher C RS dissociated from oxygenation and a lower VR. Oxygenation becomes lower after the first days and VR increased from day 1 to day 7 in COVID-19 patients. Multivariate analyses revealed that differences in C RS and VR were no longer existing at day 7, suggesting that initial specific features of COVID-19 ARDS disappeared during the first week of evolution due to the natural course of ARDS and the differences in ventilatory management. Rationale: The outbreak of SARS-CoV2 infection has affected nearly every country worldwide. Although the clinical spectrum of COVID-19 is variable, reports note increased thromboembolic events among hospitalized patients. However, the role of therapeutic anticoagulation (AC) remains unclear. We aimed at comparing prospectively the occurence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS), in the medical intensive care unit (ICU) of a university hospital center, treated with either standard prophylactic low molecular weight heparin or curative unfractionned heparin (UFH), using a before/after design. We also evaluated the occurence of major bleeding events and the ICU mortality in each group. Patients and methods/materials and methods: We analyzed 116 patients admitted for COVID-19 ARDS from March 17th 2020 to December 6th 2020; 56 patients in the prophylactic group (enoxaparin 4000 UI/day SC) and 60 in the therapeutic group (UFH continuous intravenous infusion with anti-factor Xa activity target between 0.3 and 0.6 UI/ml). The median age was 66 [58.8-73.3], 79% were male patients and the median SAPS II at the first day of admission was 48 [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] . The median body mass index (BMI) was 27.2 [24.0-30.6]. Results: The preliminary results show no significant difference between the two groups in terms of thromboembolic and major bleeding events (Table) . Nineteen patients (16%) presented at least one deep vein thrombosis during the ICU stay, 10 patients (8%) presented at least one pulmonary embolism, 2 patients (2%) presented a confirmed ischemic stroke, and 4 patients (3%) a limb ischemia. A total of 10 patients (9%) presented at least one major bleeding event. Treatment was shifted from preventive to curative in 29 patients (51.8%); 18 of them for thrombotic and ischemic events, 6 because of a respiratory aggravation or significant increase in D-dimers, 3 for arrhythmias, and 2 for continuous renal replacement therapy. Sixty-six patients (57%) needed renal replacement therapy and ICU mortality rate was 50%, without significant difference between groups. Conclusion: Therapeutic anticoagulation using UFH with careful antifactor Xa activity monitoring was not associated with more severe bleeding. However, we did not observe less thrombotic events, and mortality was comparable with standard prophylactic regimen. Rationale: CT scan findings are important for the diagnosis and prognosis of Covid-19. According to the literature, there are several scores based either on a semi-quantitative evaluation of the extent of lesions or on a quantitative evaluation taking into account the type and extension of associated lesions. We compared one of each category regarding their performance to estimate the disease severity. Patients and methods/materials and methods: This is a prospective study performed during a 5-month period (September 2020-January 2021) in a 16-bed ICU of a University Hospital. All patients with ARDS secondary to COVID-19 confirmed with RT-PCR and a chest CT scan were included. Two CT scores were calculated: score 1 (based on the semiquantitative estimation of the extent of pulmonary lesions) and score 2 based on the calculation of the disease extent between 6 lung areas weighed by the type of lesions (ground glass opacity, consolidation, air bronchogram and nodular opacities) (Ref 1). We assessed the discriminative power of the evaluated scores by measuring the area under the ROCurves (AUC) for the association with the need of tracheal intubation, and ICU mortality. Results: During the study period 101 patients fulfilled the inclusion criteria and were included in the study. The median age was 64 (IQR: 55-69.5) years and 72.3% were male. The majority (83.2%) was assisted with highflow nasal oxygen and 10 (9.9%) patients were intubated upon admission. In spontaneously breathing patients, failure of HFNO was observed in 24 (23.8%) patients and required secondary use of invasive mechanical ventilation. The AUC for score 1 and score 2 achieved were 0.66 (95% CI 0.556-0.782) and 0.74 (95% CI 0.636-0.849), respectively, indicating a good discrimination for the risk of intubation (Fig. 1) . Regarding the performance of these scores in predicting ICU mortality, the AUC were 0.73 (95% CI 0.632-0.835) for score 1 and 0.79 (95% CI 0.700-0.889), for score2. Both scores were well correlated (Pearson correlation coefficient of 0.71). Conclusion: Semi-quantitative and quantitative scores are well correlated and have acceptable performance in evaluating Covid-19 severity Rationale: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a poorly understood disease involving a high inflammatory status. Neutrophil extracellular traps (NETs) have been described as a new pathway to contain infectious diseases, but can also participate in the imbalance of the inflammatory and the coagulation systems. NETs could be a therapeutic target in COVID-19 patients. Patients and methods/materials and methods: Consecutive patients with SARS-CoV2-related pneumonia admitted to the intensive care unit were included in a prospective bicentric study. Neutrophil extracellular trap concentrations were quantified in whole blood samples at day-1 and day-3 by flow cytometry. The primary outcome was the association between the blood NET quantification at ICU admission and the number of days with refractory hypoxemia defined by a PaO2/FIO2 ratio ≤ 100 mmHg. Results: Among 181 patients admitted to the ICUs for acute respiratory failure related to SARS-CoV2 pneumonia, 58 were included in the analysis. Patients were 62 [54, 69] years old in median, mostly male (75.9%). The median number of days with severe hypoxemia was 4 [2, 6] days and day-28 mortality was 27.6% (n = 16). The blood level of NETs significantly decreased between day-1 and day-3 in patients who survived (59. 5 [30.5,116.6 [1.3,13 .0] to 5.5 [2.8,6 .9] p = 0.839 and 4 [1.3,13 .6] to 2.7 [1.4,4 .5] p = 0.421 for MPO+, Cit-H3+ and MPO + Cit-H3 + NETs, respectively). In multivariable negative binomial regression, the blood level of MPO + NETs was negatively associated with the number of days with severe hypoxemia within 7 days (0.84 [0.73, 0.97]), while neither Cit-H3 + NETs nor double-positive NETs were significantly associated with the primary outcome.

The whole blood level of NETs at day-1 was negatively associated with the number of days with severe hypoxemia in patients admitted to the intensive care unit for SARS-CoV2-related pneumonia. The lack of decrease in the blood level of NETs between day-1 and day-3 discriminated patients who died within day-28. Rationale: Early empirical antimicrobial treatment is frequently prescribed to critically ill patients with COVID-19, based on Surviving Sepsis Campaign guidelines. We aimed to determine the prevalence of bacterial co-infection in intubated patients with SARS-CoV-2 pneumonia, as compared to influenza pneumonia, and to characterize its microbiology and impact on clinical outcomes. Patients and methods/materials and methods: Multicenter retrospective European cohort performed in 36 ICUs. All adult patients receiving invasive mechanical ventilation > 48 h were eligible if they had SARS-CoV-2 or influenza pneumonia at ICU admission. Bacterial co-infection was defined by bacterial isolation, within 48 h after intubation, in endotracheal aspirates, bronchoalveolar lavage, or blood cultures, or a positive pneumococcal or legionella urinary antigen test. Results: 1050 patients were included (568 in SARS-CoV-2 and 482 in influenza groups). The prevalence of bacterial co-infection was significantly lower in patients with SARS-CoV-2 pneumonia as compared to patients with influenza pneumonia (8.6 vs 32.7%, unadjusted odds ratio (OR) 0.20 (95% confidence interval (CI) 0.13 to 0.28), adjusted OR 0.21 (95% CI 0.14 to 0.30), p < 0.0001). Gram-positive cocci were responsible for 55% and 70% of co-infection in patients with SARS-CoV-2 and influenza pneumonia, respectively. Bacterial co-infection was associated with increased adjusted hazard ratio for 28-day mortality in patients with SARS-CoV-2 pneumonia (1.71 (95% CI 1.09 to 2.68), p = 0.019). Conclusion: Bacterial co-infection within 48 h after intubation is significantly less frequent in patients with SARS-CoV-2 pneumonia as compared to patients with influenza pneumonia, and is associated with increased risk for 28-day mortality only in patients with SARS-CoV-2 pneumonia. (On behalf of the coVAPid study group) Compliance with ethics regulations: Yes in clinical research.

Rationale: SARS-CoV-2-related pneumonia may lead to different severity of acute lung injury and different CT scans patterns of the lung. Evolution to lung fibrosis has been suggested, but data are lacking on the usefulness of lung biomarkers in differentiating patients according to their clinical and radiological presentation. Patients and methods/materials and methods: Consecutive patients admitted to a tertiary medical ICU for SARS-CoV-2-related pneumonia were included in the analysis. Influenza-related pneumonia ICU patients were included as controls. Fibrosis biomarkers were assessed on sera of these patients stored were analyzed using ELISA kits (TNF-alpha, RANTES, PDGF, MIP1-alpha, MIP1-beta, MCP1, IP10, IL13, IL9, IL8, IL6, IL4, IL1ra, IFN-gamma, G-CSF, eotaxin, FGF). Kazerroni's radiological score has been evaluated by two radiologists, collecting spread of honeycomb and groun glass opacities (ranging from 0 to 5 for each). Descriptive statistics are provided. Results: 81 patients were included in the analysis (70 SARS-CoV-2 and 11 influenza) (median age 64 [57,72], 80.2% male). No difference in terms of demographics was observed between influenza and SARS-CoV-2 patients. SAPS2 score was similar in both groups as well as respiratory SOFA score while total SOFA score was higher in influenza as compared to SARS-CoV-2 patients (10 [6,11] vs. 4 [3,6]). Overall day-28 mortality was 30.4% (20 vs. 32.2% in influenza and SARS-CoV-2 patients, p = 0.686). The total radiological score was 4.6 [3.2,5.8], higher in SARS-CoV-2 patients (3 [1, 3.8] vs. 5.2 [3.4, 6], p = 0.008). No correlation was observed between the level of fibrosis biomarkers and the total radiological score nor with the honeycomb or ground glass sub-scores. Biomarkers levels were not different in patients with or without restrictive lung-function at 6-months. Conclusion: While the quantification of fibrosis on CT scan of the lung was higher in SARS-CoV-2 patients than in influenza patients admitted to the ICU, we did not observe any difference in the levels of fibrosis biomarkers allowing a better discrimination of patients. Rationale: COVID-19 displays distinct characteristics that suggest a unique pathogenesis. The objective of this study was to compare biomarkers of coagulopathy and outcomes in COVID-19 and non-COVID-19 patients with severe pneumonia. Patients and methods/materials and methods: In a prospective study, were included non-immune-compromised patients with severe pneumonia (at least 2 criteria of the quick-SOFA score and/or need for mechanical ventilation or vasopressors). COVID-19 patients were all tested positive for SARS-CoV-2 by reverse transcriptase-polymerase chain reaction, and non-COVID-19 were enrolled before the pandemic started. Clinical and biological characteristics (including plasma biomarkers of coagulopathy measured with a Luminex assay) were compared. Results: Thirty-six non-COVID-19 and 27 COVID-19 were included, most of them requiring ICU (respectively, 89% and 100%). At similar baseline severity (PaO2/FiO2 and SOFA score), COVID-19 patients required mechanical ventilation (MV) for significantly longer than non-COVID-19 patients (15 days, IQR = 7-22 vs. 4 days, IQR = 0-14.5; p = 0.0049) and more frequently developed venous thrombotic complications (7 (26%) vs. 2 (6%); p = 0.0312). Compared to non-COVID-19 patients, COVID-19 patients displayed a unique plasma signature of coagulopathy-associated biomarkers with significantly higher plasma concentrations of soluble vascular cell adhesion molecule 1 (sVCAM1) (5739 ± 3293 vs. 3700 ± 2124 ng/ml; p = 0.009), but lower levels of D-dimers, von Willebrand factor A2 (vWF-A2), soluble intercellular adhesion molecule 1 (sICAM1), soluble triggering receptor expressed on myeloid cells 1 (sTREM1), vascular endothelial growth factor (VEGF), and P-selectin (all with p < 0.05). In addition, we observed a non-significant difference for plasma levels of soluble thrombomodulin (sTM), tissue factor pathway inhibitor (TFPI), u-plasminogen activator (uPA), C-X-C motif chemokine ligand (CXCL)4, platelet derived growth factor (PDGF)-AA, PDGF-AB/BB. Principal component analysis identified two main patterns, with a clear distinction between non-COVID-19 and COVID-19 patients. In multivariable linear regression, sVCAM1 was independently associated with a longer duration of MV (p = 0.027), after adjustment for age, COVID-19 status, SOFA score and prehospital anticoagulation therapy. In addition, multivariable analysis showed that COVID-19 status was independently associated with sVCAM1. Finally, we identified close correlations between sVCAM1 and some features of COVID-19 immune dysregulation (i.e. CXCL10, GM-CSF, and IL-10).

Conclusion: Compared to non-COVID-19 patients, COVID-19 patients displayed a peculiar coagulopathy signature with significantly higher concentrations of sVCAM1, but lower concentrations of some classical biomarkers of coagulation or platelet activation. This could result into a higher level of immune-mediated endotheliopathy. sVCAM1 was independently associated with the duration of MV and could represent a major protagonist in driving coagulopathy and lung injury. VCAM-1, or the immune response driving its expression, could be considered as promising therapeutic pathway. We aimed at determining the frequency and risk-factors of fungal infections in ICU patients admitted with severe Covid-19 and requiring mechanical ventilation. Patients and methods/materials and methods: This is a prospective study conducted between September 2020 to January 2021 in a 16-bed ICU of a University Hospital. All patients with ARDS secondary to COVID-19 confirmed with RT-PCR, an age older than 18 years, with an ICU stay longer than 24 h were included. They were divided into two groups according to the occurence of fungal subinfection (F (+) and F (−)). We recorded their baseline characteristics, clinical, radiologic and biological variables on ICU admission, and their treatment during the ICU stay. We recorded ICU occurence of fungal infection at admission or during the ICU stay, and the ICU outcome. Results: During the study period, 137 patients with Covid-ARDS were admitted in the ICU. The median age was 64 years, 72.3% were males. The most frequent comorbidity was hypertension (48.9%), followed by diabetes (41.6%). For the ventilatory management, patients were assisted with both non-invasive ventilation (HFNC (79.6%) and NIV (4.4%)) and mechanical invasive ventilation (11.7%). Fungal subinfection and invasive candidiasis were found in 27.7% and 26.2% patients, respectively. Sites identified were mainly respiratory (65.8%) and urinary (57.9%). The most frequent species were C. albicans (68%) followed by C. tropicalis (42.1%). Most of patients received caspofungin (92.1%). The mortality rate was 35.8%. Comparison between infected and non-infected groups showed significant difference in their baseline characteristics in particular for diabetes (p = 0.045). The use of arterial catheter (p < 0.001), central venous catheter (p < 0.001), dialysis (p < 0.001), parenteral nutrition (p < 0.001), broad-spectrum antibiotics (p < 0.001), invasive mechanical ventilation (p < 0.001) were statistically different. The occurrence of septic shock (p < 0.001), ventilator-acquired pneumonia (p < 0.001), acute kidney injury (p < 0.001) were all significantly more frequent in patients who developed fungal infection. Rationale: Invasive pulmonary aspergillosis (IPA) in intensive care unit patients is a major concern, in particular for those with acute respiratory distress syndrome (ARDS). As observed previously for influenza-associated ARDS, the SARS-CoV-2 pandemic has shown a high proportion of COVID-19 patients with ARDS to be at risk of developing invasive fungal diseases. The shared clinical, biological, and radiological characteristics of both COVID-19-and influenza-associated invasive pulmonary aspergillosis (IPA) are still little explored. We aimed at exploring similarities and differences between COVID-19-associated pulmonary aspergillosis (CAPA) and influenza-associated pulmonary aspergillosis (IAPA) Patients and methods/materials and methods: In a monocentric cohort study, we included 120 patients, 71 with influenza and 49 with COVID-19 associated ARDS. IPA diagnosis was made in accordance with the newly published definitions of CAPA and IAPA (1) (2) . Results: Among the 120 ARDS patients, we observed equivalent prevalence of IPA in influenza and COVID-19 populations: 17 IAPA (23.9%) and 10 CAPA (20.4%). There were no significant differences in demographic or admission characteristics between patients with and without IPA. Kaplan-Meier curves showed significantly higher 90-day mortality for overall IPA patients (p = 0.032), whereas mortality did not differ between CAPA and IAPA patients. The duration of mechanical ventilation was higher for patients with IPA (23 days [IQR 17-40] than those without (17 days [IQR 9-25], p = 0.038). Patients with COVID-19 and influenza associated ARDS treated with corticosteroids were more likely to develop IPA. Radiological findings of IPA in both populations using the new criteria increased sensitivity, but with still poor specificity. Nonetheless, we observed differences between IAPA and CAPA with a higher proportion of features suggestive of IPA in IAPA patients. Conclusion: ICU patients presenting with ARDS during COVID-19 are very similar to those with severe influenza pneumonia in terms of the prevalence of IPA and outcome. The dramatic consequences on the patients' prognosis emphasize the need for a better awareness in these particular populations. Future larger prospective studies may help in designing the most well-adapted personalized management to prevent IPA, which represents a high burden of death in severe COVID-19 and Influenza pneumonia.

Cumulative 90-day mortality from admission to the intensive care unit in the whole population and among CAPA and IAPA patients Rationale: Patients with SARS-CoV-2 infection are at higher risk for ventilator-associated pneumonia (VAP) . No study has evaluated the relationship between VAP and mortality in this population, neither compared this relationship between SARS-CoV-2 patients and other populations. The aim of this study is to determine whether SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, modify the relationship between VAP and mortality. Patients and methods/materials and methods: Planned ancillary analysis of a multicenter retrospective European cohort. VAP was diagnosed using clinical, radiological and quantitative microbiological criteria. Univariable and multivariable marginal Cox's regression models, with cause-specific hazard for duration of mechanical ventilation and ICU stay, were used to compare outcomes between study groups. Extubation, and ICU discharge alive were considered as events of interest, and mortality as competing event.

Results: Of 1576 included patients, 568 were SARS-CoV-2 pneumonia, 482 influenza pneumonia, and 526 no evidence of viral infection at ICU admission. VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 (adjusted HR 1.70 (95% CI 1.16-2.47), p = 0.006), and influenza groups (1.75 (1.03-3.02), p = 0.045), but not in the no viral infection group (1.07 (0.64-1.78), p = 0.79). VAP was associated with significantly longer duration of mechanical ventilation in the SARS-CoV-2 group, but not in the influenza or no viral infection groups. VAP was associated with significantly longer duration of ICU stay in the 3 study groups. No significant difference was found in heterogeneity of outcomes related to VAP between the 3 groups. Conclusion: VAP was associated with significantly increased 28-day mortality rate in SARS-CoV-2 patients. However, SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, did not significantly modify the relationship between VAP and 28-day mortality. On behalf of the coVAPid study group. Rationale: Mortality in most severe form of ARDS is around 60%. EOLIA suggested that ECMO could be effective in some of these patients. Our objective was to assess the incidence of patients who reached EOLIA criteria, as well as their characteristics and outcome in a large cohort of moderate-to-severe ARDS patients. Patients and methods/materials and methods: Ancillary study from a cohort including 11 French intensive care units (ICU) between 1994 and 2012 (ref ). Patients with moderate or severe ARDS were included and routinely assessed using trans-esophageal echocardiography within the first 3 days following the diagnosis. All were ventilated with a lung-protective strategy. Patients with a PaO2/FiO2 < 80 mmHg with a PEEP of at least 6 cmH2O, or a pH < 7.25 and PaCO2 > 60 mmHg with a respiratory rate of at list 35 cycles/min, despite prone positionning or NO inhalation, were identified (group 1) and compared to the other patients (group 2 . Prone position and NO were more frequently used (82% and 57%, respectively). Incidence of acute core pulmonale and severe right ventricule (RV) dilatation (RV size > LV size) was higher in group 1 (42% versus 20%, p < 0.001 and 24% versus 10%, p < 0.001, respectively). In-ICU mortality was higher in group 1, while not statistically different from group 2 (46% versus 35%, p = 0.11). Among the 31 deceased patients in group 1, 3 died from hypoxic cardiac arrest, 20 from a multi-organ failure, and 5 from ECMO complication. In multivariate analysis, factors associated with mortality in group 1 were severe RV dilatation and driving pressure. Conclusion: In a non-selected and large cohort of moderate-to-severe ARDS patients, only 9% of patients could be considered for VV ECMO according to the Eolia criteria. They demonstrated higher driving pressure and more RV failure. In-ICU mortality was not significantly different from the rest of the cohort. Further studies are needed to determine among these patients those who will really benefit from VV ECMO. Rationale: The combination of veno-venous (VV)-extracorporeal membrane oxygenation (ECMO) and prone prositionning (PP) has not been fully evaluated and it is still unclear which patients are more likely to benefit from the combination of these two adjunct therapies.

Our objective was to report the characteristics and outcomes of the patients proned during (ECMO) for severe acute respiratory distress syndrome (ARDS) and to identify a lung-computed tomography pattern associated with an improvement of the static compliance of the respiratory system after proning on ECMO. Patients and methods/materials and methods: This is a retrospective, single-center study over 8 years in a 26-bed intensive care unit tertiary center. A propensity-score (PS)-matched analysis was performed to compare patients who had prone positioning (PP) during ECMO ("PP ECMO") and those who did not ("No PP ECMO"). An increase in the static compliance by ≥ 3 mL/cmH2O after 16 h of PP defined a PP-responder. The primary outcome was the time to successful ECMO weaning within the 90 days following inclusion, with death as a competing risk. Assessment of lung aeration before PP with quantitative computed tomography was performed. Rationale: Over the past decades, to limit the risk of ventilation-induced lung injury (VILI), tidal volume control has been the cornerstone of protective ventilation in acute respiratory distress syndrome (ARDS). However, recent evidence suggests that VILI may instead be related to inappropriate driving pressure. The aim of our study was to compare, in ARDS patients, the effect of driving pressure-guided ventilation versus tidal volume-guided ventilation on the mechanical power, a surrogate for the risk of VILI. Patients and methods/materials and methods: We prospectively included adult patients with moderate-to-severe ARDS. PEEP was set by attending physician. Tidal volume was first adjusted to target 6 ml/kg of predicted body weight (PBW) and subsequently modified within a range from 4 to 10 ml/kg PBW to target a driving pressure between 12 and 14 cmH2O. The respiratory rate was then adjusted within a range from 12 to 40 breaths/min until EtCO2 returned to its baseline value. Respiratory mechanics was assessed during each step in order to compute mechanical power. Results: 24 patients were included between December 2019 and January 2021. The basal driving pressure during tidal volume-guided ventilation was already within the target range of driving pressure-guided ventilation in 5 (21%) patients, above in 3 (12%) and below in 16 (67%). The change from tidal volume-to driving pressure-guided ventilation was accompanied by an overall increase in driving pressure from 9. Rationale: Various positive end-expiratory pressure (PEEP) titration strategies have been proposed to optimize ventilation in patients with acute respiratory distress syndrome (ARDS). This study aimed to compare four different strategies based on electrical impedance tomography (EIT) and respiratory mechanics with or without esophageal pressure measurement, and to assess the relationship between the determined PEEP levels and the potential for lung recruitment (PLR). Patients and methods/materials and methods: 19 moderate-tosevere ARDS patients were enrolled in this monocentric study. Airway and esophageal pressure and EIT signal were continuously recorded during the study protocol. First, gas exchange and respiratory mechanics were assessed at PEEP 15 and 5 cmH2O. Then, a decremental PEEP trial from PEEP 20 to 5 cmH2O was performed. Optimal PEEP levels determined by the following strategies were determined as the one allowing to obtain: (1) plateau pressure < 28 cmH2O (Express);

(2) tele-expiratory transpulmonary pressure > 0 cmH2O (PLe > 0); (3) center of ventilation closest to 0.5 (CoV) and (4) intersection of the overdistension and lung collapse curves (LC-OD) computed by EIT. PLR between PEEP 5 and 15 cmH2O was assessed using EIT-based recruitment-to-inflation ratio (R/IEIT), computed with the difference in end-expiratory lung volume (EELV) between the two PEEP levels estimated by EIT. Inspiratory transpulmonary plateau pressure (PLi) was calculated using the lung-to-respiratory system elastance ratio. The study population was divided in subgroups according to median values of PaO2/FiO2 and respiratory system compliance (CRS) at PEEP 5 cmH2O and R/IEIT. Rationale: Whether sepsis-induced diaphragm dysfunction may improve despite the exposure of mechanical ventilation in critically ill patients is unclear. This study aims at describing the diaphragm function time course of mechanically ventilated patients depending on the presence of sepsis at the time of intubation. Patients and methods/materials and methods: Bicentric retrospective observational study of mechanically ventilated patients in whom diaphragm function was assessed two times (within the 24 h after intubation and at recovery when patients could be switched to pressure support mode) by measuring the drop in endotracheal pressure induced by bilateral anterior phrenic nerve stimulation (Ptr, stim). In a subgroup of patients, diaphragm ultrasound was performed to measure the right hemidiaphragm thickness. Sepsis was defined according to the Sepsis-3 international guidelines. Results: Ninety-two patients were enrolled in the study. Sepsis upon intubation was present in 51 (55%) patients, among them 40/51 (78%) had a microbiological evidence of infection. In septic patients, primary reason for ventilation was acute respiratory failure related to pneumonia (36/51; 71%). In non-septic patients, main reasons for ventilation were acute respiratory failure not related to pneumonia (16/41; 39%), coma (13/41; 32%) and cardiac arrest (6/41; 15%). Ptr, stim within 24 h after intubation was lower in septic patients as compared to non-septic patients: 6.3 (4.9-8.7) cmH2O vs. 9.8 (7.0-14.2) cmH2O (p = 0.004), respectively. The median (interquartile, IQR) duration of mechanical ventilation between first and second diaphragm evaluation was 4 (2-6) days in septic patients and 3 (2-4) days in non-septic patients (p = 0.07). Between two measurements, Ptr, stim significantly improved in septic patients, from 6.3 (4.9-8.7) to 7.9 (6.7-11.2) (p = 0.03), whereas it did not change in non-septic patients from 9.8 (7-14.2) to 7.3 (4.5-12.8) (p = 0.20). The change in Ptr, stim was +19% (−13-61) in septic patients and −7% (−40-12) in non-septic patients (p = 0.005). In a sub-group of patients with ultrasound measurements (58/92; 63%), end-expiratory diaphragm thickness significantly decreased in septic patients (232 (177-269) to 202 (155-231) (p = 0.04)), whereas it did not change in non-septic patients (213 (183-253) to 187 (160-224) (p = 0.16)). Conclusion: Septic patients were associated with a significant increase in diaphragm function that was not observed in non-septic patients. Compliance with ethics regulations: Yes in clinical research.

Rationale: As compared to direct extubation, reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial (SBT) may be associated with lower reintubation rates (1). Whereas physiological explanation leading to these clinical effects remains unclear, we hypothesized that could be driven by alveolar recruitment induced by reconnection to mechanical ventilation. Our primary aim was to compare end-expiratory lung volume (EELV) measurements during the SBT and until 1 h after reconnection to mechanical ventilation. Patients and methods/materials and methods: This is an ancillary study of a multicenter randomized controlled trial comparing T-piece versus pressure-support (pressure support of 8 cmH 2 O without positive end-expiratory pressure) for SBT before extubation. All patients included were at high-risk of extubation failure, i.e. intubated at least 24 h and older than 65 years or having underlying chronic cardiac or lung disease. This physiological study was performed in a single-center participating in the trial. EELV was measured using the nitrogen washin-washout technique before SBT under mechanical ventilation, at the end of the SBT, and then 10 min, and 1 h after reconnection to mechanical ventilation. SBT was performed for around 1 h using T-piece or low pressure-support levels according to the randomization. Results: Sixteen SBTs performed in 13 patients were analyzed, including 9 (56%) SBTs performed using T-piece and 7 (44%) using pressure-support. SBT Rationale: During the COVID-19 pandemia, many patients in severe ARDS required transport to a tertiary medical center due to capacity issues or lack of advanced critical care therapies. Usually patients are transported only in supine position by emergency medical services and may require the implantation of ECMO before transportation. However, many patients improving their pO2/FiO2 in prone position would not require the implantation of ECMO if we could transport the patient in prone position. Patients and methods/materials and methods: Patients with a pO2/FiO2 in supine position between 60 and 80 due to severe ARDS with appropriate ventilatory settings and requiring transport to our medical ICU (Amiens university hospital) were prospectively screened.

Patients with a pO2/FiO2 > 70 mmHg in prone position and without high posology of norepinephrine and not indicated for immediate ECMO implantation were included. Transports were performed by a dedicated team (a nurse, an emergency and a critical care physicians) previously trained to a specific procedure for prone position transport in ambulance and/or helicopter. , viral (n = 31), fungal (n = 8), tuberculosis (n = 1). Other etiologies were the following: disease-related infiltration (n = 3), diffuse alveolar hemorrhage (n = 2) and drug-induced pulmonary toxicity (n = 1). Ninety (87%) patients received antibiotics with a median duration of 6 [2-13] days before BAL. Bacteriologic yield was significantly higher when patients did not receive antibiotics before BAL or when antibiotics duration was less than 2 days (60% vs 34%, P = 0.009). BAL led to a modification of treatment in 60 (58%) patients: broadening of antimicrobial spectrum (16%), narrowing of antimicrobial spectrum (41%), toxic drug withdrawal (2%). Deterioration of respiratory status occurred after BAL in 28 patients (51%) spontaneously breathing patients and in 4 (9%) intubated patients (P < 0.001). Intubation was required after BAL in 14 (25%) patients. Worsening of respiratory status was also more frequent in patients admitted more than 2 days after first symptoms' onset than in those admitted earlier (40% vs 20%, P = 0.029). Conclusion: BAL represents an important tool in the diagnostic strategy of ARF in HM patients. However, safety issues should be taken into account in the evaluation of benefit-to-risk balance in spontaneously breathing patients. Early realization of BAL after respiratory symptoms onset and antibiotics initiation seems to be associated with better diagnostic yield and safety. Compliance with ethics regulations: Yes in clinical research. Rationale: High-flow nasal cannula (HFNC) is a non-invasive respiratory support mainly indicated in hypoxemic patients. HFNC reduces respiratory effort in this population. Experimental data suggest an increase in respiratory drive in patients with sepsis and septic shock. We aimed to assess the effect of HFNC on respiratory drive and effort in this population.

Patients and methods/materials and methods: 25 non-intubated patients admitted to 3 intensive care units with a diagnosis of sepsis or septic shock were enrolled. Patients' characteristics (age, BMI) and sepsis severity (SOFA score and lactate plasmatic concentration at enrollment) were assessed. Study protocol was composed of 3 consecutive steps of 30 min: (1) low-flow oxygen (LFO) device at baseline, (2) HFNC, (3) LFO post-HFNC. Gas exchange, esophageal pressure (Pes) and electrical impedance tomography (EIT) were recorded toward the end of each step. Respiratory effort was measured as the esophageal negative pressure swing (ΔPes). Respiratory drive was measured as the inspiratory esophageal pressure change during the first 500 ms from start of inspiration (P0.5). Finally, dynamic respiratory system compliance was calculated as the tidal volume (measured by EIT) divided by ΔPes (VT/ΔPes). To assess predictors of effort improvement associated with HFNC, correlations between ΔPes improvement between steps (1) and (2) and physiological variables at baseline were performed. Rationale: Acute respiratory failure (ARF) in immunocompromised patients remains the leading cause of admission in Intensive Care Unit (ICU), with high mortality. Among strategies that were believed to influence outcome of critically ill immunocompromised patients, choice of the initial oxygenation modality remains debated. Despite promising results in physiological studies, a recent RCT failed to demonstrate any benefit of high-flow nasal oxygen (HFNP) in this setting (1) . The study aims to assess evolutionary profiles of oxygenation strategy and their influence on outcome. Patients and methods/materials and methods: This study is a post hoc analysis of a multicenter multinational dataset (2) using Group-Based Trajectory Modeling, a non-parametric longitudinal clustering technique derived from k-mean. Results: A total of 1547 patients were included. Rate of mechanical ventilation (MV) at day 1 was 24.3% (n = 376) while, respectively, 50.3% (n = 778), 11.4% (n = 177) and 14% (n = 216) of patients received standard oxygen therapy, high-flow nasal oxygen and noninvasive mechanical ventilation. Three clusters of oxygenation profiles were identified. Cluster A (limited need for MV and a good outcome) Rationale: Early use of mechanical ventilation is the gold standard approach for COVID-19 patients with hypoxemic acute respiratory distress. Massive influx of patients did not allow a maximalist approach for all patients. Due to their co-morbidities, advanced age or lack of space in intensive care units, many patients received a "Do not intubate" order (DNI). Few data were available concerning management of these patients. The objective of this study was to compare the mortality of patients with severe Covid-19 managed with high-flow nasal cannula (HFNC) and CPAP as ceiling therapy and patients scheduled to receive invasive mechanical ventilation if previous support failure. Patients and methods/materials and methods: Data from 4 centers across 3 European countries were collected. All consecutive patients with a severe COVID-19 with high oxygeno-dependance (HFNC or PaO2/FiO2 < 300 or SpO2 < 94% with O2 flow 10L/min) were included. We emulated a hypothetical target trial where patients with an only non-invasive ventilation strategy were compared to patients who were treated with a strategy including intubation if necessary. We set up a propensity score for the probability of belonging to the "DNI" and an inverse probability of treatment weighting to remove the confounding by indication. A logistic regression model was fitted with the variables that informed to decision to classify patients in the "able to intubate" or "DNI" group the variables that are potentially associated with mortality. Results: 400 patients were included in our analysis. Briefly, 270 (67.5%) were classified as eligible to intubation with invasive mechanical ventilation and 130 (32.5%) were classified as "DNI". In the unadjusted analyses, 72 (27%) patients eligible to intubation died compared to 77 (59%). The adjusted risk ratio to die for patients eligible to intubation was 0.803 (95% CI 0.444 to 1.453) compared to the do not intubate patients. The effect sizes for the differences between the two groups in the important prognostic factors were strongly reduced by inverse probability of treatment weighting. However, there was still a small difference for age. The median length of stay in ICU was similar between the groups for survivors (18 (10-31) Rationale: In the course of COVID-19-related acute hypoxemic respiratory failure (AHRF), nasal high-flow (NHF) has been broadly used as first-line ventilatory support. We evaluated the ROX index (1), defined as the ratio of SpO2/FiO2 to respiratory rate (RR), as an early marker of NHF response and a potential predictor of its failure in the ICU setting. Patients and methods/materials and methods: In this single-center retrospective study, all adults admitted to the ICU during the peak of the COVID-19 outbreak were screened for eligibility. Participants presenting with AHRF related to COVID-19 infection and treated with NHF as first-line ventilatory support were included. Main variables were collected from admission until NHF weaning or intubation which defined NHF failure. The ROX index was recorded several times daily. Statistical analysis included association between early response to NHF (i.e. the latest value of the ROX index within the first 4 h after NHF initiation (ROX-H0H4)) and risk for intubation (Cox's model for patients still at risk at H4). Maximization of the Youden's index led to an optimal cutoff of the ROX index to predict NHF outcome. Results: Sixty-two patients were included. Median age was 55 (IQR 48-63). Participants presented with profound hypoxemia at NHF initiation (median FiO2 and SpO2 were 0.8 (IQR 0.6-1.0) and 96% (IQR 94-98), respectively) with median RR of 25 breaths per minute (IQR 21-32). Twenty-one patients (34%) succeeded on NHF and were discharged from ICU, whereas 39 (63%) required MV and 2 (3%) died while under NHF because of do-not-intubate order. Overall ICU mortality was 17%. Median time to intubation was 10 h (95% CI 7-57). Kaplan-Meier estimates of risk for intubation (N = 60) is illustrated in Fig. Median ROX-H0H4 was 5.4 (IQR 3.9-7.1). In Cox's model, ROX-H0H4 ≥ 5.37 was significantly associated with a lower risk for intubation after H4 (HR 0.59, 95% CI 0.41-0.84; P = 0.0037) for patients still at risk (N = 45). ROX-H0H4 demonstrated a good discrimination (area under the ROC curve 0.75, 95% CI 0.60-0.90; sensitivity 0.66, specificity 0.83). Conclusion: In COVID-19-related AHRF, use of NHF as first-line ventilatory support may have obviated the need for intubation in up to a third of cases. The ROX index could be used to identify patients who will fail on NHF, in order not to further delay intubation. 31-68, p = 0.007) and a higher rate of acute kidney injury (6/6 (100%) vs 2/11 (18%), p = 0.002) but similar age, sex ratio, haemodynamic or respiratory failure rates at admission. Gut microbiota α-diversity was lower for patients colonized with ESBL-producing K. pneumoniae than ESBL-producing E. coli both regarding Shannon and Simpson index (p = 0.02 and p = 0.007, respectively), but β-diversity was not different (p = 0.44). We did not find any difference in gut mycobiota α-or β-diversity between patients colonized with ESBL-producing K. pneumoniae and ESBL-producing E. coli.

The composition of the gut microbiota differs between ESBL-producing E. coli and ESBL-producing K. pneumoniae faecal carriers. These data suggest that bacterial specie, in addition to the mechanism of resistance, should probably be taken into account when investigating the role of gut microbiota in resistance to gut colonization with ESBL-E. Compliance with ethics regulations: Yes in clinical research. Rationale: Cirrhosis is a chronic liver disease responsible for high mortality and morbidity worldwide. Liver cirrhosis induces a large range of hemodynamic disorders including peripheral vasodilatation, decreased blood pressure and increased cardiac output. Physiological studies using forearm vessel occlusion plethysmography on mediumsized arteries have reported increased vascular reactivity in cirrhotic patients when compared to non-cirrhotic patients, vascular hyperactivity being more pronounced at the advanced stages of the disease. However, microvascular reactivity of cirrhotic patients in the context of sepsis has poorly been investigated. In this study, we aimed to compare skin microvascular function in cirrhotic and non-cirrhotic patients in the context of septic shock. Patients and methods/materials and methods: During an 18-month period, we prospectively included adult patients admitted in our ICU for septic shock with and without cirrhosis. After initial resuscitation, global hemodynamic parameters were recorded and skin microvascular reactivity to local acetylcholine iontophoresis was measured. Acetylcholine acts as an endothelium-dependent vasodilator which induces the production of nitric oxide (NO) after stimulation of the endothelial NO-Synthase. Results: Thirty patients with septic shock were included (60% male), 10 with cirrhosis and 20 without, with a median age of 61 [54-74] years. Cirrhotic patients were mainly classed Child-Pugh C (80%) and all of them had ascites. SOFA score and ICU mortality of cirrhotic patients was higher compared to non-cirrhotic patients, respectively (6.5 [5. Rationale: Nosocomial pneumonia is one of the leading causes of healthcare consumption and mortality in critically ill patients. The prevalence of multidrug resistance infection is increasing in intensive care unit. Classic antimicrobial agents used to treat these infections are becoming ineffective. Tigecycline has a bacteriostatic activity against multidrug-resistant germs. It is a glycylcycline antibiotic with a broad-spectrum activity against nearly all Gram-positive and Gramnegative germs. It is indicated for treatment of skin infection, complicated intra-abdominal infections and community-acquired bacterial pneumonia. We aimed to compare the efficiency of high dose and standard dose of tigecycline in the outcomes of patients with nosocomial pneumonia Patients and methods/materials and methods: We conducted a retrospective study between 2018 and 2020 in the intensive care of a teaching hospital. Patients with nosocomial pneumonia and treated with tigecycline at standard dose (100 mg per day) or at a high dose (200 mg per day) were included in the analysis. Biological and clinical outcomes were investigated. The primary outcome was mortality. The secondary outcomes were clinical response rate, duration of mechanical ventilation, length of stay and adverse events. Results: A total of 73 patients were included. Acinetobacter baumannii (64%), Klebsiella pneumonia carbapenem-resistant (22%) and Escherichia coli (3%) were the main isolated pathogens. Thirty-one patients received standard dose. The duration of tigecycline treatment was 8 ± 3 days in standard-dose group and 9 ± 4 days in the high-dose group (p = 0.08). The evolution of C-reactive protein and white blood cells was similar in both groups. The standard-dose group had a clinical cure rate of 61% versus 50% in the other group (p = 0.238). Superinfection rate was 19% in the standard-dose group versus 18% in high-dose group (p = 0.98). The length of stay was significantly higher in standard-dose group (34 ± 29 days versus 24 ± 12 days p = 0.02).

Although not statistically significant, mortality was higher in the standard-dose group than the high-dose one (77% vs 55%, p = 0.08 Rationale: Plasma exchange therapy (PET) is used in a variety of severe conditions including autoimmune diseases. The aim of the present study was to assess the incidence of PET-related adverse events in patients treated in the intensive care unit (ICU). Patients and methods/materials and methods: All data of adults admitted to ICU of 4 French university hospitals between January 2015 and December 2019 who received PET (at least one session) were retrospectively collected from medical and procedure records. Groups with and without PET-related complications were compared using univariate and multivariate analyses. Results: During the study period, 711 PET sessions were performed on 124 patients. Most common diseases treated by PET were: thrombotic thrombocytopenic purpura (n = 32, 26%), myasthenia gravis (n = 25, 20%), acute polyradiculoneuropathy (n = 12, 10%), ANCA-associated vasculitis (n = 8, 6%), catastrophic antiphospholipid syndrome (n = 9, 7%), acute disseminated encephalomyelitis (n = 4, 3%), humoral graft rejection (n = 4, 3%), and other (n = 25, 20% Rationale: The role of gut microbiota (including both the bacterial kingdom: bacteriobiota and the fungal one: mycobiota) in human health and diseases has been investigated in the last decade thanks to the development of next-generation sequencing. Evidence is increasing that it can be a key player in numerous chronic diseases. Nevertheless, its impact on the prognosis of critically ill patients has been poorly investigated so far. The aim of this study is to assess the predictive value of gut microbiota (both bacteriobiota and mycobiota) for day 28 mortality in critically ill patients. Rationale: Mortality with rhabdomyolysis-associated acute kidney injury can be up to 80%. Experimental data from mouse models of rhabdomyolysis showed that paracetamol reduces the expected increase in serum creatinine level [1] . We aimed to assess the association between paracetamol use and the need for starting renal replacement therapy (RRT).

We conducted a propensity score-matched cohort study in a 1136-bed, public, university affiliated and teaching hospital. All patients with serum creatine phosphokinase (CK) level > 5000 IU/L between January 1, 2008 and December 31, 2017 were included. A propensity score was calculated for each included patient by using multivariable logistic regression and all available baseline characteristics. The main outcome was the incidence of RRT initiation from day 1 to day 28 in the propensity score-matched cohort between patients exposed and unexposed to paracetamol. Results: Over the study period, 1065 patients with at least one CK level > 5000 IU/L were included; 40 (3.8%) had at least one RRT session. Among the 343 matched pairs, 10 (2.9%) exposed and 24 (7.0%) unexposed patients underwent RRT before day 28 (P = 0.021). Primary time-to-event analysis showed that the exposure to paracetamol was significantly associated with reduced absolute risk of RRT: absolute risk difference = − 3.18% (95% CI: − 5.23 to − 1.20, P = 0.001) (Fig. 1 ).

All secondary analyses showed a significantly reduced absolute risk of RRT in patients exposed to paracetamol. Conclusion: Our study showed a significant association between paracetamol exposure and reduced incidence of RRT among patients with rhabdomyolysis. Cumulative incidence of RRT initiation in the 343 * 2 matched population by exposure. Incidence of RRT initiation was significantly lower for patients exposed than not exposed to paracetamol. ARD = − 3.18% (95%CI: − 5.23 to − 1.20), P = 0.001. Rationale: Although there are many studies on acid-base abnormalities in ICU patients, specific studies focusing on severe acidemia are rare and long-term outcome of this population are unknown. The aim of this study was to assess the long-term survival and quality of life of critically ill patients with severe metabolic acidemia.

We performed a post hoc analysis of the BICARICU trial1 that suggested that sodium bicarbonate infusion is associated with a decrease of mortality in patients with severe metabolic acidemia (pH < 7.20) and moderateto-severe acute kidney injury (AKI). Herein, we assessed the 5-year survival and quality of life of these patients through a telephone interview using the Short-Form 36 (SF-36) and the EuroQol health related quality of life questionnaires (EQ-5D). The SF-36 consists of eight scaled scores into a 0-100 scale (the lower the score the more disability). The EQ-5D measures health status in terms of five dimensions ranging from 1 to 5, where 1 represents the best score possible. Parametric and non-parametric tests were used and a p value less than 0.05 was considered significant. Results: Of the 389 patients included, 273 died (70%), 42 were lost to follow-up and 12 were unable to answer a questionnaire. Sixty-two patients were eventually included in the present study. Overall 5-year survival was 30% with no significant difference between the bicarbonate and the control groups. For the control and bicarbonate groups, respectively, SF-36 associated social functioning domain was conserved (scores: 82/100 and 75/100) with a low limitation due to emotional problem (scores: 96/100 and 85/100), whereas physical health was decreased (score: 64/100 and 50/100) as well as fatigue (score: 48/100 and 53/100) and patients' feelings about their general state of health (score: 59/100 and 55/100) (Fig. 1) . Quality of life reported using EQ-5D showed 9/62 (14%) patients with severe-to-extreme difficulty to perform usual activities and a relatively well-conserved self-care capacity 49/62 (79%) patients being able to wash and dress themselves without difficulty. There was no significant difference between the bicarbonate and the control groups on each domains of SF-36 and EQ-5D scores.

Five-year survival of patients with severe metabolic acidemia is 30%. In survivors, the quality of life is lower than what is expected, with a focus in the physical domains, but with reasonable scores in emotional and social functioning. The impact of rehabilitation in this high-risk population is unknown. Rationale: Intermittent haemodialysis (IHD) and continuous renal replacement therapy (RRT) with haemofiltration (CRRT) are the two main RRT modalities used in the intensive care unit for patients with severe acute kidney injury (AKI). Meta-analyses conducted more than 10 years ago did not show survival differences between these two modalities, but indication for RRT was not clear. We aimed to reassess whether the choice of IHD or CRRT as first modality affects survival of critically ill patients with severe AKI. Patients and methods/materials and methods: Secondary analysis of two trials (AKIKI and IDEAL-ICU) that compared an early initiation strategy with a delayed one. We merged the two datasets and included patients allocated to the early strategy in order to emulate a trial where patients would have been randomized to receive either IHD or CRRT within 12 h after the documentation of severe AKI. We determined each patient's modality group as the first RRT modality they received. The primary outcome was 60-day overall survival. The analysis relied on inverse probability of treatment weighting (IPTW) to balance the differences in baseline characteristics between groups. A propensity score model was estimated using logistic regression with the first RRT modality as dependent variable. Results: A total of 543 patients were included. Continuous RRT was the first modality in 269 patients (50%) and IHD in 274 (50%). Patients receiving CRRT had higher haemodynamic and total-SOFA scores. Inverse probability weighting allowed to balance the groups on all predefined confounders. Through the 60-day follow-up period, 146 patients in the CRRT group and 127 in the IHD group died. The weighted Kaplan-Meier death rate at day 60 was 54.4% in the CRRT group and 46.5% in the IHD group (weighted HR 1·26, 95% CI 1·01 to 1·60) (Fig. 1) . In further IPTW analyses, ICU mortality, hospital mortality, renal function recovery at day-28 did not differ between groups. Conclusion: Compared to IHD, CRRT as first RRT modality was associated with reduced survival within 60 days after adjustment for confounders through propensity scores methods. Given the provocative results of the study, we believe a prospective randomized non-inferiority trial should be implemented. Compliance with ethics regulations: Yes in clinical research.

Inverse probability of treatment-weighted sample CO-107 Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study Guillaume Geri 1,2,4 , Michael Darmon 3,10,12 , Lara Zafrani 3,11,12 , Muriel Fartoukh 5,7 , Guillaume Voiriot 5,7,8 , Julien Le Marec 6,7,9 , Saafa Nemlaghi 6,7,9 , Antoine Vieillard-Baron 1,2,4 , Elie Azoulay 3,10,12 1 Rationale: The spectrum of kidney damage in COVID-19 has been mostly limited to autopsies and case reports. Here, we report the first case series of patients with COVID-19 who developed kidney injury and underwent a kidney biopsy in the Paris and its metropolitan area. Patients and methods/materials and methods: We included all patients with COVID-19 who underwent a kidney biopsy between March 08 and May 19, 2020. Data were obtained through the review of the medical records. Results: Forty-seven patients (80.9% men) with COVID-19 were included in the present study. Median age was 63 years IQR [52-69]. Comorbidities included hypertension (66.0%), diabetes mellitus (27.7%), previous history of chronic kidney (25.5%), cardiac (38.6%) and respiratory (27.3%) diseases. Initial symptoms were fever (85.1%), cough (63.8%), shortness of breath (55.3%), and diarrhea (23.4%). Almost all patients developed acute kidney injury (97.9%) and 63.8% required renal replacement therapy. Kidney biopsy analysis showed two main histopathological patterns, including isolated acute tubular necrosis in 22 (46.8%) patients, and dominant glomerular injury consisting of collapsing glomerulopathy or focal segmental glomerulosclerosis in 17 (36.2%) patients. Eight (17%) patients had alternative diagnosis, which were most likely unrelated to COVID-19. Acute tubular necrosis occurred almost invariably in the setting of severe forms of COVID-19, whereas patients with glomerular injury had various profiles of COVID-19 severity and collapsing glomerulopathy was only observed in patients harboring a combination of APOL1 risk variants. At last follow-up, 16 of the 30 patients who initially required dialysis were still on dialysis, and 9 died from COVID-19 or related-adverse events. Conclusion: The present study describes clinico-pathological spectrum of kidney lesions in yet-alive patients with COVID-19. While acute tubular necrosis is correlated with COVID-19 severity, the pattern of glomerular injury is intimately associated with the expression of APOL1 risk variants. Whether SARS-CoV-2 directly underlies renal damage remains a major but unsolved issue. Compliance with ethics regulations: Yes in clinical research. Rationale: Healthcare systems worldwide faced a surge of patients with COVID-19 showing a broad spectrum of clinical presentation from pauci-symptomatic to severely critically ill. Little is known, but much attention is paid on potential long-term COVID [1] . We aimed to describe the symptoms and complaints of COVID-19 survivors 4 months after hospital discharge. Patients and methods/materials and methods: This is a prospective single-center study (NCT04704388). COVID-19 survivors admitted in the participating hospital between March and May 2020, were invited to a teleconsultation investigating respiratory, cognitive, and functional symptoms 3 months after discharge. Patients with relevant symptoms and all intensive care unit (ICU) survivors were invited to an outpatient clinic 4 months after hospital discharge. At the outpatient clinic, patients underwent pulmonary function tests, lung CT-scan, psychometric and cognitive tests and, in ICU or symptomatic patients, echocardiography Results: Among 834 eligible patients, 478 were evaluated by telephone consultation and 177 consulted at the outpatient clinic, including 97 ICU patients ( Table 1) . Half of these 97 ICU patients had received invasive mechanical ventilation (75%, N = 51). Lung CT-scan showed abnormalities in 108/170 (63%) cases, mainly subtle ground-glass opacities. Fibrotic lesions were observed in 33/170 (19%) patients, mostly ICU patients, involving < 25% of parenchyma in all but one case. Fibrotic lesions were observed in 19 (39%) patients with acute respiratory distress syndrome (ARDS), a prevalence similar as to previous cohorts of patients with non-COVID-19 ARDS. New-onset dyspnea was found in 78 (16%) of the 478 patients, mainly in ICU survivors (31% vs 10%, p < 0.001). Dyspnea was related to lung sequelae in 44 (56%) cases and dysfunctional breathing in 14 (18%) cases. Cognitive complaint was reported by 86/416 (21%) patients at teleconsultation, and cognitive impairment was diagnosed in 61/159 (38%) outpatients. Anxiety, depression and post-traumatic symptoms were observed in 22 (24%), 17 (18%) and 7 (7%) ICU patients, respectively. The left ventricular ejection fraction was < 50% in 10 (12%) ICU patients. Two new-onset chronic kidney diseases were observed, both in ICU patients. Conclusion: Four months after hospitalization, severe lung sequelae were rare, concerning mainly ICU patients. In COVID-19 ARDS patients, lung sequelae were similar to those reported in non-COVID-19 ARDS. These findings are limited by the absence pre-COVID assessments and control group; further research is needed to understand longer-term outcomes. Rationale: Coagulation disturbances are frequently observed in patients with COVID-19 as well as clinical thrombotic events. The most serious complication is pulmonary embolism (PE). Activation of inflammation and coagulation in addition to hypoxic vasoconstriction are the major phenomena in cause of occlusion of the pulmonary vessels during the COVID-19. Objective: to study the impact of PE on the progress of infection with SARS-CoV 2 in ICU patients: clinical presentation, biology, oxygenation and ventilatory mechanics, hemodynamic and survival. Patients and methods/materials and methods: Prospective double-cohort study of ICU patients hospitalized for COVID-19: those who developed PE versus those who not developed PE. The diagnostic of PE was either confirmed by CT or strongly suspected in front of a bundle of arguments (electrocardiographic, blood gas and echocardiography). All the illness process elements were followed and compared between the 2 cohorts. , p = 0.72, respectively). Exposure to tobacco, comorbidities, severity scores and the clinical features (dyspnea, cough, chest pain and hemodynamic) were present in the 2 groups similarly. For the laboratory findings: 1st point of troponin, lactate and D-dimer were higher in PE group. Alanine aminotransferase (ALT) was also higher in this group with p near to significance. CT scan extension and initial blood gas were comparable. For cardiac ultrasound, in PE group: SPAP was significantly increased (43 mmHg [38-49] vs 31 [26-33], p < 10-3) and TAPSE was close to be lower (13.5 [11-17] vs 16 [13-19], p = 0.07). Regarding the disease progress: PE was a significant impact on P/F ratio at day 10 (reduced, p = 0.05), on respiratory compliance (elevated, p = 0.033) and plateau pressure (reduced, 0.029). PE-COVID-19 patients required more mechanical ventilation (MV) (65.5% vs 40%, p = 0.035). No impact of PE was observed on MV duration (p = 0.5), ICU length of stay (p = 0.77) and mortality (0.29). The compared values are displayed in the attached table. Conclusion: Once PE occurred, it influenced the progress of a pneumonia related to COVID-19 mainly in the ventilatory behavior: increased compliance, decreased pressure plateau and P/F and required more invasive ventilation. Compliance with ethics regulations: Yes in clinical research. Rationale: Outcomes of the most severe patients who have survived COVID-19 are abundantly described, but few data are currently available on the factors influencing these possible sequelae. We aimed to evaluate prognosis factors influencing outcomes in patients who survived severe COVID-19 pneumonia. Patients and methods/materials and methods: All patients admitted to intensive care unit (ICU) were screened. Eligible patients were assessed 3 months after onset of SARS-CoV-2 symptoms. Patients underwent a physical examination, pulmonary function testing, chest CT and 6-min walk test (6MWT). The cohort was divided into patients with and without DLCO Impairment (DI) defining pulmonary sequalae, then we assessed risk factors for pulmonary sequalae. Results: 84 patients (median age 68.6 years (IQR: 60.4-73), 78.6% male, 33.3% obese) participated. The median length of ICU stay was 17 days (IQR: 1-49). 85.7% required intubation and 84.3% were treated with curare, 73.5% with prone position, 69.1% with catecholamine, 4.8% with dialysis. Lowest PaO2/Fio2 ratio median was 125 (IQR: 56.2-318.8) and median value of ventilatory ratio (VR) was 1.74 (IQR: 1.43-2.09). 35 patients (41.7%) were diagnosed with DI (median DLCO of 61.8%). There was no difference between groups regarding age, gender, comorbidities, intubation, severity and VR. Groups differed in obesity, median IGS2 score and use of dialysis. At 3 months, patients with DI had higher prevalence of velcro crackles (34.3% vs 10.2%), irregular interface (62.9% vs 36.6%), traction bronchiectasis (85.7% vs 53.7%), a lower percentage of predicted TLC, KCO, SNIP, walk distance in 6MWT and more oxygen desaturation. In multivariate analysis, length of stay (LOS) in ICU ≥ 27 days (OR = 7.40) and serum creatinine level (SCL) ≥ 92.8 mmol/l (OR = 4.23) were risk factors for DI while obesity (OR = 0.069) was protective factor (p < 0.01). Conclusion: Our findings suggest a residual pulmonary fibrosis at 3 months after onset disease. LOS in ICU and high SCL may be useful for prediction for DI while obesity can be protective factor. Followup of Covid-19 patients to manage any emerging or persistent longterm sequelae is needed. Compliance with ethics regulations: Yes in clinical research. Rationale: Many prognostic indices have been developed to assess clinical status and predict the probability of death in the intensive care unit (ICU), but none have perfect sensitivity or specificity. Lactate which has been always seen as a metabolic waste and therapeutic dead end, is now considered as a powerful prognostic tool in ICU. The aim of our study was to evaluate the prognostic value of admission lactate in patients admitted to ICU. Patients and methods/materials and methods: An analytic, prospective study was carried out in the ICU of Mongi Slim Hospital, la Marsa, over a 12-month period. Arterial bood lactate was measured at ICU admission (H0), then 6 h (H6), 12 h (H12), 24 h (H24) and 48 h (H48) after admission. Lactate superior to 2 mmol/l defined hyperlactatemia. Prognostic scores were calculated 24 h since the admission. We also recorded biological data, hemodynamic parameters and the evolution during the stay in intensive care. Primary endpoint was ICU mortality. The final step in the statistical study was to perform a multivariate analysis Results: We included 135 patients. The average age was 47.22 ± 16.88 years. ICU mortaily was 48%. The mean serum lactate on admission was 3.05 ± 2.63 mmol/l, higher in the dead group with a statistically significant difference (p < 10-3). Patients with hyperlactatemia on arrival were clinically more serious with significantly higher prognostic scores. Prognostic value of lactate on admission was less powerful than severity indices in this study, but remain excellent with an AUC > 0.7 defining "cut-off" values with a good sensitivty and specificty. In multivaritate analysis, initial lactate > 2 mmol/l was found to be an independent predictive factor of ICU mortality with an odds ratio [IC 95%] = 1.16 [1.07-3.6]; p = 0.04. A derived score including lactate > 3.4 showed the best sensitivity and specificity to predict ICU mortality (84.6% and 75.5%, respectively). Conclusion: Monitoring lactatemia in ICU could allow better identification of patients at high risk of death and the reassessment of therapeutic efficacy. Compliance with ethics regulations: Yes in clinical research. Rationale: The evolution of insulin resistance (IR) during intensive care unit (ICU) stay and the impact of IR on mortality remain to be determined. The objective of this study was to assess a non-biased effect of IR at day 3, 5 and 7 on Day-90 death Patients and methods/materials and methods: It is a post hoc analysis of the CONTROLLING study, a multicenter double-blind randomized trial comparing ICU patients who underwent either individualized glucose control (GC) to target the patient's pre-admission glycemia, or conventional GC to maintain glycemia below 180 mg/ dl. From May 2015 to July 2016, all patients of the individualized GC group, with an ICU stay > 72 h were included. Patients treated for diabetes mellitus were excluded. Case mix, severity on admission and outcomes were collected. At Day 3, 5 and 7, insulin administered and caloric intakes, and GC were recorded. IR was defined as insulin requirement to control glycemia. The primary outcome was Day-90 mortality. The covariates assessed were IR, IR with and without GC, no-IR, insulin/caloric intakes and an increase in insulin intake between landmark day and landmark day-2. We used Fine and Gray sub-distribution survival models with ponderation with inverse probability of treatment weighting (IPTW) to model the risk of death (IPTWSubHR > 1 in favor of death) with ICU discharge as competing event, at landmark Day 3, 5 and 7. Results: The study population included 572 patients, with a sex ratio of 1.5, a median age of 66 (53-76) years; body mass index of 26.2(23-30.2), HbA1c level of 5.7(5.3-6.1) and SAPS II of 49(37-63). A total of 572 patients were analysed at day 3, 476 at day 5, and 374 at day 7. On day 3, IR was observed in 354 (61.9%) patients (IR-group), including 51 (8%) without GC. In the study population, the median ICU length of stay was 8 days (5-15.5), and Day-90 mortality was 20.6%, with nosignificant difference between the IR and the non-IR groups: 22.9% vs 17%, (p = 0.09), respectively. The covariates associated with an increased Day-90 mortality were the increase in insulin intake at day 3; and IR, IR with and without GC, and an increased in insulin/caloric intake at day 5. At day 7, none of these covariates were associated with Day-90 mortality (Table 1) . Conclusion: IR at Day-5 was associated with a poor outcome. Compliance with ethics regulations: Yes in clinical research.

Associations between insulin resistance and other markers of insulin intakes and death by Day 90, using competing risk sub-distribution survival analyses with ponderation on IPTW Rationale: Covid-19 patients can develop a hyper-inflammatory syndrome which can impact on mortality. C-reactive protein (CRP), a routinely measured inflammatory marker, was increased in most patients with COVID-19. It can be used as an indicator of the severity of this disease. Objective: To evaluate the prognostic value of the CRP. Patients and methods/materials and methods: This retrospective study was conducted in an ICU at a university hospital in Tunis (Tunisia) between September 2020 and January 2021. Covid-19 patients (determined by a positive PCR result for SARS-cov-2) in respiratory distress with a ratio PaO2/FiO2 less of than 300 were enrolled. All patients received dexamethasone and curative anticoagulation. They were divided into two groups: survivors and non-survivors. Data of demographic parameters, clinical characteristics, laboratory tests and outcomes were collected. Results: Fourty-nine patients were included. There were 32 patients (65.3%) in the non-survivor group, whereas the survivor-group comprises 17 patients (34.7%). Non-survivors were older than the survivors (66 [57-72] versus 58 [52-64.5]), but the difference was not significant. Non-survivors had a significantly higher SOFA score at admission (4 [4-5] versus 3 [2-4], p < 0.001), a higher troponin level (292.53 versus 31.6; p = 0.002) and a lower PaO2/FiO2 (68 [60-91] versus 108 [90-189], p = 0.0001). There was no significant difference in white blood cell count (p = 0.081) nor in the lymphocyte count (p = 0.09). The percentage of patients requiring endo-tracheal intubation was significantly higher in the non-survivor group. (93.8% versus 2%, p = 0.0001). The area under the curve (AUC) of CRP used to assess Covid-19 mortality was 0.8 and the optimal cut-off for predicting mortality was a CRP value of 138 (specificity: 76% and sensitivity: 81%, PPV: 86% and NPV: 68%). In univariate analysis: a value of CRP greater than 138 was associated with mortality (p = 0.0001). In multivariate analysis: a value of CRP greater than 138 was the independent predictor of mortality Rationale: In COVID-19 patients, increase in high-sensitive cardiac troponin T (hs-cTnT) has been reported to be associated with worse outcomes. Early identification of critically ill COVID-19 patients with the worst prognosis could be mandatory to provide better care to the greatest number of individuals. However, in critically ill COVID-19 patients, the prognostic value of hs-cTnT remains to be assessed given that most of previous studies have involved case mix of nonseverely ill patients, and few ICU patients. Patients and methods/materials and methods: This observational retrospective cohort study was carried out from March 9, 2020 to May 3, 2020 in three French ICUs. Investigators on each site collected prospectively clinical and biological data for all critically ill patients diagnosed with a SARS-CoV-2 infection confirmed by RT-PCR. Patients were followed up until hospital discharge or death and 3 months later by phone call. ICU, in-hospital, and 90-day mortalities were recorded. Predictive factors of in-hospital mortality were then identified. Results: One hundredand eleven critically ill patients (68% of male), with median age of 67 [58-75] years, median Charlson index and Simplified Acute Physiology Score II of 3 [2] [3] [4] [5] and 37 [27-48], respectively, were included. At ICU admission, median PaO2/FiO2 ratio was 140 [98-154]) and hs-cTnT serum level was 16.00 [10.15-31.85] ng/L. Seventy-five patients (68%) were mechanically ventilated, 41 (37%) were treated by norepinephrine (> 1 µg/kg/min), and 17 (15%) underwent renal replacement therapy. In-hospital mortality was 29% (32/111). In-hospital mortality was independently associated with higher age, lower PaO2/FiO2 ratio and higher hs-cTnT serum level. Age ≥ 74 years old, PaO2/FiO2 ≤ 100 and hs-cTnT ≥ 22 ng/L had a negative predictive value of 84%, 80% and 86%, respectively, but a low positive predictive value for in-hospital mortality. Conclusion: At admission, age, low PaO2/FiO2 and elevated hs-cTnT serum level were independently associated with in-hospital mortality in critically ill COVID-19 patients. Besides age and PaO2/FiO2 ratio, hs-cTnT levels may allow early risk stratification and triage in such patients. Compliance with ethics regulations: Yes in clinical research.

ROC curves of age (purple semi-dashed line), initial PaO2/FiO 2ratio (blue dashed line), initial high-sensitive cardiac troponin T (hs-cTnT, red line), initial D-dimers (green dotted line), and initial C-reactive protein (CRP, orange dashed and dotted lin

Ines Sdiri 1,3 , Fatma Essafi 1,3 , Imen Talik 1,3 , Sana Dhorgham 1,3 , Aida Bayyoudh 2 , Ilhem Fessi 2 , Moez Kaddour 1,3 , Takoua Merhabene 1,3   1 Intensive care unit, Regional Hospital, Zaghouan, Tunisie; 2 sevice de pneumologie, Hôpital réginal de Zaghouan, Tunis, Tunisie; 3 Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisie Correspondence: Fatma Essafi -fatma.essafi@fmt.utm.tn Annals of Intensive Care 2021, 11(Suppl 1):FC-005

Rationale: Several studies have been conducted to identify the clinical, biological, and radiological risk factors associated with severe forms of COVID-19. This study aimed to analyze possible link between biological characteristics and stage of respiratory failure. Patients and methods/materials and methods: A retrospective, observational cohort study of inpatients with COVID-19 pneumonia confirmed by swab test from 1st March 2020 to 31st January 2021 was performed. Patients were categorized according to their degree of acute respiratory failure: mild group (patients who required < 6 l/mn of oxygen) and severe group (≥ 6 l/mn). Data were pooled to compare the hematologic and biochemical findings between the two groups. Twenty parameters were analyzed. Results: Our study involved 195 patients, 108 were assigned to the severe group (GI) and 87 in the mild one (G II). There were no significant differences between the 2 groups in gender (sex ratio 0.5 vs 0.9; p = 0.068) and age (63.5 ± 11.8 vs 62.5 ± 16; p = 0.63) whereas GI showed more frequently diabetes (41.7% vs 27.6%; p = 0.05), obesity (66.3% vs 44.2%; p = 0.02), and chronic obstructive pulmonary disease. The median time of symptoms at the first consultation was 9 ± 4.3 At admission, median levels of urea, serum creatinine and lactate dehydrogenase, were higher in severe patients, but were not significantly different between the two groups. The cut-off critical point was WBC ≥ 10500 elt/mm 3 , LYM < 950 elt/mm 3 , AST ≥ 30 UI/L, ALT ≥ 35 UI/L, GLU ≥ 8.5 mmol/L and CRP ≥ 80 mg/L. Conclusion: This study highlights the association of some biochemical parameters with the severity of COVID-19 pneumonia and might assist clinicians to closely monitor patients in order to predict prognosis. Compliance with ethics regulations: N/A. Rationale: The coronavirus disease 2019 (COVID-19) has spread rapidly across the world and has caused an important public health burden. It is associated with high rates of morbidity and mortality. Therefore, identification of factors contributing to worse outcomes is crucial. Thyroid disorders seem to be associated with an increased risk of severity. However, the impact of thyroid dysfunction on the prognosis of patients remains not yet elucidated. This study aimed to identify the effect of thyroid disorders on outcomes related to COVID-19.

This analytic prospective study was conducted between September 2020 and January 2021. Patients admitted to the ICU with confirmed SARS-CoV-2 pneumonia who underwent thyroid function test on admission were included. The diagnosis of Covid-19 was performed with reverse-transcription polymerase chain reaction (RT-PCR). Patients with pre-existing thyroid problems were excluded. Two groups were defined: group 1: euthyroid patients, group 2: those with thyroid dysfunction. Thyroid disorders involve hypothyroidism and hyperthyroidism (peripheral and central). Primary outcome was ICU mortality. Secondary outcomes were duration of invasive mechanical ventilation, ICU length of stay, ventilation requirement and nosocomial infection. A logistic regression analysis was used to identify if thyroid dysfunction was associated with mortality. Results: A total of 68 patients were included. The most common co-morbidities were hypertension in 48.5% and diabetes mellitus in 36.8% of cases. Mean SOFA score and APACHEII score were, respectively, 4.3 ± 2.5 and 11.8 ± 5.7. Thyroid dysfunction was found on 27.9% of included patients. Out of these, 23.5% had peripheral hyperthyroidism, 2.9% had peripheral hypothyroidism, and 1.5% had central hyperthyroidism. Overall ICU mortality was 45.6%. The characteristics of both groups were comparable (age, sex, and comorbidities). Patients having thyroid dysfunction were more likely to require invasive mechanical ventilation: 73% vs. 45.8%, p = 0.03 and to present nosocomial infection: 73.6% vs. 38.7%, p = 0.01. There were no significant differences in duration of mechanical ventilation [16 ± 11 vs 10 ± 7 days, p = 0.23] and ICU length of stay [19 ± 13 vs 15 ± 9 days, p = 0.1]. In the regression multivariate analysis, thyroid dysfunction was not associated with mortality (OR = 1.9; 95% IC [0.3-10], p = 0.43). Mechanical ventilation (OR = 13; 95% IC [4.2-23.1], p < 0.001) and septic shock (OR = 9.2; 95% IC [6.8-21.2], p = 0.003) were found to be associated with mortality. Conclusion: In the current study, we found that patients with thyroid dysfunction were more likely to require invasive ventilation and to present nosocomial infection. Compliance with ethics regulations: Yes in clinical research.

Obesity's influence on mortality in patients with COVID-19 pneumonia: myth or reality? Rihab Rajah 1 , Fatma Essafi 1,2 , Imen Talik 1,2 , Khaoula Ben Ismail 1,2 , Moez Kaddour 1,2 , Takoua Merhabene 1,2 1 Intensive care unit, Regional Hospital, Zaghouan, Tunisie; 2 Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisie Correspondence: Fatma Essafi -fatma.essafi@fmt.utm.tn Annals of Intensive Care 2021, 11(Suppl 1):FC-007

Rationale: Many observational studies have suggested that obesity confers an increased risk of morbidity-mortality in the general population and may compromise prognosis in critically ill patients. The aim of our study was to determine whether obesity is a risk factor for poor outcome in patients affected by COVID-19 admitted to ICU. Patients and methods/materials and methods: This study was performed at the Zaghouan's hospital ICU, a 10-bed secondary ICU in Tunisia. It was a retrospective study enrolled between 1st March 2020 and 31st January 2021 in patients with confirmed RT-PCR Covid-19. Body mass index (BMI) was used as indicator for obesity status. Simplified Acute Physiology Score (SAPS II), Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, comorbidities, invasive mechanical ventilation requirement, ICU length of stay and mortality were evaluated. Patients were divided into two groups: G1: obese, BMI ≥ 30 kg/m 2 and G2: non-obese, BMI < 30 kg/m 2 . Results: During the study period, 121 patients with COVID-19 pneumonia were admitted. A total of 79 patients (65.3%) with BMI-defined obesity were included in G1, and 42 (34.7%) were assigned to G2. Median age was 62.3 [34-92] years in G1, and 63 [37-92] in G2. Demographic data and comorbidities (sex ratio, SAPS II, APACHE II, hypertension, diabetes, chronic respiratory failure) were similar between the 2 groups. There was no significant difference between PaO2/FiO2 ratio at admission between group 1: 155 ± 107.4 mmHg [47-328] and group 2: 155.7 ± 73 [64-360], p = 0.97. At admission, non-invasive mechanical ventilation was prescribed in 70 patients (88.6%) in group 1, and in 33 (78.6%) in G2 with p = 0.14. Obesity does not represent limiting factor for awake prone position: instead the obese patients were more adherent to the prone position in spontaneous ventilation (68.4% vs 50%; p = 0.048). No adverse effects as pressure ulcer were observed. Length of ICU stay was similar in two groups (9.8 ± 5.7 day [2-30] vs 9.5 ± 5.7 day [2-23]). No significant differences were observed in need to invasive mechanical ventilation (39.2% vs 45.2%; p = 0.5) and mortality (39.2% vs 52.4%; p = 0.16). Conclusion: Obesity conferred an increased risk for intensive care unit admission, but it did not seem to be associated with increased risk for need for invasive mechanical ventilation, or influence ICU length of stay and/or mortality. Compliance with ethics regulations: N/A. Rationale: Malnutrition following intensive care unit (ICU) stay is frequent and could be especially prominent in critically ill Coronavirus Disease 19 (COVID-19) patients as they present prolonged inflammatory state and long length stay. We aimed to determine the prevalence of malnutrition in critically ill COVID-19 patients both at the acute and recovery phases of infection.

We conducted a prospective observational study including critically ill COVID-19 patients requiring invasive mechanical ventilation discharged alive from a medical ICU of a university hospital. We collected demographic, anthropometric and ICU stay data (SAPS2, recourse to organ support and daily energy intake). Nutritional status and nutritional support were collected at 1 month after ICU discharge (M1) by phone interview and at 3 months after ICU discharge (M3) during a specialized and dedicated consultation conducted by a dietitian. Malnutrition diagnosis was based on weight loss and body mass index (BMI) criteria following the Global Leadership Initiative on Malnutrition. Primary outcome was the prevalence of malnutrition at M3 and secondary outcomes were the evolution of nutritional status from ICU admission to M3 and factors associated with malnutrition at M3. . Thirty-three (86%) patients were followed up to M3. Prevalence of malnutrition increased during the ICU stay, from 18% at ICU admission to 79% at ICU discharge and then decreased to 71% at M1 and 53% at M3. Severe malnutrition prevailed at ICU discharge with a prevalence of 55% decreasing to 45% at M1 and 32% at M3 at the benefit of moderate malnutrition (Fig.) . At M3, the only factors associated with malnutrition in univariate analysis were the length of invasive mechanical ventilation and length of ICU stay (25 [16, 39] vs. 11 [9, 12] days, P = 0.006 and 28 [21, 42] vs. 15 [11, 17] days, P = 0.010, respectively), while no ICU preadmission and admission factors, nor energy and protein intakes distinguished the two groups. Only 32% of undernourished patients at M3 had benefited from a nutritional support. Conclusion: Malnutrition is frequent, protracted and probably under-recognized among critically ill Covid-19 patients requiring invasive mechanical ventilation with more than half patients still being undernourished 3 months after ICU discharge. A particular attention should be payed to the nutritional status of critically ill Covid-19 patients not only during their ICU stay, but also following ICU discharge. Compliance with ethics regulations: Yes in clinical research.

Nutritional status of patients from ICU admission to 3 months post-ICU discharge nutritional status at ICU admission, ICU discharge, 1 month (M1) and 3 months (M3) following ICU discharge was determined by body mass index (kg/m2) and weight loss Rationale: Lower gastro-intestinal (GI) tract dysfunction has been proven to be associated with relevant outcomes such as mortality or time spent on mechanical ventilation (MV) in intensive care unit (ICU) patients. A significant subset of COVID patients harbor GI symptoms, whose prognostic significance remain elusive. No studies have characterized the transit of severe COVID ICU patients, and its prognostic value is unknown. Patients and methods/materials and methods: Single-centre, retrospective analysis of all COVID patients admitted in a 12-bed ICU, between February and December 2020. Demographic data, time spent under MV, treatments, transit and survival were compared according to occurrence of delayed transit, as defined by a delay of 6 days or more without stool passage [1] . Early and late delayed transit were defined as occurring, respectively, in the days following ICU admission or later during the ICU stay. Conclusion: A high incidence of delayed transit was found in COVID patients. Delayed transit was associated with invasive MV, catecholamine and NMBAs. Delayed transit did not appear to be an independent risk factor for survival. Late, rather than early delayed transit was associated with worse outcomes, raising the question of prophylactic management in this subset of patients. Rationale: Nutrition has become an essential part of the standard care of patients admitted to the Intensive Care Units (ICU). The main goal of this adjunctive therapy is to reduce impairment of nutrition status induced by "aggression" and ICU stay. The objective of the study is to assess the effect of the implementation of a nutrition protocol on the caloric and protein intakes received by critically ill patients, according to recent expert French guidelines.

In a monocentric before-after study, we compared the implementation of a nutrition protocol in a general intensive care unit. The "before" phase was performed during 3 months at the beginning of 2018 and the "after" phase during a period of a same duration in 2019. Nutrition protocol was introduced to the medical staff at the end of 2018. All adult patients admitted for 3 days or more in the ICU were included. One hundred and seven patients and 72 patients were included in the "before" and "after" groups, respectively. The calorie targets were based on the recommendations of the Société de Réanimation de Langue Française published in 2014. The nutritional support was mixed, oral and/or enteral and/or parenteral. Calorie and protein intakes among both periods were compared at day 0, day 3 and day 7. The efficiency and safety of the protocol was assessed indirectly by insulin therapy-induced glycemic control and phosphoremia repeated measurements. Results: Following the protocol implementation, calorie intakes increased from 159 to 525 kCal/day (p < 0.0001) at day 0 and 584 to 853 kCal/day (p = 0.007) at day 3. Similarly, protein intakes were improved among periods at day 0 and day 3, respectively. This difference between groups was no more observed at day 7. At day 7, only 33.4% of the patients had a delivered calories/maximum expected calories ratio greater than 75%. No adverse events were observed during the "after" period. There was no effect of the protocol on the main outcome of the patients. Conclusion: Our study confirms that implementation of a nutrition protocol according to recent guidelines allows early improvement of the caloric and protidic intakes in critically ill patients with safety. Better adhesion to protocol from the team is, however, necessary to target maximum expected calorie intake in all patients.

Calorie and protein intake on Day 0, 3 and 7 before and after implementation of the nutrition protocol Rationale: Prealbumin is an early marker of malnutrition. ICU and post-ICU mortality rates are higher in elderly patients than in younger populations. Age itself explains only a small part of the increased hospital mortality, suggesting that specific information such as nutritional status should be collected to predict mortality in elderly ICU patients.

The main objective of this study was to determine if prealbumin is a predictor of 30-day mortality of patients aged 75 years and older admitted in intensive care for at least 24 h, regardless of the reason for admission. Rationale: Abdominal sepsis is one of the most frequent digestive emergencies and one of the leading causes of septic shock, involving the life-threatening prognosis of patients who are often elderly or who have underlying pathologies. The management of abdominal sepsis is multidisciplinary. The objective of our study is to describe the epidemiological, clinical, bacteriological and evolutionary data of abdominal sepsis, and to assess the predictive factors of mortality as well as the role of therapeutic de-escalation in the improvement of the vital prognosis.

We carried out a retrospective descriptive and analytical study spanning 3 years (between January 2017 and December 2019) on 134 cases of abdominal sepsis, hospitalized in the intensive care unit of the P33 surgical emergencies of CHU Ibn Rochd Casablanca. Adult patients with community-based or postoperative abdominal sepsis who received medico-surgical treatment were included in our study. The parameters studied are demographic, clinical, radiological, perioperative, bacteriological and evolutionary data. Statistical analysis was performed using SPSS software.

Results: The incidence of abdominal sepsis in our work during the study period was 22%, it was divided into community sepsis (69%) and postoperative sepsis (31%). The average age was 52.9 years, with a sex ratio of 1.5. Clinical signs were dominated by abdominal pain (71%), vomiting (51%), extra-abdominal signs (55%), hemodynamic failure (71%), renal failure (63%), and respiratory disorders (41%). Therapeutic management was based on perioperative resuscitation, treatment of organ failure, probabilistic antibiotic therapy and surgery by median laparotomy. The main etiologies of abdominal sepsis were: purulent effusion (36%), serous effusion (17%) and small bowel perforation (15%). Bacteriological samples taken during the operation allowed to have the profile bacteriological: predominance of BGNs (87%) dominated by E. coli (29%) followed by Klebsiella pneumonia (25%) and Acinetobacter baumannii (16.5%). The mean hospital stay was 10.67 days. The death rate was 59%. The main prognostic factors that emerged in our univariate analysis study were: advanced age, diabetes, prior antibiotic therapy, organ failure and development of septic shock. Therapeutic de-escalation was a protective factor Conclusion: Abdominal sepsis is a serious condition with high mortality. The improvement of its prognosis is based on a screening of risk factors, an updating of medico-surgical protocols, a management guided by operators and senior resuscitators and an adapted antibiotic therapy which will depend on the direct examination of the samples, and also on the bacterial ecology of the service. Compliance with ethics regulations: N/A. . The aim of this study was to estimate the prevalence of thromboembolic complication in critically ill patients with COVID-19 and to identify the clinical, radiological and biological characteristics associated with these complications.

We conducted a retrospective study of symptomatic patients with laboratory-proven COVID-19 admitted to ICU (Mars 2020-January 2021). We searched thromboembolic complication including venous thromboembolism (VTE), ischemic stroke, acute coronary syndrome (ACS) or myocardial infarction (MI) and catheter-related thrombosis (CRT). Characteristics of patients, radiological data and anticoagulant treatment were recorded.

Results: A total of 82 critically ill patients were studied (median age: 63 years, 58.5% men). The median intensive care unit stay was 13 days (2-80 days). 8 patients have a prior arterial or venous thrombosis event, 16 patients have a history of cancer. Thromboprophylaxis was used in 100% of ICU patients. Therapeutic doses were used in 26 patients. Thromboembolic events occurred in 18 patients. Three patients presented more than one event. The incidence of thromboembolic complication was: distal VTE: 4 cases, proximal VTE: 1 case, pulmonary embolism: 10 cases, CRT: 6 cases, ACS: 2 cases. Parenchymal involvement was noted in 17 patients. Median level of fibrinogen and D-dimers in patients with thromboembolic complication were, respectively, 6 g/L (5.0 e 7.5) and 4 μg/mL (3.2 e 5.6).

The high number of arterial and, in particular, venous thromboembolic events diagnosed among the few COVID-19 patients suggest that there is a need to improve specific VTE diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in critically ill COVID-19 patients. Strict clinical surveillance is needed to detect new events that can occur despite anticoagulation. The prophylactic anticoagulant dose may need to be increased in patients with a low risk of bleeding. Compliance with ethics regulations: N/A. ) and 4 had blood type AB (3.3%). Our results showed that blood group A was associated with a higher risk for acquiring severe COVID-19 compared with non-A blood groups (odds ratio = 3.26, p = 0.009) and higher mortality (OR = 2.26; p = 0.005) versus all others, whereas blood group O was associated with a lower risk of mechanical ventilation (OR = 0.81) and acquiring nosocomial infections (OR = 0.64) compared with non-O blood groups.

We report an association between the ABO blood group and COVID-19 susceptibility, demonstrating the latter to be a biomarker differentiating the former. Our findings require to be confirmed by further studies. Compliance with ethics regulations: Yes in clinical research. Rationale: Anemia is a significant complication in pediatric intensive care units (PICUs). Diagnostic blood testing is a recognized contributor. Yet, little is known about current blood testing practices in PICUs. We aimed to characterize the blood collected for laboratory testing and the transfusion practice in our PICU, and its impact on the incidence of anemia.

We conducted a prospective observational single-center cohort study in children admitted to the PICU of CHU Sainte-Justine between September 2019 and January 2020. Diagnostic blood volumes and volumes discarded were collected throughout the PICU stay. Data collection further included admission diagnoses, length of stay (LOS) in PICU, ventilatory support, vascular access, first and last hemoglobin during PICU stay, and transfusion. Anemia was defined according to the Canadian Blood Services diagnostic criteria. Results: 423 children (mean age 4.9 ± 5.6 years) were enrolled. The most common medical diagnoses were respiratory illness (36.9%), neurological disease (8.3%), intoxication (4.5%), septic state (3.3%), and non-septic shock (4.3%). 33.1% were admitted postoperatively, including 50 (35.2%) following cardiac surgery. The mean LOS was 4.5 days with a mean worst PELOD2 of 4.9 ± 3.9. Invasive and noninvasive ventilation was used in 29.8% and 46.8% of patients, respectively. A total of 31.7% had a central venous line, 28.4% an arterial line. The mean blood volume drawn was 5.3 ± 6.3 mL/patient/day, with a mean volume discarded of 1.1 ± 1.8 mL/patient/day. The total blood loss was 3.9 ± 0.9 mL/kg/stay, corresponding to 5% of total blood volume. Patients with blood-drawing access had more blood sampled compared to patients without (8.2 ± 6.4 vs. 3.1 ± 5.3 mL/patient/day; p < 0.0001). Cardiac surgery patients and septic patients were sampled the most (14.3 and 11.0 mL/patient/day, respectively), while the least sampling occurred following otorhinolaryngologic procedures (1.8 mL/patient/day). Mean hemoglobin values were 117 ± 23 g/L and 110 ± 21 g/L at PICU admission and discharge, respectively (p < 0.05). Over half of PICU survivors (56.2%) were anemic at discharge, including 16.25% with a hemoglobin < 90 g/L; 10% received ≥ 1 red blood cell transfusion during PICU stay. Multivariate analysis revealed no significant risk factors for a hemoglobin decline during PICU stay, except for a correlation with sampling volumes > 5 ml/kg/stay. Conclusion: Blood sampling is significant in PICU patients, accounting for 5% of children's total blood volume. Indwelling catheters, sepsis, and cardiac surgery are associated with higher blood loss. Improved blood testing strategies are needed to decrease the incidence of iatrogenic anemia. Compliance with ethics regulations: Yes in clinical research. . On ICU admission a respiratory and renal SOFA subscore ≥ 2 was present in 20 and 29 patients, respectively, and the disease requiring TPE previously diagnosed in 16. The main indications for TPE were: thrombotic microangiopathy (21 patients/149 sessions), including thrombotic thrombocytopenic purpura (5 patients) and hemolytic uremic syndrome (13 patients); neurologic disorders (13 patients/56 sessions), including Guillain-Barré syndrome (9 patients); vasculitis (10 patients/67 sessions), including anti-neutrophil cytoplasmic antibodies-associated vasculitis (9 patients); and hyperviscosity syndromes (10 patients/13 sessions), including hypertriglyceridemia (N patients). TPE was started within the first 24 h of ICU admission in 50 patients. TPE was performed using a dialysis catheter in 54 patients, regional citrate anticoagulation was systematically used, and the TPE technique was centrifugation in 279 (89%) sessions and double filtration plasmapheresis in others. The type of replacement fluid was plasma frozen with or without albumin 5% in 271 sessions and albumin 5% in the others. Twenty-eight (9%) of TPE sessions were reported with at least one adverse event, including mostly allergic reactions (n = 8) and bleeding (n = 7); hypotension, hypocalcemia and transfusion-related acute lung injury were observed for each one, in one case. (2) have been developed to help clinicians in the early identification of patients with thrombotic thrombocytopenic purpura. However, the validity of these scores in thrombotic microangiopathy cohorts with low thrombotic thrombocytopenic purpura prevalence remains uncertain. Thus, we aimed to evaluate the diagnostic performance of these scores in routine clinical practice using an unbiased cohort of thrombotic microangiopathy patients. We also analyzed the value of proteinuria when added to PLASMIC and French scores for thrombotic thrombocytopenic purpura prediction.

We retrospectively included all consecutive patients between 01/01/2010 and 12/31/2019 with a biological thrombotic microangiopathy syndrome at admission in a tertiary hospital. Thrombotic microangiopathy etiology was retrieved and scores were assessed. Modified scores including proteinuria were compared to original scores for thrombotic thrombocytopenic purpura prediction. Results: Among 273 patients presenting with a full biological TMA syndrome, 238 were classified as having TMA diagnosis after chart review. Data for PLASMIC and French scores were available in 225 patients (94%) with a TTP prevalence of 6.2% (scores cohort). In this population, the area under the curve (AUC) of PLASMIC and French scores for TTP diagnosis were 0.67 (p = 0.02) and 0.65 (p = 0.06), respectively. Proteinuria at admission was assessed in 134 patients. In this population (modified scores cohort), the AUC of modified PLAS-MIC score for TTP diagnosis was 0.76 (p = 0.006), significatively higher than the standard score (p = 0.003) and the AUC of modified French score was 0.81 (p = 0.001), tending to be higher than the standard score (p = 0.07) (Fig. 1 ). Specificity and predictive positive value of high-risk modified scores were significantly improved by adding proteinuria. Conclusion: PLASMIC and French scores have low predictive values when applied to an unbiased TMA cohort. Addition of proteinuria to original scores improves their predictive performance for TTP diagnosis. Compliance with ethics regulations: Yes in clinical research. Rationale: Fever control by external cooling is proposed to help in controlling shock in septic patients. However, little is known about the optimal method. The aim of this study was to assess the performance of a water-circulating cooling device (Arctic Sun ® -BD) for controlling fever in patients with septic shock. Patients and methods/materials and methods: We conducted an observational, retrospective, monocentic study, in 16 febrile septic shock patients. Inclusion criteria were fever > 38 °C in patients requiring norepinephrine, mechanical ventilation and sedation. External cooling was applied to achieve fever control with a targeted core temperature at either 36.7 or 38 °C according to physician choice. The oesophageal core temperature recorded every minute was extracted from the Arctic Sun ® system. To evaluate the performance of the system, we recorded the time to reach target expressed by cooling rate (°C/h) and the percentage of time at the target ± 0.5 °C calculated from the time of target reached to H24 after cooling start or to the end of therapy, whenever which came first. We assessed whether patient's characteristics influenced the efficacy of cooling and the association between cooling efficacy and evolution of shock at 24 h. Data are presented as median and 25th-75th interquartile range. Funding of the study: none. Rationale: Critical illness is associated with immune suppression and administration of immune stimulatory agents has been suggested as a novel therapeutic approach in patients showing immunological evidence of this host response aberration. We here tested the hypothesis that the extent of immune suppression is proportional to the degree of systemic hyperinflammation in critically ill patients. Patients and methods/materials and methods: 77 consecutive critically ill patients admitted to the intensive care unit (ICU) in a tertiary hospital in the Netherlands. Blood was collected on the first morning after ICU admission. Leukocytes were stimulated with lipopolysaccharide (LPS) and cytokines were measured in supernatants. Results: Patients were stratified into four groups of increasing immune suppression based on quartiles of LPS-induced tumor necrosis factor (TNF)-α production (from normal to severely reduced). Reduction in TNF-α production capacity was associated with a proportionally reduced release of IL-1β and IL-6 upon stimulation with LPS. Measurements of 15 plasma biomarkers reflecting major pathways involved in the pathogenesis of critical illness showed that the extent of impairment of TNF-α production by blood leukocytes was associated with enhanced systemic inflammatory responses, enhanced endothelial cell activation, loss of vascular integrity and increased procoagulant responses. Rationale: Dexamethasone decreases mortality in severe forms of COVID-19. The release of this result resulted in the premature termination of trials evaluating hydrocortisone for ethical reasons. Their lack of power has left a doubt about its effectiveness. In the CAPE-COVID trial [1] , low-dose hydrocortisone, compared with placebo, did not significantly reduce treatment failure at day 21, nor did it significantly reduce death at day 21 (14.7 vs. 27.4%, p = 0.057). We report here a post hoc analysis of the longer-term effects of hydrocortisone in this trial. Patients and methods/materials and methods: ICU patients with a severe form of COVID-19 (mechanically ventilated and/or PaO 2 / FiO 2 < 300) were randomized to receive hydrocortisone 200 mg/d initially or placebo, in a double-blind fashion. Mortality at day 28 and 90 were analyzed using two-proportion z-tests based on normal approximation. Differences of proportions were estimated with their confidence interval. Lengths of ICU stay were compared in the framework of a competing risk model, with death considered as a competing event of end of stay. Figure 1 shows ICU mortality and ICU discharge as a function of time. Conclusion: In this double-blind, placebo-controlled, multicentric trial, post hoc analysis suggests a decrease in mortality at day 28 in patients with severe forms of COVID-19 receiving hydrocortisone. Early termination of the trial made it underpowered to show a significant difference on other endpoints. Rationale: Tuberculous meningoencephalitis (TME) is the most severe form of tuberculosis disease. The clinical features are non-specific and the diagnosis is based on brain imaging and cerebrospinal fluid (CSF) analysis. We aimed to study the diagnostic, therapeutic and outcome characteristics of TME in immunocompetent patients. Patients and methods/materials and methods: Retrospective and descriptive study including immunocompetent patients hospitalized in ICU from January 2016 to June 2020 for TME. All clinical, paraclinical and outcome data were collected. Results: During the study period, there were 758 admissions including 36 for tuberculosis among them 18 TME, resulting to an annual incidence of 23.3/1000 admissions and 50% of cerebral location. Gender ratio = 1.57, mean age = 48 years, median SOFA = 4, and previous tuberculosis was reported in 3 patients. The time from initial signs to consultation and admission was 14 and 21 days, respectively. Fever was present in all patients and seizures in 13 cases. On admission, 2/3 had a median GCS at 8.5. All patients had lymphopenia, mean CRP = 117 mg/l and procalcitonin = 0.23. Severe hyponatremia was observed in three patients. In 11/18, the cerebral CT revealed hydrocephalus and hypodensities. 14 had additional MRI which was contributory in seven cases, particularly in terms of tuberculomas and vasculitis. For CSF analysis, the lymphocyte formula was predominant (14 cases), the mean glucorrachia/blood glucose ratio = 0.36, the median proteinorrachia = 1.6 g/l and median lactatorrachia = 5 mmol/l and PCR was positive in two cases. Isoniazid/rifampicin/pyrazinamide/ethambutol quadruple therapy in addition to dexamethasone was prescribed for all patients and two had an external ventricular bypass. Invasive ventilation was indicated in 13 patients including one for ARDS related to miliary tuberculosis. Outcome: 13 patients (72%) had favourable outcome and the others: brain death (2), vegetative state (2) and major deficit (1) . Mortality (all cause combined) was 39% (7/18) . For the current state: three of the nine contacted have fully recovered and six have no serious sequelae. Conclusion: TME is a non-rare affection with severe morbidity and mortality, particularly motor and cognitive sequelae. The clinical signs lack specificity and brain imaging, especially angio MRI, in addition to CSF analysis, are the key elements of diagnosis. However, the delay in their reports leads to therapeutic delay, which is a determining factor in the prognosis. The establishment and generalization of the PCR technique using the MTB/RIF (Xpert) Ultra gene is an absolute priority, the only guarantee of a rapid diagnosis and thus an early treatment. Compliance with ethics regulations: Yes in clinical research. Rationale: Neurological failure is a strong determinant of outcome in critically ill patients with infective endocarditis (IE). Current guidelines (European Society of Cardiology (ESC) 2015) recommend systematic brain imaging in pre-operative evaluation. However, the impact of such imaging has never been evaluated in critically ill patients. Our aim was to assess the impact of CT-defined NC on functional outcome of critically ill IE patients. Patients and methods/materials and methods: This retrospective cohort study included all consecutive patients aged ≥ 18 years with a severe (SOFA ≥ 2) left-sided definite IE (diagnosed according to Duke criteria) hospitalized ≤ 30 days after initiation of antimicrobial treatment in a tertiary care hospital's ICU. Patients with no baseline brain CT, transferred to ICU after cardiac surgery for IE or with ICU-acquired IE were excluded. Baseline CT-scans were classified in five mutually exclusive categories (normal CT, moderate-to-severe acute ischemic stroke (AIS), minor AIS, intracranial hemorrhage (ICH), other abnormal CT) using a double reading, blinded to patients' characteristics and outcomes. Main outcome was the proportion of patients with 1-year favorable outcome, defined as a modified Rankin Scale score between 0 (asymptomatic) and 3 (moderate disability). Factors associated with favorable outcome were identified by multivariable logistic regression. Secondary outcome was the rate of post-operative severe NC. Neurological surgical contraindication was defined according to ESC 2015 guidelines as hemorrhagic (any ICH) or ischemic (AIS with Glasgow Coma Scale < 10). Results: Between 06/01/2011 and 07/31/2018, 156 patients (male 71%, 63 years old [54-70]) were included in the analysis (284 included, 128 excluded due to pre-specified criteria). 87/156 (56%) had a CT-defined NC: moderate-to-severe AIS n = 33/156 (21%), ICH n = 24/156 (15%), minor AIS n = 29/156 (19%), other n = 3/156 (2%). 69 patients (45%) had a 1-year favorable outcome. Factors associated with favorable outcome are detailed in Table 1 . Compared to normal CT, only moderate-to-severe AIS was associated with a higher rate of post-operative severe NC (n = 8/23 (35%) vs. n = 1/46 (2%), p < 0.01). Urgent surgery was performed in 28 patients despite neurological contraindication. One-year favorable outcome was more frequent in patients operated despite hemorrhagic contraindication than in patients operated despite ischemic contraindication (n = 12/18 (67%) vs. n = 2/10 (20%) p = 0.046). Conclusion: Moderate-to-severe AIS had an independent negative impact on 1-year functional outcome in critically ill IE patients, whereas other complications, including ICH, had no such impact. Sensitivity analyses conducted in operated patients revealed similar findings. Systematic use of brain imaging might improve management of critically ill patients with left-sided IE. Compliance with ethics regulations: Yes in clinical research. Rationale: In Herpes simplex virus (HSV) encephalitis (HSE), among patients who require intensive care admission, 70% have a poor neurological outcome (modified Rankin score (mRS) 3-6) at 90 days [1] . HSE remains a diagnostic challenge, notably because of possible initial normal cerebrospinal fluid (CSF) content. Although the sensitivity of HSV PCR is around 95% [2] , there are case reports/series reporting false-negative results if PCR is performed within 4 days of symptoms onset. We aimed to describe the prevalence, associated factors and impact of a first false-negative HSV PCR in a large database of critically ill CSF PCR-proven HSE patients Patients and methods/materials and methods: We conducted a re-analysis of retrospective multicenter database of PCR-proven HSE patients from 47 ICUs in France between 2007 and 2017 [1] . Logistic regression was used to identify the specific effect off an initial false-negative HSV PCR on poor neurological outcome, defined as an mRS ≥ 4 (indicating severe disability or death) at hospital discharge Results: A total of 273 patients, age: 64.6 [55.5; 73.7] years, Glasgow Coma Score: 9 [6; 12] at ICU admission, were included. Time from first symptoms to first lumbar puncture (LP) and ICU admission were 1 [0; 3] and 2 [1; 4] days, respectively. Initial HSV PCR was negative in 12 (4.4%) cases. Poor outcome at hospital discharge occurred in 101 (37%) patients. In univariate analysis, the only clinical feature positively associated with a first negative PCR was the presence of focal neurological signs (6/12 (50%) vs. 62/259 (23.9%), p = 0.04). Compared to patients with a first positive PCR, patients with a first negative PCR had lower CSF pleocytosis (4 [3; 62] vs. 51 [12; 160] cells/mm 3 , p = 0.02) and lower CSF protein levels (0.5 [0.3; 0.6] vs. 0.7 [0.5; 1.2] g/L, p = 0.01). There were no false-negative HSV PCR when LP was performed ≥ 4 days after the onset of symptoms. Having a first false-negative HSV PCR was associated with an increased delay between LP and acyclovir treatment (2.5 [1.5; 7] vs. 0 [0; 0] days, p < 0.01). Multivariable analysis revealed that an initial falsenegative HSV PCR was independently associated with a poor neurological outcome (Table 1) . Conclusion: In critically ill HSE patients, a first false-negative HSV PCR occurred in 4.4%, only in LPs performed less than 4 days from symptom onset. False-negative HSV PCR were associated with lower CSF inflammation, increased delay in acyclovir treatment, and were independently associated with worse neurological outcome at hospital discharge Compliance with ethics regulations: Yes in clinical research. Rationale: COVID-19 ARDS is associated with long periods of mechanical ventilation and sedation. Alterations of the cognitive state were reported in 69% of patients suffering from COVID-19 ARDS. Not only do the exact pathophysiological mechanisms behind neurocognitive dysfunction in COVID-19 patients remain unknown, but it is also difficult to predict which patients are likely to suffer from this phenomenon. In this retrospective study in all patients admitted for hypoxia due to COVID-19, the impact of demographic factors as well inflammation-related factors at ICU admission on the development of delirium during ICU stay were evaluated.

After approval of the ethical committee, we included patients admitted to the ICU of the CHU de Charleroi, Belgium, between March to December 2020 for invasive mechanical ventilation with sedation due to COVID-19 ARDS. Pregnant patients and patients requiring ECMO support were excluded. A standard case report form was used for de-identified data collection. Data including delirium status, were collected from the patients' medical records by three independent researchers. Statistical methods included classical parametrical and non-parametrical tests for qualitative and quantitative variables, as well as calculations of areas under the ROC curve (AUC ROC) for delirium binary prediction. Results: 78 patients were included in this study. Demographic factors and comorbidities were not different between patients with or without ICU delirium. Out of several ICU admission inflammation markers (ferritin, CRP, white blood cells, lymphocytes, D-dimers, fibrinogen), higher fibrinogen levels were associated with altered cognitive state during ICU stay (7.19 [6.58-8.30] in patients with delirium vs. 6.63 [5.41-7 .77] mg/dL in patients without delirium, p = 0.025; AUC ROC: 0.65 [95% CI: 0.53-0.75], p = 0.02) ( Table 1) . Discussion: Recently, fibrinogen has been used as a marker of blood brain barrier disruption in neurodegenerative diseases, such as Alzheimer's disease and multiple sclerosis. Increased fibrinogen levels can indeed lead to microglial activation through the CD11b/CD18 pathway and have been associated with cognitive decline (1). Interestingly, some authors have suggested that neurological symptoms in COVID-19 patients might be due to blood brain barrier disruption and subsequent microglial activation (2) . Conclusion: This retrospective study highlights the role of ICU admission plasma fibrinogen as an easy-to-dose marker of cognitive impairment in mechanically ventilated COVID-19 patients. Large prospective clinical trials are needed to confirm this finding. Rationale: More than one-third of COVID-19 hospitalized patients present with neurological manifestations [1] . This prevalence is even higher in the most severe forms, i.e. requiring intensive care. In particular, ICU-associated encephalopathy has been commonly found in these patients, evaluated in up to 84% of ICU-admitted patients in a French monocentric observational study [2] . Thus, the aim of this study was to identify the central neurological symptoms in ICU-admitted COVID-19 patients and their long-term prognosis.

A retrospective multicentric observational study was conducted between March 1st and April 30th 2020. Consecutive patients admitted to the ICU for a COVID-19 disease and for whom clinicians described central neurological manifestations such as encephalopathy, encephalitis, stroke, or epilepsy were included, according to a predefined protocol. Clinical characteristics such as preexisting comorbidities, cognitive and functional status, COVID-19 disease severity, organ failure occurrence, neurological symptoms were collected, as well as biological, electrophysiological and radiological parameters when available. Nine-month outcome was collected by a standardized telephone interview. Results: Sixty-six patients were included, 79% were male; they were 60 [IQR = 14-8] years old, 58 (88%) patients had coexisting comorbidities, mainly cardiac diseases (67%), diabetes (41%), obesity (24%) and smoking (22%). Fifty-seven patients (86%) presented with encephalopathy, five (8%) with encephalitis, seven (11%) with stroke, four (6%) with epilepsy. At 9 months, seven patients (11%) had died, three patients (4.5%) were lost to follow-up. Among survivors, four (7%) remained in hospital (including two with persistent disorders of consciousness), 11 (20%) reported persistent central neurological symptoms. Patients are planned to be evaluated at 1 year. Conclusion: Encephalopathy is the main neurological manifestation presented in our cohort while encephalitis appears to be rare. This result suggests that central neurological complications could be mainly caused by organ failure and intensive care therapies, known contributing factors to ICU-associated encephalopathy, rather than neurotropic invasion by SARS-CoV-2. An overall low mortality rate was observed, and 20% of patients reported persistent neurological complaint at 9 months. The 1-year neurological and neuropsychological assessment will enable the evaluation of the frequency and severity of long-term neurological sequelae through a standardized cognitive assessment, as well as quality of life and the presence of post-traumatic stress disorder. Rationale: Polytrauma is one of the major reasons for patients to be admitted in intensive care unit (ICU). Hypoxemia is one of the major complications observed in this group of patients. However, there is little data about this subject. This is why we conducted this study to evaluate the incidence of hypoxemia to determine each cause and to study its impact on outcome.

We conducted a prospective study during the period between March the 1st 2019 and December 31st 2019 on 110 patients admitted to the ICU of the academic medical center Habib Bourguiba of Sfax to understand the causality of the hypoxemia in polytrauma patients and to analyze its prognosis. Results: Out of 110 polytrauma patients, 83 showed hypoxemia manifestations. The mean age of polytrauma patients with hypoxemia was 35 years and the sex ratio was 5.4 (M/F). The average coma Glasgow score was 8 ± 4. The SOFA score, the SAPS II and the APACHE II score were assessed on the day of admission and the day hypoxemia first appeared and they showed averages of 8, 32 and 14, respectively. The blood glucose levels ranged from 0.5 to 4 g/dL with a mean of 1.34. The blood gas analysis showed that 53 patients developed a hypoxemia on day of admission with a PaO 2 /FiO 2 ratio under 300 mmHg. Ninety-five percent of the patient underwent a body scan revealing brain contusion and cerebral hemorrhage in around half the cases and pulmonary contusion in 41% of the cases. Catecholamines were used in 59% of the cases while artificial respiration aid was needed in 94% of the patients. One-third of patients underwent a surgical intervention while 41% of the cases needed a blood transfusion. Factors associated with a poor prognosis in univariate analysis were lower PAO 2 /FiO 2 ratio (p = 0.01), lower blood pH (p = 0.01), elevated blood sugar level on admission (p = 0.007), the need for blood transfusion (p = 0.022), surgical interventions (p = 0.037), elevated SOFA (p = 0.002), SAPS II (p = 0.028) and APACHE II (p = 0.023) scores. Multivariate analysis showed that advanced age (OR = 1.08), higher SOFA score (OR = 1.86) and sugar blood rates (OR = 1.64) were associated with a poor prognosis. Rationale: Prediction of outcome in chest trauma patients by scoring system is of vital importance to predict morbidity, and therefore institute early intensive focussed care.

This was a retrospective observational study done in our intensive care unit. We noted demographic parameters, history, vital parameters and necessary investigations including chest X-ray and chest CT-scan when patient was admitted in trauma unit. The CTS was composed of four different components with a point system assigned: age (< 45 years = 1, 45-65 = 2, > 65 = 3); pulmonary contusion (none = 0, unilateral minor = 1, bilateral minor = 2, unilateral major = 3, bilateral major = 4); number of rib fractures (< 3 = 1, 3-5 = 2, > 5 = 3); and the presence of bilateral rib fracture = 2. Number of rib fractures and pulmonary contusion were noted from chest X-ray and chest CT-scan. Each parameter has been assigned specific score and final score was calculated by adding scores of each parameter. Final CTS was then calculated which ranges from 2 to 12. Results: Out of 32 patients, admitted from January 2016 to December 2019, 14 (43.8%) patients were younger than 45 years, and nine (28.2%) were older than 65 years. The mean ± SD age of the patients admitted with isolated chest trauma was 48.9 ± 22.4 years. An epidural analgesia have been place in 12 cases (37.5%) out of 32. Seven patients (21.9%) required mechanical ventilation. Association between high CTS (≥ 5) and mortality was not found to be statistically significant (Chi-square coefficient of 1.027 and p-value of 0.311). However, an area under the receiver operating characteristic curve (ROC) for mortality shows an acceptable value of 0.766 (Fig. 1) . At CTS score 9 maximum sensitivity was 66.7% and specificity 84.6%. Conclusion: CTS of at least 9 is associated with worse patient outcomes in our population. Increased vigilance is needed with trauma patients who present with a CTS > 9 at initial presentation. This simple scoring system may improve early identification of vulnerable patients and expedite therapeutic interventions. Compliance with ethics regulations: N/A. Rationale: Injuries are a major cause of death in all ages. They are accompanied by major morbidity with sometimes serious consequences both on a personal, family and social level, particularly for elderly patients whose number continues to increase with the increase in life expectancy. The aim of this study was to assess the prognosis and quality of life after multiple trauma in patients over 65 years. Patients and methods/materials and methods: This is a retrospective study including all patients over 65 years of age admitted to surgical intensive care for multiple trauma between 2017 and 2020. Epidemiological data, the circumstances of the accident, the lesion assessment and morbi-mortality in intensive care and in long term were collected. The quality of life of survivors was determined using the qualitative VAS (0-100) before and at a distance from the trauma and the SF36 questionnaire collected by phone. Rationale: The cannulation of the subclavian vein may seem difficult due to the proximity of the clavicle and the pleura. Changing the arm position amends the anatomical relationship between the clavicle and the vein and could amend its access. To confirm this hypothesis, we conducted a preliminary anatomical study on the hospitalized patients. The aim of this study was to compare the subclavian vein diameter in two arm positions: neutral position (PN) and 90° abduction and 90° external rotation position (ARE).

This prospective study was conducted during 3 months. Patients older than 18 years, hospitalized consecutively in the ICU were included. A unique expert operator performed the ultrasound exams with a vascular probe. The probe was placed perpendicularly to the skin, parallel to the clavicle in its median third portion. The measures were realized for the right side exclusively. At each time, after obtaining a cross section of the vein, the depth and the diameter of the vein were measured, as well as the distances vein-pleura and vein-artery. Results: Thirty-five patients were included. The median age of patients was 62 years. The subclavian vein diameter increased significantly after the arm mobilization (11 mm vs. 14 mm, p = 0.03). The artery, the pleura and the brachial plexus were viewed as frequently in both positions without a significant difference in the distance between these structures and the subclavian vein (p = 0.06). (Fig. 1) . Mean dose of norepinephrine was stable in B-IHD and slightly decreased in AFB. Mean PvCO 2 , bicarbonate concentration and pH after the dialysis filter (i.e. in blood returning to the patients) were 60 ± 4.4, 32 ± 2.3 and 7.34 ± 0.04 in B-IHD compared to 45 ± 9.6, 24 ± 4.9 and 7.35 ± 0.07 in AFB (p < 0.001, p < 0.001 and p = 0.79, respectively). The mean CO 2 removal with bicarbonate zero dialysate was 120 mL/min. The final CO 2 load (i.e. [total CO 2 content "after" minus "before" filter]*blood flow) induced by AFB was 70% lower than with B-IHD. Conclusion: AFB is safe in critically ill patients and is better tolerated than usual bicarbonate-IHD, mainly due to increased diastolic BP suggesting optimization of arterial tone. Euhydric hypercapnia in blood returning from B-IHD probably accounts for hemodynamic instability that is significantly fewer observed with AFB. In-depth characterization of systemic and pulmonary hemodynamic changes (especially, pulmonary arterial resistances) during AFB and B-IHD sessions is warranted. Compliance with ethics regulations: Yes in clinical research. There was no difference in efficacy and safety between the two time periods (2015 and 2017) . Conclusion: RCA with calcium infusion by diffusive influx from dialysate for IHD was easy-to-implement with stable long-term efficacy and safety, but did not improve efficacy and could be associated with an increased risk of circuit clotting compared to heparin anticoagulation in non-selected ICU patients. Randomized trials to determine the best anticoagulation for IHD in ICU patients should be conducted in a variety of settings. Rationale: The occurence of hypertension after withdrawal of vasopressor is poorly described in intensive care units (ICU), but appears to be frequent (1) . Hypertension could result in a second injury to the kidney following septic shock (2) . The objectives of this study were to describe the incidence of early hypertension after norepinephrine withdrawal and investigate its association with acute kidney disease (AKD). Because of the specificity of COVID-19-induced AKI associated with a highly inflammatory state, a higher incidence of CKD at 3 months could be expected. However, this report seems to be reassuring and the low proteinuria supported this hypothesis. Nevertheless, prolonged and careful follow-up is necessary with larger multicenter studies. Compliance with ethics regulations: Yes in clinical research. T60,  T75 , EOV, SV300, Osiris), and one ICU (SV600). The e-SPIRO operated through the mechanical compression of an Ambu bag by two horizontally pivoting arms equipped with 3D-printed jaws moved by a stepper motor. The expiratory valve uses a low pressure electromagnetic control valve generated by the bag pressure itself during insufflation. Positive end-expiratory pressure (PEEP) is generated by a tube dipping in water at the set level controlled by the stepper motor. The overall system is hosted in two plastic boxes (total 48 × 40 × 60cm weighting 27 kg). Alarms, touch-screen interface and manual end-expiratory and end-inspiratory airway occlusions complete the set-up. A robust control is achieved by independent software and state machine running on a STM-32 controller. Each ventilator was set in volume control, respiratory rate 20 breaths/min, inspiratory time 0.8 s, FIO2 21%. We tested three VT (300, 400 and 500 ml), each at 5, 10 and 15 cmH2O PEEP. Each ventilator was connected to an ASL5000 lung model set in passive condition with three combinations of resistance (R in cmH2O/ L/s) and compliance (C in ml/cmH2O) of 10/50, 20/60, 10/40 aimed at mimicking normal, chronic obstructive pulmonary disease and acute respiratory distress syndrome clinical conditions, respectively. Same circuit was used, including High Efficiency Particulate Air (Iso-Gard HEPA light) at both inspiratory and expiratory valve inlets and one Humid-Vent HEPA at the ASL5000 inlet. V T error was computed as ((set V T − measured V T )/set V T )*100 and was assessed across the 10% accuracy boundaries. Results: The median VT error was within the 10% accuracy window in all of the ventilators, including the Open Source (e-SPIRO), but the Osiris (Fig. 1) . This latter under-delivered V T at each RC condition (Fig. 1) . (2) In dynamic conditions, the work of breathing (WOBimposed) induced by the filter and the consequent tidal volume (VT) reduction at low (− 5 cmH2O) and high (− 10 cmH2O) effort were assessed on a lung simulator. Two levels of CPAP (6 and 10 cmH2O) were tested at a resistance of 5 cmH2O/L/s and 15 cmH2O/L/s and a compliance set at 50 mL/cmH2O. The theoretical increase in patient WOB (WOBpatient) required to maintain the same VT after the addition of the filter was also assessed. We finally evaluated the risk of aerosolization by observing smoke exhalation dispersion.

The static airway CPAP pressure effectively delivered was not affected by adding a filter. Dynamic measurements showed that adding a filter variably increased the WOBimposed by the CPAP from 61% to 78% (mostly with a higher filter resistance [DAR-F]) and decreased VT from 236 ± 104 ml to 203 ± 85 ml for a given effort (mostly with a lower filter resistance [CG-F]). The estimated increase of the simulated patient's effort to sustain initial VT without filter varied from 12 to 31% of its total effort, especially with a higher filter resistance [DAR-F] (Fig.) .

Smoke exhalation was visible through the conventional B-CPAP, but not through the filter-B-CPAP. Conclusion: Adding a filter to limit contamination doesn't affect B-CPAP performances on static CPAP level delivered while ensuring low viral aerosolization. It slightly increases the WOBimposed and reduces the VT, requiring increasing the initial WOBpatient, that must be taken into account in a clinical situation. Compliance with ethics regulations: N/A. Rationale: In March 2020, expert agreements preconised the use of the hydrophobic filter in ICU, in order to protect the ventilation devices (optiflow, respirator) in the COVID-19 patient in addition to those usually used in ICU: the electrostatic filter and the hydrophilicpatient filter. Their use was explained in internal procedure. However, in view of the numerous stock shortages, the sources of supply were multiple, leading to confusion between the different filters (color/ form/filter link made in the absence of standardization). The purpose of this work is to make an inventory of the good use of filters and to set up improvement actions; Patients and methods/materials and methods: In September 2020, a multidisciplinary group was formed, composed of intensivists, health managers, the critical care pharmacist (CP) and the pharmacist specialized in medical devices (PMD). An audit grid has been drafted to enable the CP and PMD to perform an EPP (Evaluation des Pratiques Professionnelles) in ICU. Areas for improvement were established and implemented (good use sheet, training). Results: Four audits were conducted between November 2020 and January 2021. At the beginning of November, 67% of the filters usage were in conformity. Work was then carried out jointly by the pharmacy and the ICU (verification of the storage areas, discussions with the nurses/health managers), and a poster was produced and put in place in the storage areas and in units (see appendix). Despite these measures, compliance remained stable at 67% and dropped 2 weeks later to 29%. Following these results, during 1 month, 8 short training sessions for caregivers (70% of the personnel trained [65 caregivers]) were conducted, resulting in a compliance rate of 73% during the 4th audit (the main "non-compliance" being the presence of a hydrophobic filter machine in the non-COVID patients, i.e. an overprotection of the machine).

The COVID-19 period is marked in ICU by an increased activity, medical and paramedical staff coming in for support and practices evolving every day. In this context, the link between ICU and pharmacy, facilitated by the presence of a CP, which was put to the test during this period, was strengthened and made it possible to carry out projects with good use. Results: Of the 332 cases collected, there is a clear male predominance over the entire study period with a sex ratio of 4.9. The average age is 43 ± 17 years. To better assess the severity of infected patients, we mainly used the following scores: the GCS was on average 10 ± 3; the IGS II was on average 28 ± 9. In terms of history, 28.2% of infected patients have a pathological history of which diabetes is the most common. Among 1932 patients hospitalized during the study period, 1725 were hospitalized for more than 48 h, of which 332 were infected, for an incidence of 19.25%. The overall incidence density was 36.6 per 1000 hospital days and that per infectious site shows a high rate of pneumonia. In terms of infectious sites, pulmonary infection ranked first throughout the study period. Of our infected patients, 34.3% received prior antibiotic therapy. Conclusion: Nosocomial infection is associated with heavy mortality and morbidity. Not to mention the high cost which represents an economic burden adding to the budgetary constraints of hospitals. In order to limit this damage, a preventive strategy must be organized which will be based on general measures, mainly washing hands by friction with a hydroalcoholic product, the proper use of gloves, isolation of patients at risk, and the geographical organization of services. Rationale: Intrabdominal hypertension and cirrhosis were identified as risk factors for ventilator-associated pneumonia (VAP). However, no study to date has evaluated the impact of cirrhosis on microaspiration. The aim of our study was to determine the relationship between abundant microaspiration of gastric content and cirrhosis in intubated critically ill patients.

We performed a case-control study using data from three randomized controlled trials on abundant microaspiration in patients receiving invasive mechanical ventilation for more than 48 h. Each cirrhotic patient was matched with 2 controls, based on sex, age, SAPS-II and ICU admission category. Cirrhosis was defined by histology or the association of clinical, laboratory and radiological evidence. Abundant microaspiration was defined by the presence of pepsin and alpha amylase in tracheal aspirates at significant levels. All tracheal aspirates were collected for the first 48 h of study period. Abundant gastric content microaspiration was the primary outcome. Secondary outcomes included abundant microaspiration of oropharyngeal secretions, VAP incidence, duration of mechanical ventilation, ICU length of stay and mortality. Results: Of all 599 patients, 38 (6.3%) had cirrhosis, and were successfully matched with 71 controls. Shock at admission was significatively more frequent in cases than in controls (84.2% vs 59.2% p = 0.014 (0.07-0.63)). Abundant microaspiration of gastric contents did not differ between the two groups (55.6 vs 59.4% (95% CI (0.85-1.35), p = 0.59)). There was no significant difference in duration of mechanical ventilation, ICU length of stay, or ICU mortality (HR = 1.44; 95% CI 0.72-3.02, p = 0.28). Cirrhotic patients had significantly higher risk to develop VAP (HR = 2.0; (95% CI 1.02-3.93), p = 0.04) (Fig. 1 = 0.4) . The most common histories were hypertension (14 cases in G1 and G2, p = 1), diabetes (10 cases in G1 and 8 cases in G2, p = 0.75) and obesity (14 cases in G1 and 12 cases in G2, p = 0.55). Patients in G2 consulted the emergency department later (p = 0.02) with a mean time from symptom onset to hospitalization of 9.6 days (vs. 6.5 days for G1). On admission, they were more asthenic (p = 0.024), with a mean spo2 of 89% (vs 95% in G1, p = 0.008). Patients returned by the Emergency Mobile Unit had less recourse to orotracheal intubation (11 cases vs 21 in G2, p = 0.01). Mortality was significantly higher in G2 patients (21 cases vs 10 in G1, p = 0.04). Conclusion: COVID-19 patients who were hospitalized in intensive care in coordination with the prehospital emergency care and transported via the intensive care unit, have had a better prognosis compared to patients who were hospitalized via the emergency room. Compliance with ethics regulations: Yes in clinical research. Rationale: We analyzed the epidemiological, clinical and prognostic differences between the two waves of Covid.

This was an observational retrospective study, we collected data of Covid patients admitted into ICU during 2020. We have considered as first wave the period between from March 2020 to July 2020 and the second from August 2020 to December 2020. Results: In the first wave, 75 patients were included in the study. Median age was 58 (28-81); mortality rate was 29% (n = 22). Median SAPS was 35.9 (12-60), male sex patients were 55 (73%), median BMI was 30 (16-68), diabetic patients were 21 (28%). The patients presenting AKI were 19 (26%), the chronic kidney diseases were 7 (9.5%), 10 of them (13%) have needed RRT; 50 (66.7%) patients were treated with NIV and 43 (57%) have received mechanical ventilation for a median duration of 11.5 (1-59) days with a mortality of 42% (18) 

This is an observational, single-center and prospective, cohort study. All surviving patients admitted for COVID 19 in our ICU between March and September 2020, were contacted by telephone 6 months after ICU discharge to provide their respiratory status using the Medical Research Council (MRC) dyspnea score (a 1-5 stage scale used to determine clinical grades of breathlessness) and QoL using the EQ 5D scale (a health-related QoL in five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Each EQ 5D health state was converted into a single summary index (EQ 5D Index) using country-specific value sets. Patients were also asked to record their overall health status using a visual analogue scale (EQ-VAS, 0 to 100 -19) has become a global public health crisis. One of the most feared complications is acute respiratory distress syndrome (ARDS) due to its high mortality. The global experience of managing patients with COVID-19-associated ARDS is rapidly expanding. Several reports have assessed the feasibility and effectiveness of prone positioning in awake, non-intubated patients with COVID-19, but benefits on mortality and the ulterior need of mechanical ventilation remain controversial. We conducted this study to evaluate the effectiveness of prone position in the management of critically ill patients.

We report the experience of an intensive care unit between September 2020 and January 2021. We included all patients with confirmed SARS-COV2 infection developing severe ARDS without ventilatory assistance. Respiratory parameters were measured at 2 time points: on supine position and during proning. Primary outcome measures were the change in oxygen saturation (SpO2), respiratory rate and the presence of signs of respiratory struggle. The secondary outcome was the incidence of intubation and mortality rate. Results: A total of 79 patients were included. 64 (81%) experienced prone position during spontaneous breathing with high-flow nasal oxygen or on non-re-breather mask. A significant improvement in oxygenation was found from supine to prone positioning in 58 (90.6%) patients (responders). Respiratory rate decreased from 30.4 ± 12.4 to 21.3 ± 4.7 (p < 0.001). Oxygen saturation increased from 88.1 ± 9.7 to 95.7 ± 3.7 (p < 0.001). Signs of respiratory struggle disappeared in the 78.1% of cases. Non-responders to proning evidenced a higher mortality (83.3% versus 34.5%; p = 0.02; OR = 9.5). No differences in mortality or in rates of intubation were seen in those who experienced proning compared with those who refused it. Conclusion: While our results may not show statistically significant effects on mortality, we clinically observed improvement in respiration status of patients by applying prone positioning which makes this strategy feasible and a useful option in the management of acute respiratory failure due to this disease. Other studies are needed on this subject. Compliance with ethics regulations: N/A. [1] have hypothesized the existence of two phenotypes in intubated patients with SARS-CoV2: type L for low elastance, low shunt and low lung weight and type H for high elastance, high shunt and high lung weight. It has been suggested that these phenotypes may benefit from different management in ICU in terms of tidal volume, PEEP and prone positioning [1, 2] . We aimed to assess response to prone positioning in SARS-CoV2-patients and according to ARDS phenotype.

This is a singlecenter study in a French medical ICU. We included patients receiving mechanical ventilation for SARS-CoV2-ARDS and undergoing at least one proning session. We categorized patients in the L or H groups according to their respiratory system compliance before the first proning session: patients with a respiratory compliance ≥ 40 mL/ cmH2O were classified in the L group. We considered patients to be prone responders if they fulfilled at least one of the three following criteria: an increase in PaO2 to FiO2 (PF) ratio ≥ 20 mmHg, a PF ratio increase ≥ 20% or a decrease in PaCO2 of at least 5 mmHg. Results: Seventy patients were included in our study. Median age was 61 ± 12 years and median SOFA on admission was 6 ± 4. Overall mortality was 65%. Most patients (85%) had low compliance < 40 mL/ cmH2O before prone positioning. Respiratory characteristics before prone positioning and response to proning are shown in Table 1 . Type L patients were taller, and consequently received higher tidal volume. Tidal volume standardized with predicted body weight was similar in both groups. Most patients (74%) met at least one criterion for response to proning. Patients with high compliance had higher initial PaCO2 and a non-statistically significant rate of patients having a PaCO2 decrease of 5 mmHg or more. Discussion: Difference in height and tidal volume may impact respiratory system compliance calculation. Though non-significant, decrease in PaCO2 with proning in the group of patients with lower elastance suggests benefits of the procedure by limiting overdistension and dead-space.

Most patients with SARS-COV2-associated ARDS presented altered compliance and responded to proning, regardless of their initial respiratory system compliance. Further research is needed to better understand the determinants of L and H phenotypes and their responses to prone position in terms of PCO2 reduction. [1] . The factors associated with gas exchange improvement during prone position as well as the evolution of the response to prone over successive sessions are currently unknown.

This single-center observational study was performed in a medical ICU between March 2020 and February 2021. Patients receiving mechanical ventilation for SARS-CoV2-ARDS who had at least 2 proning sessions with respiratory mechanics measurement and arterial blood gas drawn before and at the end of both sessions were included. We considered patients to be prone responders if they fulfilled at least one of the following criteria: a PaO2-to-FiO2 (PF) ratio increase ≥ 20 mmHg; a PF ratio increase ≥ 20%; and/or a decrease in PaCO2 ≥ 5 mmHg. This study aimed at determining the characteristics of the patients benefiting from prone position and the evolution of this response between the first two sessions of prone position. Results: A total of 46 patients were included in this analysis, aged [mean (SD)] 62 (11), with a BMI of 29 (6) kg/m 2 , admission SAPS2 of 41 (14) and SOFA of 6 (4). Half of them had hypertension, 37% diabetes and 17% chronic kidney disease (comprising 7% with chronic dialysis). Most patients were responders (70%, n = 32) to the first proning session, including 8 (17%) not responding to the second session; 33 patients were responders to the second session (72%), including 9 (20%) who were not responders to the first one. Finally, 5 patients (10%) were not responders to any of the proning sessions. Responders to both sessions had lower PF and pH before the 1st session (Table) . At the moment of the analysis, 7 patients were still intubated in the ICU and ICU survival (excluding these patients) was low: 20% in patients who did not respond to at least one of the proning session and 38% in patients who responded to both sessions (p = 0.35) Conclusion: Patients with COVID-19-related ARDS requiring several proning sessions have a high mortality. Gas exchange improvement with prone position is highly variable between patients and within patients from one session to another. Patients with most severe initial arterial blood gas seem to show greater benefit in terms of gas exchange. Reference Compliance with ethics regulations: N/A. The main aim of this study was to investigate the modification of the PaO2/FiO2 ratio, the compliance of the respiratory system in patients under VV-ECMO with refractory hypoxemia. The secondary objective was to evaluate the safety and feasibility of the inclined position for ECMO.

We retrospectively reviewed the electronic records and lists of all 23 COVID-19 patients who were placed for the first time in prone position (PP) with an average duration of 16 h (Fig. 1) . Patient characteristics, pre-ECMO characteristics, ventilator/ECMO settings, and changes in ventilator/ECMO settings and blood gas analysis before and after PP were recorded. 

Samuele Ceruti 1 , Andrea Saporito 3 , Maira Biggiogero 1 , Andrea Glotta 1 , Patrizia Urso 1 , Alain Borgeat 2 , Christian Garzoni 1 thromboembolism. We reported as primary outcome the effects of low-PEEP strategy on P/F ratio evolution during IMV; moreover, ICU length-of-stay (LOS), length of the IMV and ICU mortality rate was reported as secondary outcomes. 

Feriel In univariate analysis, NIV failure was associated significantly to an age above 68 years (p < 10-3), a severe form of ARDS (p < 10-3) and SAPS II score above 29 (p < 10-3). It showed that C-reactive protein > 150 mg/l and fibrinogen > 6.5 g/l (p < 10-3) were also associated to NIV failure. Complications such as acute kidney failure and nosocomial infections were associated significantly to NIV failure. In a multivariate analysis, 2 independent factors predictive of NIV failure were found: Severe form of ARDS at admission (OR:18.1; 95% CI: 1.01-321; p = 0.049), and acute kidney failure (OR: 21.8; 95% CI: 1.70-281; p = 0.018). NIV failure was associated to an extended ICU stay (p < 10-3) and a higher mortality (p < 10-3). Conclusion: A severe form of ARDS at admission and acute kidney failure were reported in our study as independent risk factors predicting NIV failure. This therapeutic complication is associated to an extended ICU stay and a higher mortality. Compliance with ethics regulations: Yes in clinical research. Rationale: High-flow nasal oxygen (HFNO) which reduces the need for endotracheal intubation in patients with acute respiratory failure, is now widely used as first line oxygen delivery means in patient with acute respiratory failure (ARF) caused by COVID-19 pneumonia. The aim of the study is to identify the predictive factors of HFNO failure (shift to invasive mechanical ventilation (IMV)) in patient with ARF.

This was a single-center, observational study performed between October and December 2020. We included patients aged more than 18 years with confirmed SARS-CoV-2 pneumonia and receiving HFNO at admission. Patients intubated within 24 h were excluded. Two groups were identified: HFNO success group (patients discharged from ICU without requiring IMV) and HFNO failure group (requirement of IMV). Collected data: demographic characteristics, time from illness onset to ICU admission, clinical parameters, SOFA score and ROX-index at admission, thoracic CT results, length of stay on ICU and ICU mortality. Results: A total of 70 patients were included. The common comorbidities were diabetes (43%) and hypertension (54%). Mean SOFA and APACHEII were, respectively, 3.9 ± 1.6 and 10 ± 3.5. Time from illness onset to ICU admission was 8 ± 4 days. Mean Rox-index was 3.9 ± 1.1. Prone position (PP) was used on 49% of patients. The mean duration of HFNO was 5.5 ± 2 days and the mean duration of ICU stay was 15 ± 10 days. HFNO failure rate was 43% and mortality rate was 33%. APACHEII score and SOFA scores were higher in the HFNO failure group (12 ± 4vs 8 ± 2, p < 10-3 and 4.8 ± 2 vs 3.2 ± 0.5, p < 0.001). Time from illness onset to ICU admission was shorter in the HFNO success group (6.5 ± 3 vs 9.5 ± 5 days, p = 0.008). PP was more commonly used in the HFNO failure group (88% vs 54%, p = 0.005). Respiratory rate (RR) was higher in the failure group (33 ± 4 vs 28 ± 4, p = 0.008) and PaO2 to FiO2 ratio was lower in the same group (77 ± 25 vs 108 ± 39, p < 0.001). ROX-index was higher in the HFNO success group (4.5 ± 1 vs 3 ± 07, p < 0.001). Rationale: Human cell infection by SARS-CoV-2 leads to ACE2 intracellular pathway downregulation [1] . ACE2 is involved in the baroreflex pathway. Therefore, SARS-CoV-2 could alter responses to hypotension in COVID-19 patients. To assess baroreflex function in COVID-19 intensive care patient, we aimed to compare heart rate (HR) variations in response to dialysis-induced hypotension between COVID-19 and non-COVID-19 septic patient.

We screened all consecutive patients admitted to the Intensive Care Unit (ICU) of the Tenon university hospital (Paris, France) who underwent CVVHDF with ongoing net ultrafiltration and stable catecholamine infusion level from February 2018 to April 2020. Patients who experienced DIH defined as a systolic BP < 90 mmHg with a fall > 30 mmHg (or mean BP < 65 mmHg with a fall > 10 mmHg) were enrolled. Exclusion criteria were non-sinus rhythm, administration of medications inducing bradycardia at the day of DIH onset (cardio-vascular medication including betablockers, neuroleptic, dexmedetomidine), therapeutic modification 2 h before DIH (fluid loading, ultrafiltration, sedative drug), and neurologic disease. Endpoint was the HR variation defined as the HR at DIH onset minus last HR before DIH. Results: Overall, 6 COVID-19 patients (66.7% men; age 58[53-64] years) and 12 non-COVID-19 septic patients (58.3% men; age 67[51-71] years) were included. Baseline characteristics, laboratory finding, and hemodynamic parameters before DIH were similar between the two groups. Catecholamine, dialysis settings and sedative drugs infusion before DIH were similar between two groups except for propofol and midazolam infusion rates that were significantly higher in COVID- Fig. 1 ). After adjustment on absolute HR at DIH onset and infusion rates of propofol, midazolam, and sufentanil, COVID-19 status remains independently associated with a lower HR variation (− 10[− 16 to − 4] bpm; p = 0.004). Discussion: While numerous COVID-19 cardiovascular involvements have been reported including myocarditis, arrhythmias, and bradycardia, ANS dysfunction has not been yet described [2] . Conclusion: In conclusion, we report inappropriate heart rate response to hypotension in COVID-19 intensive care patients, probably related to ANS dysfunction. Intensivists should be aware of this cardiovascular involvement for hemodynamic management of these patients. Rationale: Even after successful resuscitation, out-of-hospital cardiac arrest (OHCA) is a high-mortality condition due to death related to anoxic brain injury and/or post-resuscitation shock (PRS). Predictors of death due to PRS have been poorly investigated (1,2), despite direct therapeutic implications since PRS may be successfully managed with mechanical circulatory support. We performed a retrospective multi-center study in three French university hospitals, in order to determine predictors of death due to PRS.

We included patients successfully resuscitated from non-traumatic OHCA between May 2011 and March 2020, and we assessed baseline and OHCA characteristics, laboratory, hemodynamic parameters on admission and mode of death. Death due to PRS was defined as death from persistent shock despite adequate fluid repletion and catecholamine treatment or due to recurrent cardiac arrest. We performed logistic univariable and multivariable analyses to determine factors associated with death due to PRS and validated the results in a replication cohort. Data are expressed as mean ± standard deviation or median (interquartile range IQR) as appropriate and numbers (percentages). (Fig.) . After adjustment for age and gender, HYPERION and AWARE trial status were associated with lower physical but higher mental component score.

Health-related quality of life of unshockable cardiac arrest survivors evaluated at 3 months was similar to ICU survivors and significantly lower than in individuals from the general population, especially in the physical dimensions. Compliance with ethics regulations: Yes in clinical research. [1] . We aimed at evaluating the prevalence of anxiety and depression symptoms among healthcare workers in intensive care units during the COVID-19 pandemic in Tunisia. Patients and methods/materials and methods: We conducted a cross-sectional study using an online French language questionnaire created with Google Forms and submitted through social media. The participation was entirely voluntary. We used the 7-item Generalized Anxiety Disorder scale (GAD-7) and the 9-item Patient Health Questionnaire (PHQ-9) to evaluate, respectively, the level of symptoms of anxiety and depression. Results: In total, 80 healthcare workers participated in the study. Among the participants, 53.8% were physicians and 46.3% were nurses. The majority of respondents were female (57.5%). The median age was 29 years (interquartile range: 27-30). Before the COVID-19 pandemic, only 16.3% reported having poor or fair mental health, while during the COVID-19 pandemic, poor or fair mental health was reported by most of respondents (71.3%). The mean GAD-7 score was 7.39 ± 4.4. Among the participants, 28.8% reported having symptoms of moderate-to-severe anxiety. Participants with moderate-to-severe levels of anxiety were more frequently nurses than physicians (65.6% vs 34.8%; p = 0.031), were living more frequently in urban areas than rural ones (78.3% vs 21.7%; p = 0.04), and belonged mores frequently to healthcare workers caring for COVID-19 patients (91.3% vs 8.7%; p = 0.012). The mean PHQ-9 score was 9 ± 5.3. Almost half of the respondents (45%) reported having symptoms of moderate-to-severe depression. No significant differences were disclosed between having moderate-to-severe level symptoms of depression and occupation (50% for both physicians and paramedical personnel; p = 0.54), place of residence (urban areas vs rural areas: 88.9% vs 11.1%; p = 1) and management of COVID-19 patients (those caring for COVID-19 patients vs those who did not: 75% vs 25%; p = 0.5). Conclusion: COVID-19 pandemic can affect the mental health of healthcare workers especially those in intensive care units. Interventional studies should be conducted to show the impact of group therapy on the mental health of these healthcare professionals. Reference The main co-morbidities were high blood pressure (28%) and diabetes (23%). The low availability of biological data did not allow us to make a systematic evaluation of SAPS II or SOFA scores. Fifty (20%) patients presented with shock (defined as the need for catecholamine infusion). Overall hospital mortality rate was 42%; it increased when catecholamines (80%) or invasive mechanical ventilation was required (80% and 82%, respectively); conversely, the malarial etiology of sepsis and the performance of interventional treatment for source control were associated with lower mortality. Conclusion: Sepsis is a major cause of mortality in Mali, particularly when circulatory or respiratory organ support is required. A special effort is needed to improve the availability and quality of organ support in limited resources countries Compliance with ethics regulations: Yes in clinical research. Rationale: Pneumonia are common after severe brain injury. They are either inhalation or ventilator-associated pneumonia (VAP). The combination of amoxicillin and clavulanic acid (ACA) or a 3rd generation cephalosporin is recommended by the SRLF and SFAR (2017) for the probabilistic treatment of early VAP (< 5 days) without risk factors for multi-resistant bacteria. The aim of this study was to study microbial epidemiology and to evaluate the frequency of bacteria resistant to the amoxicillin-clavulanic acid combination during early VAP in severely brain injured patients. Patients and methods/materials and methods: Retrospective study in a ten-bed neurosurgical intensive care unit between 01/08/2018 and 30/04/2020. VAPs were considered early if they occurred after 48 h and before the 6th day of mechanical ventilation (MV). VAPs were defined by the association of clinical and radiological signs with a positive culture of a protected distal sampling (> 10 3 cfu/mL) or bronchoalveolar lavage (> 10 4 cfu/mL were associated with GNB insensitive to ACA. Patients with early VAP who had received antibiotic therapy (n = 28) before the onset of pneumonia (including intraoperative antibiotic prophylaxis) were more likely to have GNB insensitive to ACA (p = 0.02). No other variable were associated with pneumonia untreatable by ACA. Bacterial epidemiology of early VAP according to the antibiotic therapy statute is described in the table. Conclusion: In severely brain injured patients admitted to our institution, the amoxicillin-clavulanic acid association is not appropriate in more than a third of early VAP. It should not be used as a probabilistic treatment, particularly in the case of pre-admission antibiotic therapy, including surgical antibiotic prophylaxis Rationale: Early distinguishing ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP) remains difficult in the daily practice. However, this question appears clinically relevant, as treatments of VAT and VAP currently differ (1) . In this study, we assessed the accuracy of sepsis criteria according to the Sepsis-3 definition in the early distinction between VAT and VAP.

Retrospective single-center cohort, including all consecutive patients with a diagnosis of VAT (n = 70) or VAP (n = 136), during a 2-year period. Accuracy of sepsis criteria according to Sepsis-3, total SOFA and respiratory SOFA, calculated at time of microbiological sampling were assessed in differentiating VAT from VAP, and in predicting mortality on ICU discharge. Results: Sensitivity and specificity of sepsis criteria were found, respectively, at 0.4 and 0.91 to distinguish VAT from VAP, and at 0.38 and 0.75 for the prediction of mortality in VA-LRTI. A total SOFA ≥ 6 and a respiratory SOFA ≥ 3 were identified as the best cut-offs for these criteria in differentiating VAT from VAP, with sensitivity and specificity, respectively, found at 0.63 and 0.69 for total SOFA, and at 0.49 and 0.7 for respiratory SOFA. Additionally, for prediction of mortality, a total SOFA ≥ 7 and a respiratory SOFA = 4 were identified as the best cut-offs, respectively, yielding sensitivity and specificity at 0.56 and 0.61 for total SOFA, and at 0.22 and 0.95 for respiratory SOFA. Conclusion: Sepsis criteria according to the Sepsis-3 definition show a high specificity but a low sensitivity for the diagnosis of VAP. Our results do not support the use of these criteria for the early diagnosis of VAP in patients with VA-LRTI. Rationale: SARS COV 2 pandemic is distinguished by a raised antibiotic prescription. This is justified by bacterial co-infection and superinfection risk and antiviral and immunomodulator effect of macrolide antibiotics. Actually, this prescription is increasingly controversial. Our objective was to assess the impact of empiric antibiotic therapy in COVID 19 critically ill patients and to determine its supporting arguments.

Descriptive, prospective and monocentric study including all patients admitted in an intensive care units (ICU) department between 09/07/2020 and 12/31/2020. Demographics, clinical, biological, radiological, bacteriological, therapeutical data and outcomes were collected. Results: Among the 67 patients included and infected by the SARS-COV-2, sex ratio was 1.6 and median age was 64 year. Median SAPS II was 35. Severe acute respiratory distress syndrome (ARDS) was present in 31 patients, moderate ARDS in 32, and mild ARDS in 4. Fever was present in 14 patients (21%) at admission and mean value of C-reactive protein (CRP) was 162 mg/l. All patients received empiric antibiotics associated to a parenteral corticosteroid therapy, including a combination of antibiotics in 64 cases. The remaining three patients received a monotherapy with a macrolide before admission. Antibiotic therapy prescribed was a third-generation cephalosporin in 63 cases, a macrolide in 62 cases, ureidopenicillins in four cases, quinolones in two cases and metronidazole in one case. The mean duration of antibiotic therapy was 7.6 days and global mortality was 49% (n = 33). The empiric antibiotic prescription was justified by high procalcitonin value in 19 cases and by parenchymal infiltrates in chest CT-scan in 38 cases. No microbiological evidence of a community bacterial superinfection was found. Conclusion: COVID-19 pandemic is associated to an over-consumption of antibiotics, especially in ICU. This systematic prescription is not justified by a bacterial superinfection rarely established. Measures of rationalization by more microbiological investigations are needed. Compliance with ethics regulations: Yes in clinical research. -19) remains an increasing global pandemic with significant morbidity and mortality. COVID-19 has been accurately described as the cause for a pro-inflammatory and hypercoagulable status which increases risk of pulmonary embolism (PE) in critically ill patients. The incidence of PE is reported to be up to one-third of those requiring intensive care unit (ICU) admission.

In this study, we aimed to assess the prevalence of PE and its impact prognosis in our cohort.

We conducted a retrospective study in an intensive care unit including critically ill patients with confirmed SARS-COV2 infection who underwent Computed Tomography Pulmonary Angiography (CT-PA) between September 2020 and January 2021. Results: We evaluated 122 patients with COVID-19 admitted to our institution. The mean age was 62 ± 13 years and 95 patients (78%) were male. Among these patients, 57(47%) had hypertension, 52 (43%) had diabetes and 11(9%) had chronic lung disease. 43% of patients were obese (BMI > 30 kg/m 2 ). Mean SAPSII score on ICU admission was 34 ± 16 and mean SOFA score was 5 ± 3. On admission, most of patients were haemodynamically stable (84%). The mean rate of troponin was 0.048 ng/ml. All inpatients received anticoagulation (enoxaparin 40 mg twice daily in ward patients, or enoxaparin 60 twice daily in obese according to local practice). They were referred for CT-PA at initial presentation or in patients who had presented clinical deterioration during hospitalization such as an increased need for oxygen. PE was diagnosed in 5 patients with an incidence of 4%. In patients with PE, emboli were located in segmental arteries in 60% of cases and in proximal arteries in 40% of cases. PE was mainly unilateral (80%). No statistical difference between PE-positive and PE-negative groups was noted regarding age, sex, co-morbidities and in outcomes including mortality, the need of mechanical ventilation and length of stay. Disease extent on CT-PA was not significantly different between patients with or without PE. Conclusion: Our data suggest a low incidence of PE in our population when compared to the literature. However, this low incidence of PE may be attributed to the optimal prescription of therapeutic anticoagulation by front-line physicians in our country even for mild-tomoderate COVID-19 infection. 

This was an observational multicenter study, with retrospective data collection. Patients were 18 years of age or older, hospitalized for suspected or confirmed infection with COVID-19. The SAPS II or SOFA scores could not be systematically evaluated due to the incomplete availability of biological data. The Quick-SOFA (Sepsis 3 definition) was used to evaluate respiratory, circulatory and neurological dysfunctions. Results: Among the 2646 patients admitted for COVID-19 infection, 220 (8%) needed oxygen treatment and were included in the study. The mean age was 58 ± 16 years (range from 18 to 92 years). There were more men (68%) than women. The main co-morbidities were high blood pressure (32%) and diabetes (17%). The QuickSOFA at entry was positive in the majority of patients for respiratory function (75%), in a minority for neurological function (18%), and exceptionally for circulatory function (2%). During hospital stay, only a minority of patients received organ support, either non-invasive respiratory support (12%), invasive respiratory support (8%) or circulatory support (5% received catecholamine infusion). Vital status was collected in 207 patients, with an overall hospital mortality rate of 25%. This mortality was significantly higher in patients with neurological dysfunction at admission (63%) and in those who required intubation (72%) or catecholamines (80%) during the hospital stay. Rationale: In addition to standard ICU scores, several specific prognostic scores have been developed to evaluate the risk of death in patients with confirmed SARS-CoV-2 infection requiring ICU admission. Determining which patients are at high risk of mortality is essential for appropriate clinical decision-making. In this study, we aimed to evaluate the prognostic prediction value of severity scores to help predict mortality.

This is a prospective study performed during a 5-month period (from September 2020 to January 2021) in a 16 bed-ICU of a teaching Hospital. All patients with ARDS secondary to COVID-19 confirmed with RT-PCR, and aged 18 years and more, expected to stay more than 24 h in the ICU were enrolled in this study. They were evaluated according to their baseline characteristics, clinical, radiological and biological variables on ICU admission, as well as the therapeutic characteristics and the evolution during hospitalization. Three scores were calculated to identify high-risk patients for in-hospital mortality: SAPSII, SOFA, and a new COVID-19 severity score [1] , ranging from 0 to 10, based on age, oxygen saturation, mean arterial pressure, blood urea nitrogen, C-reactive protein, and the international normalized ratio was calculated on admission. The performance of these scores in mortality predication was assessed by calculating the area under the receiver operating characteristic curves (AUC). Results: During the study-period 109 patients fulfilled the inclusion criteria and were included in the study. The median age was 64 (IQR: 55-70) years, and 72% were male with a BMI of 28 (27-31). The most frequent comorbidity was hypertension (51%). For the therapeutic approach, the majority (83%) was assisted with high-flow nasal oxygen on admission, and 41 (37%) required invasive ventilation during their ICU stay. The median SAPS II and SOFA score were 29 (24-34.5) and 4 (3-5), respectively. Mortality occurred in 37 patients (34%). The ROC curve is displayed in Fig. 1 Rationale: The objective of the early management of these patients is to preserve a maximum of brain cells and not to aggravate a hemorrhagic process. Currently, the management of blood pressure in patients with ischemic stroke is consensual while the attitude is much less clear in the context of hemorrhagic stroke. We aimed to assess the control of the blood pressure of patients eligible for intravenous thrombolysis.

Patients and methods/materials and methods: Prospective study over a period of 12 months (April 2019 to February 2020). All patients with acute localized neurological deficit presenting to the emergency department eligible for intravenous thrombolysis were included. The data collection was based on an evaluation of the NIHSS score (National Institutes of Health Stroke Score), biological assessment, a brain scanner. The admitted patient was monitored (PNI, FC, FR, SCOPE). The parameters thus studied were epidemiological, clinical in particular the blood pressure profile, paraclinical, therapeutic and progressive controlling hypertension by administering a calcium channel blocker (nicardipine) to achieve blood pressure targets of 180 mmHg/100 mmHg or less. During episodes of hypotension, treatment with vasopressor or volume expansion was initiated cautiously with a blood pressure target of PAS > 150 mmHg. Results: Ninety-three ischemic stroke patients eligible for IV thrombolysis, only 20 patients (21.5%) benefited from IV thrombolysis. We note a slight male predominance 62%, with an average age of 55 years (21-82 years), 6/20 patients required the administration of an antihypertensive treatment to control hypertension and only one case required a vasopressor treatment to control low blood pressure. We noted two thrombolysis failures, no hemorrhagic transformation, and no deaths. Conclusion: A poorly managed hypertension treatment is very harmful because it decreases the cerebral perfusion therefore the perfusion of the penumbra zone, leading to an extension of the ischemic process. Relative hypertension in the early phase of ischemic stroke is beneficial especially when the patient has carotid stenosis. Apart from specific clinical situations, antihypertensive treatment should not be undertaken. One of the objectives of the initiation of antihypertensive treatment is the absolute necessity of varying the blood pressure figures slowly and gradually. All jolts are very harmful. Compliance with ethics regulations: Yes in clinical research. However, visual assessment of EEG-R is liable to inter-rater variability, prompting us to develop predictive models taking into account connectivity analysis with two quantitative (qEEG) measures of EEG-R, namely spectral analysis (FFT: Fast Fourier Transform) and phase synchronization analysis (PLI: Phase Lag Index) following auditory and nociceptive stimulations. Our aim is to assess whether FFT and PLI better predicts awakening within 28 days after non-traumatic brain injury than visual EEG-R and MMN. Patients and methods/materials and methods: We prospectively enrolled comatose patients admitted in neuro-intensive care (monocentric study) for acute brain-vascular injury (poor grade subarachnoid hemorrhage, malignant cerebral infarction and intra-parenchymal hematomas) and who required invasive mechanical ventilation for more than 48 h. Neurophysiological tests included ERPs and EEG to assess MMN and reactivity to auditory (clapping, patients' own name and first name) and nociceptive stimulations (nail bed pressure), respectively. Visual assessment of EEG-R was performed by two experienced neurophysiologists. The predictive models took into account the best variations of qEEG across channels and frequencies, expressed as relative differences (RD) before and after stimulations. The ability of each RD to discriminate reactive and non-reactive EEGs was assessed using the area under the receiver operating characteristic curves (AUC-ROC). Subsequently, an automated stepwise approach was used to select qEEG features for inclusion in a multivariable logistic regression model, with awakening at day 28 as the dependent variable.

We have currently analyzed 59 out of 100 enrolled patients. Neurophysiological tests were performed at a median of 3 (interquartile range, IQR: 3;5) days after brain injury. Median (IQR) GCS and RASS were 3 (3;4) and − 5 (− 5; − 2), respectively. 38 (74.5%) patients had EEG-R, 25 (49%) had positive MMN and 37 (77%) awoke before 28 days. The ability of the final model to predict awakening within 28 days after brain injury was significantly better than that of the EEG-R visual analysis (AUC 0.93 versus 0.55, p = 0.007) but not significantly higher than that of the MMN (AUC 0.93 versus 0.73, p = 0.26). Conclusion: Our preliminary results suggest that assessment of quantitative EEG connectivity with spatial and frequency resolution improves prediction of awakening in comatose brain-vascular injured patients at 28 days. Compliance with ethics regulations: Yes in clinical research. Results: A total of 151 patients were included. The mean age was 54 years, and 60% were female. The average Glasgow score at admission was 13. The most common symptom was headache (87%). Almost 47% of patients were intubated at hospital admission. The mean World Federation of Neurosurgical Societies score was 2. The mean FISHER Score was 3.2. Sixty-five patients benefited from the placement of a temporary Cerebral Spinal Fluid drainage. Among the 151 patients analyzed, 45 patients (30%) died at 1 year follow-up. In multivariate analysis, several independent criteria at admission were associated with the risk of death at 1 year: the motor deficit, a Fisher score equals to 4 on the initial CT scanner, intracranious hypertension or Glasgow score < 7 before take-off. In this study, the mean GOS score was 3.6 and the mean Rankin score was 2.5 at the follow-up. Median transfer time to RCF is 1 day after hospital admission. Conclusion: Compared to literature data on SAH, patients requiring an early transatlantic transportation demonstrated no impairment of their 1-year clinical prognosis. We identified four prognostic criteria able to help clinicians in the decision to send the patient to the remote neuroradiological center (Fig. 1) . These results deserve a comparative study between patients with initial air transportation and those treated without air transportation. Rationale: This study assessed the efficacy of the predicting power for in-ICU mortality of non-specific gravity scoring systems for severe traumatic brain injury in intensive care unit (ICU).

A retrospective study was conducted over a period of 10 months in an intensive care unit including severe traumatic brain injury with age > 18 years and ICU stay > 48 h. APACHEII, IGSII scores at admission and SOFA, MODS and LODS scores were calculated at day 1, 3 and 5.

Results: Of the 37 included patients, mean age (SD) was 42 ± 15 years with a sex ratio of 6. Mean (SD) GCS was 6.8 ± 1.6. The mortality rate was 16% (6 patients). IGSII and APACHEII in deceased patients were higher than in survivors: 57 ± 21 vs. 38 ± 14 (p = 0.004) and 25 ± 7 vs 17 ± 4 (p = 0.001), respectively. ROC curve showed that IGSII > 53.5 had AUC = 0.82, Se 83% and Sp 93% (p = 0.013), and APACHE II > 20.5 has AUC = 0.84, Se 83% and Sp 87% (p = 0.01). LODS day1 and MODS day1 were higher in deceased patients than in survivors: 11 ± 5 vs 5 ± 2 (p = 0.034) and 10 ± 4 vs 5 ± 2 (p = 0.034), respectively. ROC curve showed that LODS day 1 > 6.5 has AUC = 0.847, Se 83% and Sp 87% (p = 0.008) and MODS day 1 > 5.5 has AUC = 0.815, Se 83% and Sp 67% (p = 0.016). LODS day 3 and MODS day 3 were higher in death patients than survivors: 9 ± 4 vs 4 ± 2 (p = 0.037) and 10 ± 5 vs 4 ± 2 (p = 0.05), respectively. ROC curve showed a MODS day 3 > 6.5 has AUC = 0.86, Se8 3% and Sp 90% (p = 0.005) and LODS day 3 > 6.5 has AUC = 0.88, Se 83% and Sp 93% (p = 0.003). The SOFA day 5, LODS day 5 and MODS day 5 were higher in deceased patients than in survivors: 11 ± 6 vs 5 ± 3 (p = 0.048), 9 ± 4 vs 4 ± 2 (p = 0.02) and 10 ± 5 vs 4 ± 3 (p = 0.032), respectively. ROC curve showed that a SOFA day 5 > 6.5 has AUC = 0.819, Se 83% and Sp 79% (p = 0.015), that LODS day 5 > 6.5 has AUC = 0.911, Se 83% and Sp 93% (p = 0.002) and MODS day 5 > 6.5 has AUC = 0.855, Se 83% and Sp 89% (p = 0.003).

The IGS II at admission was better to predict ICU-mortality than APACHE II, LODS d1 and MODS d1 with better sensitivity and specificity. The GCS did not demonstrate its validity as a predictive tool in severe traumatic brain injury. LODS d3 was superior to MODS d3, and LODS d5 was superior to MODS d5 and SOFA d5 with better sensitivity and specificity. Compliance with ethics regulations: N/A. Rationale: The prevention of cerebral ischemia is the main objective of initial resuscitation of brain-injured patients. The first hours are crucial for the prognosis. The evaluation of cerebral perfusion is essential and feasible from the pre-hospital phase by transcranial Doppler (DTC), which helps to evaluate intracerebral hemodynamic rapidly and non-invasively at patient's bedside, thus it facilitates the adaptation of immediate therapeutics.

This is a descriptive prospective study of 71 cases conducted in the anesthesia and resuscitation department of the Mohammed VI Oujda University Hospital, over a period of 1 year between August 2017 and July 2018, including all traumatized serious skulls having benefited from a DTC, performed by the team of anesthesia-resuscitation department of the University Hospital Mohammed VI Oujda Results: The mean age of patients was 39 years [8-83], with a male predominance. Reasons for admission were severe trauma (73%) followed by isolated head injury (27%), 17 patients (57%) had a GCS at admission less than 8 points. In 5 patients, DTC was in favor of a cerebral haemodynamic emergency with pulsatility index > 1.4 associated with a diastolic velocity < 20 cm/s. 39 measurements were supported, based on DTC. Evolution was marked by a total improvement in 33% of patients, 25% had a partial improvement due to diffuse axonal lesions in the majority of cases, 11 patients had a secondary neurological aggravation. The mortality rate was 15%. The mean duration of DTC was 7 min with extremes ranging from 16 min and 1 min. A marked improvement in the duration of the examinations was noted between the beginning and the end of the study. Conclusion: DTC is the tool of choice to detect patients at risk of cerebral ischemia for optimizing immediate and individualized therapy and reducing the duration of cerebral ischemia that improves the prognosis. The use of DTC is rapid, non-invasive, feasible at the patient's bedside, easy learning and reproducible, but requires regular practice. DTC has proved its place in the management of traumatic brain injury in the acute phase in detecting hemodynamic cerebral emergencies, and screening patients at risk of secondary neurological aggravation, and to guide the patient. Current efforts by the industry to miniaturize the components allow this technique to be considered in the resuscitation ambulance. Compliance with ethics regulations: Yes in clinical research.

decided to conduct a study to evaluate antibiotics consumption and prescribing practices.

We conducted a descriptive analytical, retrospective study of patients admitted to the pediatric intensive care unit at Ibn Rochd hospital, in year 2014. Data were collected from a standardized survey form. The adequacy of the antibiotic prescribed initially was analyzed and compared to clinical guidelines and bacteriological data. Results: In this study, 314 patients were treated with antibiotics. The incidence of prescribing was 72%. The mean hospital stay was 7.9 days. While 47% of patients received antibiotic treatment prior to hospital admission, the empirical antibiotic therapy concerned 90% of the cases (data available in 86% of patients). The mean duration of antibiotic therapy prior hospital admission was 4.3 days. After admission, 88% of patients received curative antibiotic therapy, while only 16% of patients received a surgical antibiotic prophylaxis. The curative antibiotic therapy was empirical in 94% of cases based on clinical, biological, radiological and on the ecology of the hospital units. Communityacquired pneumonia (72%) was the main infection. The most frequent prescribed molecules were third-generation cephalosporins (61% of cases) followed by aminoglycosides and carbapenems. Only 16% of patients received monotherapy, while 84% of patients received a combination antibiotic therapy. The initial antibiotic therapy was modified in 72 patients or 26% of the cases. In 39% of cases, modification of initial antibiotic therapy was required to avoid worsening symptoms in 43% of the cases. The average duration of curative antibiotic therapy was 8.1 days. The results of the present study showed that the majority of antibiotics prescriptions in the intensive care unit were justified (98%) and consistent with bacteriology results in 87% of cases. However, only 75% of prescriptions were in accordance with clinical guidelines. The curative antibiotic therapy was excessive in 12% of cases, insufficient in 10% of cases, and inadequate in 1% of cases. The evolution antibiotic was associated with favorable response in 52% of patients. The prognosis was influenced by the age (p < 0.008), the severity of initial symptoms (p < 0.001) and accordance with clinical guidelines (p = 0.009). Conclusion: All these findings showed that adequate antibiotic therapy prior to hospital admission had an impact on patient outcome suggesting that evaluation of prescribing practices can improve the antibiotics use. Rationale: The increase of carbapenem resistance is a major health problem and improving the use of carbapenem is now crucial. Although the pediatric population is very specific, there still be a lack of data in children. Our aim was to assess the compliance of carbapenem prescriptions with guidelines in pediatrics.

We carried out a retrospective study over a 1-year period (2019) in our university hospital. All children admitted who received at least one dose of carbapenem were included. The use of carbapenem was considered as appropriate when 1/compliant with the most recent local/national/international guidelines and/or 2/approved by an pediatric infectious disease consultant at initiation and/or 3/approved by two infectious disease consultants when reviewed retrospectively. As a secondary outcome, we analysed the review of carbapenem at 72 h after initiation.

We collected a total of 96 carbapenem prescriptions (80 (83%), 10 (10%) and 6 (6%) for meropenem, imipenem and ertapenem, respectively) in 75 patients (median age 46 months [IQR 4-115], 34 males). In 61 cases, a bacteria was isolated including 19 (29%) extended spectrum β-lactamases (ESBL)-producing Enterobacteriaceae, mostly Escherichia coli (n = 12, 63%) and Klebsiella pneumoniae (n = 6, 32%). Overall, most of carbapenem prescriptions were considered as appropriate at initiation (n = 89, 93%) whether there were empirical (n = 71, 92%) or documented (n = 18, 95%). The main reasons for carbapenem prescription according to the physician in charge were the unfavorable evolution while treated by another antibiotic (n = 33, 34%), the presence of ESBLs-producing bacteria risk factors (n = 21, 21%), the degree of criticalness (n = 22, 23%) or the presence of neutropenia (n = 19, 20%). The treatments were stepped down at 72 h in 30 (31%) of prescriptions. For 38 (39%) of prescriptions, there was no alternative to carbapenem given the bacteriological documentation. Conclusion: We found that most of carbapenem prescriptions were considered as appropriate at initiation in a retrospective pediatric cohort. At 72 h after initiation of carbapenem, around two thirds of prescriptions should have been improved with a step down strategy. Compliance with ethics regulations: Yes in clinical research.

antibiotic. We aimed to depict the use and related impact of TDM in critically ill children.

We conducted a 6-month prospective single center study to review how TDM was performed and applied by clinicians in critically ill children receiving antibiotics. Blood samples were collected during routine laboratory tests and antibiotics were quantified using LC-MS/MS or HPLC-UV. Results: From June to December 2019, 209 children with a median [IQR] age of 2.4 [0.5-9] years received antibiotics. TDM was performed in 58 (28%) patients with a total of 208 samples. Children undergoing TDM had more organ dysfunctions (3 vs 1, p < 0.05), were more often immunocompromised (64% vs 29%, p < 0.05) and received longer antibiotic therapies (96% vs 89% long treatments, p = 0.012). Median [IQR] time to results was three [1] [2] [3] [4] [5] days and majority of the patients did not reach the PK/PD targets; 40 (53%) of the 75 off-target concentrations available in due time led to dosing adjustments. After adjustment, concentrations better achieved PK/PD targets (70% vs 20%, p 0.013). Initial pharmacological evaluation using surrogates from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) data were not consistent with remote analysis based on measured minimum inhibitory concentration (MIC) in ten (20%) cases. Discussion: This study demonstrates, once again, that antibiotic dosing in PICU is not adequate, with frequent low concentrations. Facing this, TDM in PICU led to changes in practices with dosing adjustments that improved achievement of the PK/PD targets. A few weaknesses limited the value of TDM such as long time to results and the use of surrogates for MIC. Moreover, other PK tools are being developed to guide dosing adjustment at the patient's bedside. Conclusion: TDM may be effective to improve antibiotic exposure in critically ill children. It requires timely available antibiotic plasma concentration and measured MIC. It is mandatory to define which patients should benefit from TDM and how TDM should be managed. Rationale: The present study aims 1/to report the incidence of cerebral arterial vasospasm in a cohort of children with subarachnoid hemorrhage (SAH), 2/to describe how transcranial Doppler can be useful in this clinical application and 3/to describe the management of patients with cerebral arterial vasospasm.

A single-center retrospective study performed over a 10-year period, from January 2010 to December 2019. All patients from one month to 18-years old admitted to the pediatric or adult intensive care unit (ICU) with a diagnosis of SAH were eligible. Results: Data from 80 patients (65% male, median age 8.6 [3.3-14.8] years) were available. SAH was trauma-related in most of patients (n = 59, 74%) and a total of 14 patients (18%) developed a cerebral vasospasm. The non-trauma cause of SAH was the only independent factor associated with the occurrence of vasospasm (p < 0.001). The vasospasm was suspected by TCD before being confirmed by CT or MR angiography in eight patients out of 14 (57%). Increased velocities and decreased pulsatility index were found in these patients. All 14 patients who developed vasospasm were treated by curative intravenous milrinone without side-effect. Finally, death occurred in 12 (15%) patients with a similar incidence between patients who developed vasospasm and those who did not. Rationale: Diabetic ketoacidosis (DKA) is a metabolic emergency and one of the main causes of morbidity and mortality in diabetic children through its complications.

We conducted a retrospective study, including 122 cases admitted to the pediatric intensive care unit, between January 2010 and January 2020. The different variables collected on admission were analyzed and then compared between two groups: the deceased patients d and the survivors. Statistical analysis was carried out with SPSS 21 software. Results: 122 cases of diabetic ketoacidosis were identified. The average age was 7.6 years old. Consanguinity was found in 13% of our patients. Ketoacidosis is inaugural in 62% of cases. The polyuro-polydipsia syndrome was found in all patients, followed by digestive disorders in 56% of cases. The mean GCS on admission was 12. A state of shock was found in 17% of cases and polypnea with Kussmaul-type breathing in 71% of cases. 10% of patients had severe dehydration.

The mean capillary blood glucose on admission was 4.9 g/l. Arterial gas analysis was performed in 60 patients, 36 patients had profound metabolic acidosis. The procalcitonin was requested in 47 patients (33%), positive in 15% of patients. ECBU was requested in 84 patients (59%), it revealed a urinary tract infection in 9 (6%) of them. Brain CT was performed in 77 patients (54%). It was normal in 53% of cases, on the other hand it objectified a cerebral edema in 33 patients or 43%. The mortality rate was 15%. The treatment consisted in an adequate rehydration associated with insulin therapy, according to the protocol for the service. In analyzed united varied, factors significantly associated with mortality are the altered consciousness, shock, fever, use of antibiotics on admission, brain edema, nosocomial infection, use of mechanical ventilation, use of vasopressor and setting up a catheter exchange. In multivariate analysis, factors associated with mortality were the alteration of consciousness, brain edema, nosocomial infection, use of mechanical ventilation, administration of vasopressors.

The diagnosis of DKA must be made early and requires a well-codified management. Difficult access to care, poor hospital equipment and the lack of sufficient pediatric intensive care and resuscitation units remains the main challenge responsible for an increasing incidence of DKA and a non-negligible mortality rate. Rationale: The occurrence of acute renal failure (AKI) complicating rhabdomyolysis is often multifactorial, however more common in adults in the intensive care unit of medico-surgical emergencies in a hospital establishment. Our objective is to determine the risk factors for the occurrence of this AKI sequel to rhabdomyolysis and to define the prognosis.

Retrospective study on the charts of patients admitted for medical and surgical emergencies over a period of 2 years (2017-2019). We identified all the complicated rhabdomyolysis from an AKI. AKI was defined according to the RIFLE criteria, the parameters studied: demographic variables, time to onset of AKI, causes of rhabdomyolysis, biological Discussion: Multivariable analysis showed that the severity of uncorrected hypovolemia and bed rest remain major risk factors for the onset of post-rhabdomyolysis ARI in intensive care. Due to the shortage of resuscitation nurses, nursing care cannot be done properly to avoid complications from agitation. AKI occurrence in the context of rhabdomyolysis is frequent in intensive care units and is fraught with significant morbidity and mortality. Conclusion: Post-rhabdomyolysis AKI is common in intensive care. Its treatment is long and complex, however its prevention is simple by identifying risk situations including rhabdomyolysis, its treatment consists of the rapid correction of hypovolemia in time. Rationale: Snakebite envenoming is an acute emergency requiring an early care delivery. However, in some cases, patients can take several hours before consulting or attending the hospital and receive antivenom (AV). We conducted this study to search for the effectiveness of antivenom in patients consulting tardily after snake bite in French Guiana.

Our study is a prospective observational work. It was conducted in the Intensive Care Unit (ICU) of Cayenne General Hospital between January 1st, 2016 and, December 31, 2019. We included all patients hospitalized for snakebite envenoming. We excluded all patients who received AV in less than 6 h from SB. Our study contained two groups (without AV, AV > 6 h). Results: During the study period, 106 patients were included. The mean age of patients was 40 ± 17 years and 74.5% were male. The meantime from SB to the first medical consultation was 9:27 ± 16:51. The mean time from SB to antivenom therapy was 20:28 ± 14:41. The main clinical symptoms were edema (98.1%) and pain (96.2%). Biological parameters at admission showed defibrinogenation in 96 cases (91.4%), thrombocytopenia in 38 cases (36.5%), hemolysis in 28 cases (26.7% %), and rhabdomyolysis in 38 cases (36.2%). International normalized ratio was > 2 in 79 cases (75.2%), and partial thromboplastin time was > 1.5 in 49 cases (46.7%). Time from SB to normal clotting analyses was shorter in patients receiving AV.

Patients receiving AV > 6 h showed a reduction in the time to return to normal clotting tests, as compared to those managed without AV. We suggest that AV is effective in patients consulting lately after snake bite and receiving AV > 6 h.

Time from SB to normal value of fibrinogen, Factor II, V, VII and VIII according to time of AV injection (without AV vs > 6 h). Rationale: The 3.4 methylenedioxymethamphetamine, known as ecstasy, is one among many methylated amphetamine derivatives. It has become the recreational drug of choice for adolescents. Ecstasy poisoning can cause sever life-threatening pathologies which remain poorly codified. The aim of this study was to identify the initial gravity of ecstasy absue.

This was a retrospective study from February 2019 to November 2020 including patients with acute ecstasy poisoning managed in the emergency department (ED). We collected clinical and therapeutic findings and early outcome Results: 80 cases were enrolled. The gender ratio was 4.3. The median age of patients was 24 ± 7 years. Most patients were attended on summer months (August and September). A history of drug abuse was recorded in 45%. Forty-one percent of patients had consumed additional drugs (alcohol 23%; cannabis 21% and cocaine 6%). The main reasons for attendance at the ED were cognitive disturbances (35%); agitation (20%) and chest pain (7%). The initial neurological examination noticed agitation (20%), hemiparesis in 4 cases. The electrocardiograph showed morphological abnormalities in 8 cases. Rhythm disturbances were found in 10 cases (sinus tachycardia n = 8 and atrial fibrillation n = 2). Biological findings showed rhabdomyolysis in 7 cases and high troponin I concentration in 2 cases. The short-term outcome was favorable in 88% of cases. Six patients were admitted to the ICU. A number of pills > 2 (p = 0.05; OR = 2.8; IC95% = 1.521-15.678) and heart rate > 100 beats per minute (p = 10 −3 ; OR = 8.9; IC95% = 1.474-54.024) were significantly associated with admission ICU.

Studies have shown the severity of NMDA abuse were correlated with rhabdomyolysis and male gender. This difference could be explained by the heterogeneity of drug composition. Conclusion: Ecstasy overdose is a serious problem. The occurence of sever forms is related to quantity consumed > 2 pills and heart rate > 100 bpm. Rationale: Pregabalin use have been recently associated to recreational drug abuse, outshining other substances as we have witnessed a recent increase in the number of patients presenting to emergency. Therefore, it would be interesting to acknowledge the particularities of this rising intoxication.

We conducted a review of all patients presenting with pregabalin usage during 25 months, starting from January 2019 to January 2021. Cases were identified and noted. Results: Twenty-six cases were collected during the study period.

Median age was 20 [21; 53] with extremes ranging from 15 to 53 years. Gender ratio was of 1, 13 males and 13 females. Globally, intoxications became more frequent in August (11%), September (15%), October (15%) and mainly in January (19%). Only three patients (11%) had a history of drug abuse. Five (19%) had a follow-up in psychiatry for a depressive disorder, including a patient who attempted suicide with a rodenticide identified as chloralose that required invasive mechanical ventilation. Two (8%) had diabetes mellitus, one (4%) was dyslipidemic and had chronic obstructive pulmonary disease. The mean delay to presenting to the emergency department was of 6 (± 3.2), [1; 12] h. Pregabalin use was unanimously voluntary. It was associated to other substances in seventeen cases (65%) largely benzodiazepines in nine cases (35%) led by prazepam (11%) and alprazolam (8%).In addition, two patients (8%) smoked cannabis and another used 3,4-methylenedioxymethamphetamine and ethyl alcohol. No opioids, nor cocaine were taken. Twenty-five (96%) patients ingested pregabalin and one (4%) sniffed it. Median pregabalin supposed ingested dose was of 750 [431; 1687] with extremes from 150 to 4500 mg. At first consultation, two (8%) were comatose, two (8%) had seizures, both (8%) showed dysarthria and the rest of sixteen (61%) did not show any sign of poisoning. Pupils examination showed mydriasis in three (11%) cases and miosis in one (4%) case. Osteotendinous reflexes were sharp in only one of the poisoned patients. In total, seven (27%) were admitted to the intensive care unit. Among them four (15%) required mechanical ventilation. Four were transferred to a psychiatric unit and thirteen have evolved well during observation in the emergency room. Conclusion: Doctors should be aware of pregabalin toxicity and illicit misuage leading to dependency and furthermore to poisoning, although current data and opinion suggest that pregabalin has a very low potential for abuse. Moreover, larger surveys should be run regarding its accurate incidence. Compliance with ethics regulations: Yes in clinical research. ]. The length of ICU stay was 6.73 days (with 3 patients who stayed more than 18 days). We observed 63% of acute kidney injury (KDIGO ≥ 2), only one with severe hepatic cytolysis but 12 with prothrombin < 70%. 2/3 had criteria of disseminated intravascular coagulation (DIC). 3 patients died and one suffered from severe neurological disability. We found a tendency between initial temperature and SOFA score but our study lacked statistical power. We dichotomized patients between classical or exertional. Patients with classical heatstroke had more medical history, and morbi-mortality was higher. Exertional heatstroke patients were younger (36.57 years old), none hade medical history Only 6 patients had external cooling, with ice on the body every time. Cooling seems to reduce ICU stays but it was non-significative. Conclusion: This is the first multicenter study, with only ICU patients suffering from heatstroke. Exertional and classical heatstrokes share the same physiology but are different on clinical, biological and prognostic plans. These results need to be confirmed with a bigger group on a prospective study in the South of France in the context of global warming. Compliance with ethics regulations: Yes in clinical research. Rationale: Suicide attempt (SA) is an urgent health problem worldwide. Mental disorders are known as the strongest risk factors for suicide attempts and deaths. In this study we aimed to compare the epidemiologic, clinical features and the outcome of suicide attempters with and without psychiatric history (PH) admitted in the intensive care unit (ICU).

A 3-year (2018 to 2020) prospective analytic observational single-center study including all suicide attempters admitted in a 6-bed intensive care unit. The cohort was divided in 2 groups (group A: patients with PH and group B: patients without PH). Statistical analysis was performed using the statistic software SPSS 23. Results: Among 81 patients enrolled 33 (41%) had history of mental disorder. The most common were depression and bipolar disorder. Mean age was 29 ± 13 years with female predominance (sex ratio = 0.37). There was no significant difference between the 2 groups; in the gender, socio-economic conditions, marital status and the type of intoxication. Severity of the initial clinical presentation (GCS, hypoxemia and hemodynamic instability), need of invasive ventilation and evolutionary complications were also comparable in the 2 groups. Mortality rate was 6% and doesn't vary between them. However, there was a significant difference in the age (p = 0.001) as well as patients with PH were older (with mean age in group A = 37 ± 16 years and 23 ± 9 in group B). Besides patients with PH had more previous episodes of SA (p = 0.016) and the majority of them had no occupation (p = 0.007). Mean SAPS II was higher in group A than in group B(45 ± 19 versus 36 ± 12 with p = 0.023). Even though the need of invasive ventilation were similar in the 2 groups, its mean duration was longer in patients with PH (4 ± 6 days versus 2 ± 1 day with p < 10 −3 ). The mean length of stay was longer in group A (6 ± 7 days versus 3 ± 2 days with p = 0.003). Conclusion: Suicide attempters with mental disorder were older and recidivists compared with patients without PH. Even though there were no significant difference in the method of suicide and the severity of the initial clinical presentation; SAPS II, mean length of ventilation and ICU stay were significantly higher in patients with mental disorder. This emphasizes the importance of an optimal psychiatric care in order to prevent both relapse of mental disorders and recurrence of SA. Patients and methods/materials and methods: Retrospective study over a 5-year period. All patients aged 85 years or more admitted in ICU after unplanned surgery were included. Demographic data, place of living, autonomy, chronic disability and frailty were registered in the pre-operative period. = 26) . Overall ICU and hospital survival were, respectively, 72.4% and 66.7%. Pre-operative assessment: more pre-frail and frail patients had a bad evolution (66% vs. 94.8%, p = 0.013). These patients also had a higher pre-operative ODIN score. In univariate analysis, frailty and pre-operative ODIN score were associated with survival.

Only frailty was associated with outcome in multivariate analysis (9.55 [2.43-37.4]; p = 0.0013). Post-operative assessment: ODIN score and its kidney and haematologic components and SAPS II were associated to survival. In univariate analysis, SAPS II, post-operative ODIN score and the increase in ODIN as compared to pre-operative evaluation were associated with ICU survival. LSTL occured in 31 patients, consisting in 19 withholding and 12 withdrawing decisions. Age, baseline decreased autonomy and baseline kidney disease were associated with the occurrence of LSTL decision. LSTL decisions occurred as soon as the first ICU day in 18 patients. These early LSTL consisted in 11 withholding decisions leading to 3 deaths within 1 [1-3.3] days and 7 withdrawal decisions leading to 7 deaths within 1 [1-1.8] days Conclusion: Overall ICU survival of very old patients after unplanned surgery was 72.4%. Frailty was a reliable and independent pre-operative prognostic factor. Managing patients in the post-operative setting in ICU can be very stressful and demanding. Therapeutic endpoints should be clearly defined together with patients and family whenever possible, to deliver the most appropriate care and avoid caregiver's moral distress. Compliance with ethics regulations: Yes in clinical research. Rationale: The French prehospital healthcare delivery system (SAMU-SMUR) allows the admission of patients directly in ICU. The objective of our study is to describe the epidemiological and clinical characteristic of elderly patients (> 80 years old) admitted in ICU by SAMU-SMUR and to verify that pre-hospital treatment, admission into ICU and the management were coherent.

We conducted a retrospective observational study that included all elderly patients (> 80 years old) admitted to the intensive care unit (ICU) of general hospital between January 2018 and December 2020. We collected demographic and clinical data, prehospital treatment, management in ICU. Exploratory outcomes include univariate analyses of baseline characteristics associations with 90-day mortality. The statistical analyses were conducted in accordance with the predefined statistical analysis plan. Results: During the study period, a total of 59 elderly patients admitted to the ICU by SAMU-SMUR. The mean of age was 84 (80-94). The sex ratio (M/W) was 1.18. 93% of patients had GIR score 5-6. The most common comorbidity was cardiovascular diseases (74%). The other co-morbidities were diabetes (33%), COPD (27%) and chronic kidney disease (15%). Reasons of calling SAMU-SMUR were respiratory distress (57%), cardio-pulmonary arrest (16%), coma (11%) and shock (10%). The prehospital diagnosis was confirmed by the hospitalisation report in 95% of cases. Prehospital management consisted of oxygenotherapy (74%), CPAP (28%), mechanical ventilation (27%) and fluid replacement ± vasopressors (20%). In ICU, 40% of patients were mechanically ventilated [(median duration: 6.4 days (1-40)], 40% of patients were given vasopressors, and 28% of patients underwent CPAP. The mortality in ICU was 32% and 90-day mortality was 37%. The mean stay in ICU was 6.8 days (1-60) . The mean duration of hospitalization of the patients who survived was 17 days (1-110). On the basis of an univariate analysis: male, mechanical ventilation and shock were associated with increased mortality (p < 0.01).

Our results show that the admission of elderly patients in ICU as well as prehospital management seems justified. Others studies are needed on this subject. Compliance with ethics regulations: Yes in clinical research. Rationale: The lesions of nephroangiosclerosis are the histopathological consequences of malignant hypertension (MH). The pathophysiology of MH is commonly extrapolated from the essential arterial hypertension and aging processes. Genetic causes are poorly understood, especially in young patients with renal impairment. Some authors even consider the renal disease per se as the very starting point of MH when associated with renal failure. The objective of our study is to identify both clinical and prognosis data in patients under 40 years old at enrollment receiving a kidney biopsy at their diagnosis of MH. Patients and methods/materials and methods: Patients were identified retrospectively and prospectively through the pathology department databases of 8 French hospitals over 35 years (1985-2020) with the key words "nephroangiosclerosis" and "thrombotic microangiopathy". Results: 114 patients have been included, they were men (N = 77, 67%) aged from 34 years on average; 35% were Caucasians and 35% were African Americans. Diagnosis of an "indeterminate" vascular disease (IVD) was made in 52% of cases. The diagnosis of a primary glomerulopathy was eventually made for 24% of the patients; among them 39% were Berger's disease. We observed serious events associated with the kidney biopsy procedure in 6%. In our selected population, only 7% of the patients had normal renal function, 33% required dialysis and 21% were eventually transplanted. Mortality was 1%. After multivariate analysis, the prognostics factors significantly associated with renal prognosis (dialysis at 6 months) was creatininemia at the time of admission to the hospital (OR = 1.56, 95% CI: [1.34-1.96], p < 0.001) and renal fibrosis > 30% (10.73, [1.53-112 .03], p = 0.03). Astonishingly, presence of thrombotic microangiopathy lesion on renal biopsy was a protective factor (0.14, [0.02-0.60], p = 0.01). Moreover, no significant pathologic or prognostic differences were found between Caucasians and African-Americans patients. Conclusion: IVD/nephroangiosclerosis has been found alone only in 52% of patients in this selected population. Our work shows that a kidney biopsy should be performed in any young patient suffering from malignant hypertension in order to highlight specific pathological features that may be considered as surrogate markers of the underlying renal disease. Indeed, the kidney biopsy led to the discovery of a superimposed renal disease in more than 24% of all cases. In this cohort, elevated creatininemia at the time of admission, fibrosis > 30% and thrombotic microangiopathy represents the only marker predictive of End Stage Renal Disease. Compliance with ethics regulations: Yes in clinical research. Rationale: Static glomerular filtration rate (GFR) formulas are not suitable for critically ill patients because of non-steady-state GFR and variation in the volume of distribution. Kinetic GFR formulas remain to be evaluated against a gold standard. We assessed the most accurate kinetic GFR formula as compared with iohexol clearance among patients with shock. Patients and methods/materials and methods: We conducted a retrospective multicentric study in three French intensive care units in tertiary teaching hospitals in 57 patients within the first 12 h of shock. On day one, we compared kinetic GFR formulas to iohexol clearance, with or without creatinine-concentration correction according to changes in volume of distribution and ideal body weight. We analyzed 3 static GFR formulas (Cockcroft and Gault, Modification of Diet in Renal Disease, Chronic Kidney Disease-Epidemiology Collaboration), urinary creatinine clearance, and 7 kinetic GFR formulas (Jelliffe, Chen, Chiou and Hsu, Moran and Myers, Yashiro, Seelhamer, Brater).

We evaluated 33 variants of these formulas after applying corrective factors. The bias ranged from 12 to 47 mL/min/1.73 m 2 . Only the Yashiro equation had a lower bias than urinary creatinine clearance before applying corrective factors (15 vs 20 mL/min/1.73 m 2 ). The corrected Moran and Myers formula had the best mean bias, 12 mL/ min/1.73m 2 , but wide limits of agreement (−50; 73). The corrected Moran and Myers value was within 30% of iohexol clearance-measured GFR for 27 (47.4%) patients and was within 10% for 9 (15.8%); other formulas showed even worse accuracy. Conclusion: Kinetic GFR equations are not accurate enough for GFR estimation in the first hours of shock. They can both under-or overestimate GFR. Applying corrective factors to creatinine concentration or volume of distribution did not improve accuracy sufficiently to make these formulas reliable. Clinicians should not use kinetic GFR equations to estimate GFR in patients with shock. Compliance with ethics regulations: Yes in clinical research. Rationale: Acute kidney injury (AKI) is a common metabolic complication of the Diabetic ketoacidosis (DKA). Few studies have reported the incidence and characteristics of AKI in DKA. The aim of our study was to describe the epidemiologic, clinical and biological features of patients admitted for DKA in intensive care unit (ICU) in order to deduce the risk factors of developing AKI. Patients and methods/materials and methods: A 7-year (2014-2020) retrospective analytic observational single-center study including all patients admitted for DKA. The KDIGO classification was adopted for the definition and classification of AKI. Statistical analysis was performed using the statistic software SPSS 20. Results: Among 62 patients included, 32 had developed AKI on admission. According to KDIGO criteria patients were staged class I (13 cases), II (9 cases) or III (10 cases). The median age was 42 ± 15 years with a female predominance (sex ratio 0.77). The most common type of diabetes was type 1 (50%), followed by type 2 (31%) then inaugural diabetes (19%). The mean duration of diabetes was 10 ± 12 years. The most common comorbidity was hypertension (28%). The mean duration of symptoms before hospitalization was 6 days. The mean capillary blood glucose measurement was 5.86 ± 1.68 g. The mean IGS II and APACHE II were 33 ± 18 and 17 ± 10, respectively. On admission, 14 patients (22%) had shock. The mean levels of pH and bicarbonates were 7.13 ± 0.15 and 7 ± 4, respectively. Infection was the predominant precipitating factor of DKA (41%). The average of length of ICU stay was 8 days. The symptoms resolved after rehydration, insulin therapy, and antibiotics with a mean duration for the normalization of renal function of 3 ± 3 days. Only 16% required hemodialysis. Mortality rate was 16% and the onset of AKI did not have an impact on prognosis. In univariate analysis: the duration of diabetes (p = 0.02), hypertension (p = 0.027), SAPS II (p = 0.001), APACHE II (p < 10-3), high capillary blood glucose (p < 10-3) and shock (p = 0.03) were all predictors of AKI in our study. Besides; Only SAPS II (p = 0.003) and APACHE II (p = 0.002) were the independent risk factors in multivariate analysis. Conclusion: Although the occurrence of AKI during DKA was frequent in our study, it resolved within a few days and did not worsen the prognosis. The duration of diabetes, co-morbidities, high glucose levels, and severity of the initial clinical presentation (severity scores and shock) were significantly associated to AKI. These results need to be confirmed by further larger studies. Compliance with ethics regulations: Yes in clinical research. Rationale: Proteinuria and acute kidney injury (AKI) are frequent in patients with COVID-19 and associated with poor outcomes. Our objective was to measure markers of proximal tubular dysfunction in patients with acute respiratory distress syndrome (ARDS).

We performed a detailed analysis of urinary markers of kidney dysfunction with urinary protein electrophoresis (UPE) in a prospective cohort of consecutive patients admitted to the Intensive Care Unit (ICU) for COVID-19-related ARDS at the onset of mechanical ventilation. We explored 55 consecutive patients admitted to an ICU for COVID-19-related ARDS. Results: All patients had moderate-to-severe ARDS. No patient had a history of chronic kidney disease. Obesity was the most frequent medical condition. Only 2 patients had received a nephrotoxic medication. Median serum creatinine at the onset of mechanical ventilation was 84.5 µmol/L and only 12 (21.8%) patients displayed AKI. Serum uric acid level was low in 47.5% of patients, and 47 (96.2%) patients had glycosuria while only 15 (27.3%) were diabetic. Microscopic haematuria was detected in 50 (90.9%) patients. Median urinary protein/creatinine and albumin/creatinine were 576 and 68 mg/g, respectively. UPE showed: a tubular profile in 96% of patients, with a superimposed glomerular profile in 17% of patients. No patient displayed a solely glomerular injury. Analysis of urinary proteins showed a massive leakage of alpha-1-microglobulin (a1m, 97.1% of patients), beta-2-microglobulin (b2m, 95.8% of patients), free light chains lambda and kappa (FLCK) (respectively, 96.9% and 100%) and Vitamin-D-Binding-Protein (87.5% of patients). After a median follow-up in the ICU of 24 days, 14 (25.5%) patients had died, 32 (58.2%) had recovered, and 9 were still in critical condition; 28 (50.9%) had developed AKI (KDIGO stage 3 in 10, requiring dialysis in 3). Patients developing AKI had higher baseline serum urea (11.3 ± 1.1 vs 7.2 ± 0.6 mmol/L, p = 0.005), serum creatinine (132.9 ± 16.7 vs. 64.3 ± 4.1 µmol/L, p = 0.001) and serum phosphate (1.10 ± 0.09 vs. 0.88 ± 0.07 mmol/L, p = 0.03) levels and a1m/ creatinine (140 ± 16 vs. 90 ± 18 mg/g, p = 0.05) ratio, and lower eGFR (64 ± 6 vs. 100 ± 4 mL/min/1.73 m 2 , p = 0.001) and serum bicarbonate (21.1 ± 0.6 vs. 23.7 ± 0.6, p = 0.003) at baseline. a1m/creatinine, b2m/ creatinine and FLCK/creatinine ratios were higher in patients who died than in patients who recovered (p = 0.007, p = 0.005 and p = 0.02, respectively). Conclusion: Patients who develop respiratory failure from COVID-19 nearly uniformly display proximal tubular dysfunction, which precedes clinical AKI. Proximal tubular damage seems an important mechanism of COVID-19-induced nephropathy and could be a marker of disease severity. Rationale: Acute kidney injury (AKI) is one of the most common complications observed in ICU patients. Next to risk factors associated to AKI occurrence related to comorbidities and/or severity at ICU admission, several studies have found a protective renal effect favoring the use of balanced solution. This could have been explained by the deleterious effects of hyperchloremia acidosis induced by a highly concentrated solution in chlorine. We aimed to assess the effect of chloremia on AKI occurrence. , p < 0.001 for hypo-and hyperchloremia, respectively). Four trajectories of chloremia during ICU was identified: initially low and high increase (class 1, n = 55), initially normal and moderate increase (class 2, n = 448), initially normal and slow decrease (class 3, n = 5256) and initially high and moderate decrease (class 4, n = 1705). AKI was more frequently observed in class 1 (20%) and class 2 (14.3%) compared to patients with class 3 (7.8%) and class 4 (10.3%) suggesting a potential renal impact of increasing of chloremia.

The present study showed that chloremia is associated with AKI in ICU patients. If both hypochloremia and hyperchloremia at ICU admission were associated with AKI, increasing of chloremia seemed to strongly impact renal outcome within ICU stay. Compliance with ethics regulations: Yes in clinical research. Patients who were hospitalized for less than 24 h are excluded. Phosphatemia was daily strictly monitored. Results: Seventy-five patients were enrolled (median age was 63 ± years with a sex ratio of 2.12) with 569 phosphate measurements. 34(45.3%) had at least 1 episode of hypophosphatemia, 17(22.7%) had at least 1 episode of hyperphosphatemia and 14(18.7%) had showed episodes of mixed hypo and hyperphosphatemia. Demographic characteristics, co-morbidities and nutritional status were comparable between the 4 groups. All patients received steroids, vitamin D supplementation (2000 UI) and parenteral feeding. Hypophosphatemia was earlier onset than hyperphosphatemia (3.3 ± 2.5 day vs 8 ± 5.6 day). Patients who had developed hyperphosphatemia or mixed disorder have required more frequently invasive mechanical ventilation (82%, p = 0.001) with a difficult weaning in comparison of others groups. Those patients had also showed more healthcare-associated pneumonia (59%, p = 0.006), acute kidney failure (44%, p = 0.00001) and septic shock (40%, p = 0.001). The normophosphatemic group showed the lowest ICU length of stay with a median of 7 ± 3.26 days compared to the mixed group (8.5 ± 4.3), the hypophosphatemic group (11 ± 4.7) and hyperphosphatemic group (14 ± 6.6). ICU mortality was significantly higher in patients with hyperphosphatemia: 82% vs 30% in normophosphatemia group. Conclusion: Phosphate disorder in severe COVID-19 patients was associated with poorer clinical outcomes and showed significant impact on ICU management. Therefore, phosphate measurement can be adopted as a severity marker in COVID-19 critically ill. Compliance with ethics regulations: Yes in clinical research.

Malek Rationale: Hypophosphatemia is a metabolic disorder leading to serious complications. It occurs generally in Intensive Care Units (ICUs) and can be associated with poor prognosis. To identify prevalence and associated risk factors of hypophosphatemia in ICU and to investigate whether it is associated with higher mortality.

A single-center retrospective study of all patients admitted to the Zaghouan's ICU over the period of 1 year (Jan-Dec 2020), regardless of the reason for admission, in whom serum phosphate level was measured at least once during their ICU stay. Are excluded from the study patients who were hospitalized for less than 24 h. Patients were divided into 2 groups: G1 = hypophosphatemic group (patients with at least one phosphate value < 0.85 mmol/l) and G2 = normophosphatemic group: patients with explicitly normal phosphate values (0.85 < P < 1.45 mmol/l). Results: A total of 300 adults patients were admitted to our ICU during the study period. One hundred and thirty-one patients (43%) met the inclusion criteria with a sex ratio 1.78 and a median age 57 ± 16 years old. The main reason for ICU admission was respiratory distress (78%). The phosphate median level measured in the first day was 0.97 ± 0.38 mmol/l. Eighty patients (61.1%) had developed at least one episode of hypophosphatemia during their hospital stay, median level was 0.69 ± 0.13. Hypophosphatemeia was noted in 30% of cases at ICU admission. Median of occurrence was at the third day after admission . In multivariate analysis, independent risk factors of hypophosphatemia were: acute respiratory failure ((OR = 4.5, 95% CI 1.10-9.33, p = 0.05), parenteral feeding (OR = 3.2, 95% CI 0.25-2.51, p = 0.033), use of corticosteroids (OR = 2.6, 95% CI 0.14-1.2, p = 0.039) and vasopressors agents (OR = 3.08, 95% CI 0.18-1.90, p = 0.001). Significantly higher invasive mechanical ventilation was applied for patients in the hypophosphatemia group (53.8% vs 35.3%; p = 0.039) and it was also more often associated with more often weaning failure (47.5% vs 25.5%; p = 0.012). Patients with hypophosphatemia had showed more healthcare associated pneumonia (36.3% vs7.8% p < 0.05) and longer ICU stay 11 ± 6 vs 6.6 ± 4 day (p < 0.05). In comparison with normophosphatemic patients, hypophosphatemia was significantly associated with an increased risk of ICU-in-hospital mortality 31.7% vs 16.1% (OR = 1.94,95% CI 0.34-1.50, p < 0.05). Conclusion: hypophosphatemia is a frequent and early metabolic disorder in critically ill adults. Identified risk factors were acute respiratory disease, parenteral feeding, use of vasopressors and corticosteroids. Phosphate monitoring seems to be necessary since it appears to be associated with poorer clinical outcome. Compliance with ethics regulations: Yes in clinical research. Results: During the study period, 945 patients (75% males; age 53 ± 17 years) were included, 84% of whom had a performance status (PS) ≤ 1.

The patients had numerous comorbid conditions, particularly respiratory (67%). On ICU admission, the mean volume of bleeding was 215 ± 184 ml, and 13% of patients required mechanical ventilation within the first 24 h. Lung cancer was the first cause of SH, followed by bronchiectasis, tuberculosis, pneumonia and aspergillosis (Fig. 1) . Episodes of hemoptysis related to pneumonia had increased, as compared with the historical cohort (11% vs. 5%; p < 0.001). The pulmonary artery was involved in 110 cases (12%), mainly during pneumonia (23%), cancer or aspergillosis (20% for both). Noteworthy, the pulmonary arterial mechanism had increased, as compared with the historical cohort (12% vs. 5%; p < 0.001). Altogether, a procedure of vascular interventional radiology was performed in 81% of patients, allowing immediate bleeding control in more than 75% of cases, while emergency surgery was very rarely required (0.9%) for bleeding control. Finally, the in-hospital mortality rate had marginally increased, as compared to that of the historical cohort (8.7% vs. 6.5%; p = 0.08). Independent factors of in-hospital mortality were tobacco use, PS ≥ 1, infiltrates of ≥ 2 quadrants on the admission radiograph, mechanical ventilation within the first 24 h, and lung cancer or aspergillosis as the cause of bleeding (area under the ROC curve at 0.90). Conclusion: During the past decade, the etiologies of SH have changed, lung cancer being the leading cause, and non-tuberculous pneumonia having an increasing role. The most frequent involvement of the pulmonary artery vasculature might be the result of these two latter etiologies. In-hospital mortality has also slightly increased, mainly due to the greater proportion of cancer-related episodes, as compared to that of the historical cohort. [1] admission because of multiorgan involvement with end-organ failure(s), whose may need a VA-or VV-ECMO support. Data focusing on ECMO in SRD patients are scarce and many questions persist. We undertook this study to determine the outcomes and unfavorable outcome-associated factors of severely ill SRD patients requiring ECMO support. Patients and methods/materials and methods: This French monocenter, retrospective study included all SRD patients requiring venovenous (VV)-or venoarterial (VA)-ECMO admitted to a 26-bed ECMO-dedicated ICU from January 2006 to February 2020. The primary endpoint was in-hospital mortality. The secondary outcomes included patient's characteristics (laboratory findings, in-ICU organfailure treatment(s), SRD-specific manifestations and treatment(s), complications). Were compared the primary and secondary outcomes for the entire population and in the following subgroups: flare-/infection-related admission and VA/VV-ECMO. Results: Ninety patients (male/female ratio: 0.5; mean age at admission: 41.6 ± 15.2 years) admitted to the ICU received VA/VV-ECMO, respectively, for an SRD-related flare (n = 69, n = 38/31) or infection (n = 21, n = 10/11). The flow chart reports patients' outcomes according to the reason for admission and ECMO hook-up (Fig. 1) . SRD was diagnosed in-ICU for 31 (34.4%) patients. In-ICU and in-hospital mortality rates were 48.9% and 51.1%, respectively. Nine patients were bridged to cardiac (n = 5) or lung transplantation (n = 4), or left ventricular assist device (n = 2). The Cox multivariable model retained the following independent predictors of in-hospital mortality: in-ICU SRD diagnosis, day-0 Simplified Acute Physiology Score (SAPS) II score ≥ 70 and arterial lactate ≥ 7.5 mmol/L for VA-ECMO-treated patients; day-0 SAPS II score ≥ 70, ventilator-associated pneumonia and arterial lactate ≥ 7.5 mmol/L for VV-ECMO-treated patients whereas vasculitis independently predicts hospital survey. Rationale: Drowning is a major health problem worldwide and especially in low-income countries. The most serious cases are admitted in intensive care unit and often require mechanical ventilation. The aim of our study was to describe the epidemiologic and clinical features of seawater drowning victims, the management and the evolution in the intensive care unit in order to deduce the independent prognostic factors of mortality. Patients and methods/materials and methods: A 5-year (2016 to 2020) retrospective analytic observational single-center study including all victims of seawater-drowning admitted in a 6-bed intensive care unit. Statistical analysis was performed using the statistic software SPSS 23. Results: Forty patients were enrolled. Mean age was 29 ± 17 years with sex ratio of 2,3. The main cause of drowning was exhaustion (38%) followed by current waves (32%), medical cause (20%), fall (5%) and suicide attempt (5%). Mean submersion time was 4.8 ± 4 min and mean time to first resuscitation was 15 ± 10 min. More than half of patients arrived to the emergency at an advanced stage of drowning (severe hypoxia-anoxia and stage 5 or 6 according to the szpilmann classification). Mean SAPS II and APACHE II scores were 35 ± 21 and 15 ± 10, respectively. On admission, 50% of all patients were comatose and 27% shocked. The main biological anomalies were hyperleukocytosis, hypernatremia, metabolic acidosis and rhabdomyolysis. Mean PaO 2 /FiO 2 was 177 ± 113 mmHg and 60% of all cases required invasive mechanical ventilation. The mean length of stay was 7 days and the mortality rate was 20%. In univariate analysis: submersion time ( Results: Forty patients were included. Mean age was 62 ± 12 years with male predominance (sex ratio = 3). The most common comorbidities were obesity (57%), hypertension (50%) and diabetes (40%). Three patients had regular oral steroid with immunosuppressor treatment. The mean symptom duration before hospitalization was 5 days. The mean length of stay in various units (emergencies or COVID departments) prior to ICU admission was 5 days. The most common symptoms reported were shortness of breath (95%), fever (82%), flu syndrome (77%), cough (45%) and digestive symptoms (20%). The mean SAPS II and APACHE II were 32 ± 15 and 14 ± 6, respectively. The mean PaO 2 /FiO 2 ratio was 150 ± 90 mmHg (mild, moderate and severe ARDS in 5, 19 and 16 cases, respectively). Lymphopenia was found in 67% of all cases. Chest computed tomography scan conducted for 31 patients (77%) showed bilateral peripheral multifocal ground glass opacities. The mean lung damage was 60 ± 20%. High-Flow Nasal Cannula oxygenation and noninvasive positive pressure ventilation (NIV) were prescribed in 2 and 27 cases, respectively. Invasive ventilation (IV) was initiated on admission in 11 cases and after NIV failure in 16 cases. The mean duration of IV was 12 ± 10 days, respectively. Prone positioning was done for 15 patients (11 with IV and 4 with NIV). Empiric antibiotic's therapy was initiated upon admission in 75% of patients. All patients received curative doses of anticoagulant, steroids and multi-vitamins. Only three received monoclonal antibodies. Evolutionary complications occurred in 80% of cases. The most common were septic shock (47%) and healthcare associated pneumonia (40% CT scan was normal in 1 patient (7%) and displayed mild anomalies in 13 patients (93%): mild ground-glass anomalies in 5 (35%) and mild reticular pattern in 12 (86%). No fibrosis pattern was observed. Pulmonary function tests were abnormal in 10 patients (71%): All had restrictive disorder and reduced DLCO. MRC score was 60 (57-60). HAD scale results (n = 12) were (Absent/Doubtful/Certain): Anxiety: 7 (58%)/4 (33%)/1 (8%); Depression: 9 (75%)/0 (0%)/3 (25%). IES-R scale results (n = 11) were (mild/moderate/severe PTSD): 7 (64%)/3 (27%)/1 (9%). The systematic assessment allowed to diagnose diabetes mellitus in one patient and a catheter-related arteriovenous fistula in one patient Conclusion: Three to six months after ICU admission for severe COVID-19, survivors still have mild anomalies on CT scan, and abnormal pulmonary function tests. Anxiety, depression and PTSD seem to be as frequent as usually after ICU admission. A prolonged follow-up of these patients may be warranted. Compliance with ethics regulations: Yes in clinical research.

A retrospective comparative double cohort study. Results: we recorded 2 independent groups: COVID-19 ARDS group, n = 62 versus non-COVID-19 ARDS group, n = 59. Clinical characteristics: the median age of patients with COVID-19 was higher (63 vs 48 years, p < 10-3). Co-morbidities: it was showed more of hypertension in COVID group (55% vs 25.5%, p = 0.002) and more of chronic respiratory failure in non-COVID group (34% vs 18%, p = 0.04). The APACHE II score was higher in non-COVID group (17 vs 10, p < 10-3). Blood gas: at admission, the non-COVID group had had more respiratory acidosis (pH = 7.23 vs 7.42, p < 10-3 and PCO2 = 51 vs 41, p = 0.045) and were less hypoxic (P/F ratio = 122 vs 117, p = 0.014). Biology: CRP was higher in non-COVID group (185 vs 174 mg/l, p = 0.004) and conversely LDH was higher in COVID group (675 vs 513, p = 0.009). ARDS severity: the majority of patients among the 2 groups were classified as severe ARDS without difference (79% vs 84%, NS). Management: invasive ventilation was more required for non-COVID ARDS patients (98% vs 56%, p < 10-3). Non-invasive ventilation alternated to high nasal flow oxygen was used for almost all COVID patients. The prone position (PP) was more used in COVID group (60% vs 18%, p < 10-3). Steroids were more prescribed in COVID group (100% vs 62%, p < 10-3) and antimicrobials were more prescribed in non-COVID group (98% vs 77%, p = 0.034). Ventilatory behaviors and outcome: compliance did not differ at the start and in the middle of the follow-up, while it was higher at the end of the follow-up in COVID group. Pulmonary embolism was more common in the COVID group, septic shock and acute renal failure occurred more in the non-COVID group and mortality was high and similar in both groups (table attached) Conclusion: There were many differences: COVID-19-ARDS patients were older with more hypertension and had lower pH, higher capnia, less use of ventilation, more PP and steroids use. The ventilatory behavior was marked by a compliance which increased throughout the follow-up and these data further distinguish the specificity of this type of ARDS. Compliance with ethics regulations: Yes in clinical research. has become a global pandemic mainly associated with acute respiratory distress syndrome (ARDS) leading to significant morbidity and mortality. Previous reports showed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated ARDS was characterized by poorly altered respiratory system compliance (CRS) and severe hypoxemia. Various ARDS phenotypes were also described and suggested. Though increase in pulmonary vascular permeability index (PVPI) associated with accumulation of excess extravascular lung water (EVLW) is the hallmark of ARDS, evaluation of such variables are scarce during SARS-CoV-2 related ARDS. We aimed therefore to measure and investigate these parameters in our critically ills SARS-CoV-2 patients. Positive and moderate correlation was found between worst EVLW and worst PVPI (r = 0.74, p < 0.01) but the negative correlation between worst EVLW and worst PaO2/FiO2 ratio (r = − 0.21, p = 0.21) was not significative as well as between worst PVPI and worst PaO2/FiO2 ratio (r = − 0.25, p = 0.14). EVLW and PVPI were not correlated to the severity of ARDS (Table 1) . Conclusion: In this study, mechanically ventilated SARS-CoV-2 patients had an EVLW more than 10 ml/kg and PVPI almost greater than 3. Our results strongly suggest that patients with SARS-CoV-2 related ARDS behave like 'typical' ARDS with an increased vascular permeability. Compliance with ethics regulations: Yes in clinical research. and the changes in aCOHb over time were different between COVIDrelated ARDS and COVID-unrelated ARDS patients.

This is a monocentric retrospective observational cohort study. Consecutive patients with COVID-related ARDS, admitted between March 1st and May 31, 2020 were compared with a historic cohort of consecutive patients with COVID-unrelated ARDS, admitted between 2015 and 2018. All patients were under invasive mechanical ventilation and fulfilled ARDS criteria according to Berlin Definition. Results: 33 COVID-related ARDS were compared with 42 COVIDunrelated ARDS. Baseline characteristics were not different between groups, except for the proportion of active smokers (3% in COVIDrelated vs 31% in COVID-unrelated group, p = 0.002). Despite lower baseline severity in COVID-related ARDS group (APACHE II and SOFA scores at 16 ± 6 and 5 ± 2 vs 24 ± 7 and 9 ± 3, respectively, p < 0.001), ICU mortality was similar (48% vs 52%, p = 0.73). Baseline aCOHb level was significantly lower in COVID-related ARDS group (0.9 ± 0.3 vs 1.5 ± 0.8%, p < 0.001), with no difference in peak aCOHb levels (2.5 ± 1.1 vs 2.2 ± 0.7%, p = 0.15). While there was an increase over time of aCOHb in both group, this increase was significantly larger among COVID patients (p = 0.004). aCOHb values (baseline, peak or delta peak-baseline) were not related with outcomes. Those findings persisted after adjustment for smoking status. Discussion: Our data show that there is a significant difference in the changes over time of aCOHb between COVID-unrelated and COVID-related ARDS patients, with a lower baseline value and a larger increase over time in the latter group. Different kinetics in aCOHb could be related to increased CO production through a more sustained upregulation of the expression of the heme oxidase (the enzyme synthesizing carbon monoxide in cells) in COVID patients, possibly induced by prolonged oxidative stress. Alternatively, it could reflect a progressively impaired CO elimination through a more severely damaged alveolo-capillary barrier, paralleling the evolution of lung injury. Conclusion: Time course of aCOHb is different between mechanically ventilated COVID-related and COVID-unrelated ARDS patients. (Fig. 1) . Dynamic strain at PEEP increased from 0.15 ± 0.08 to 0.20 ± 0.9 with the change from SP to PP. Conclusion: Changes in pulmonary mechanics during prone-ventilation in Covid-ARDS has a similar pattern than that usually observed in other types of ARDS. Further studies should confirm these preliminary results.

Variation in FRC from supine position (SP) to prone position (PP) for each patient Rationale: Airway closure is a physiological phenomenon in which the distal airways are obstructed when the airway pressure drops below a given threshold during expiration. We assessed this phenomenon in coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS).

This study was conducted in the intensive care department of Amiens university hospital (Amiens, France) from January to October 2020. We included mechanically ventilated patients with eligible criteria for moderate and severe ARDS and with a positive RT-PCR assay for SARS-CoV-2. We evaluated airway closure during low-flow (5 L/min) insufflation starting at a PEEP of 5 cmH2O. We defined airway closure as the presence of an inflection point on the time-pressure curve, and considered that the airway opening pressure (AOP) was the pressure at the inflection point. An AOP above 5 cmH2O was considered to be clinically significant.

We included 27 patients with COVID-19-related ARDS, of whom 12 (44%) had an AOP above 5 cmH2O. The median AOP was 8 cmH2O (IQR, 7-10), with a maximum value of 17 cmH2O. Four patients had an AOP of 10 cmH2O or more. Three patients had a baseline positive end-expiratory pressure lower than AOP. The optimal PEEP was 21 cmH2O (IQR, 19-21) according to the ARDS network protocol and 17 cmH2O (IQR, 15-18) according to the Express protocol. In one patient, the PEEP level according to the Express protocol remained below the AOP and would have led to airway closure. Discussion: Airway closure interferes with the assessment of airway pressure at end-expiration and exhaled tidal volume (causing errors in driving pressure measurement and in the interpretation of the recruitment to inflation ratio). Moreover, repeated opening and closure movements lead to bronchiolar damage and promote ventilationperfusion mismatch. In some patients, the AOP may be high (up to 17 cmH2O, in our cohort) and so the PEEP recommended by the ARDS Network or the ExPress study might not be sufficient. However, one must to bear in mind that airway occlusion is not always complete and may only concern some lung areas (due to ARDS-induced lung inhomogeneity). That is why increasing the PEEP to stop airway occlusion might lead to alveolar overdistention. Conclusion: Airway closure is a common phenomenon in COVID-19 related ARDS. The use of a low PEEP suggested by some clinicians exposes the patients with high AOP to consequences of airway closure. In these patients, it is therefore essential to maintain the PEEP above the AOP. Compliance with ethics regulations: Yes in clinical research. (1, 2). Turbines of CPAP devices may be compelled to develop high flows to achieve the set pressure level in patients with high respiratory demand, thereby increasing substantially the oxygen flow rate needed to achieve a high FiO2. We carried out a bench study to measure the oxygen flow rates needed to reach high FiO2, in a model aiming to reproduce the characteristics of severe COVID-19 patients. Patients and methods/materials and methods: Three different setups were used: (i) Resistance (R) 5 cm H2O/l.s and compliance (C) 60 ml/cmH2O. (ii) R = 5 cm H2O/l.s and C = 40 ml/cmH2O. (iii) R = 5 cm H2O/l.s and C = 60 ml/cmH2O with deported leaks using a T-connector. Each experiment A, B and C were run at 22, 30 and 35 cycle per minute (cpm), with and without non-intentional leakage. FiO2 was measured at 5, 15, 30, 50, 60 and 80 l/min of O2 or the experiment was stop when 100% FiO2 was reached.

Results: An O2 flow rate of at least 30 L/min was necessary to reach a FiO2 > 95% regardless of the set-up, in the absence of unintentional leaks. In the set-ups including unintentional leaks, O2 flow rates of up to 80 l/min were required to reach a 100% FiO2. In those models, the higher the respiratory rate the higher the FiO2 for similar oxygen flows. Rationale: Central venous oxygen saturation (S cv O 2 ), veno-arterial difference in CO 2 tension ('PCO 2 gap') and the ratio of PCO 2 gap with the arteriovenous difference of oxygen (PCO 2 gap/O 2 AVD) can be used to assess the circulatory status of critically ill patients. These parameters are validated and calculated from a venous blood sample taken from the superior cava territory. However, it is sometimes impossible to place a venous catheter in the superior cava territory in critically ill patients for several reasons. The value of these indices measured in the inferior vena cava is unknown. We aimed therefore to assess the link between these indices measured in superior and inferior cava territories. Rationale: Atrial fibrillation (AF) is a frequent condition in patients admitted in Intensive Unit Care (ICU) with acute circulatory failure leading to increased mortality. Landiolol is a short acting beta-blocker used for more than 15 years in AF patients either to control heart rate or to prevent supra-ventricular arrythmia occurrence in case of cardiac surgery. Here, we described in critically ill AF patients admitted in ICU for SARS-CoV-2 infections, our experience in using landiolol in term of efficacy and safety.

We prospectively collected data from adult patients admitted for SARS-CoV-2 infections with persistent AF when heart rate was over 120 bpm. Landiolol was started at a minimum dose of 0.2 µg/kg/min and progressively increased to achieve 20% reduction in heart rate. Classical hemodynamic and parameters were recorded every 2 h during the first 24 h of drug infusion. The measurement of LV GLS using TEE is feasible in three-fourth of ICU ventilated patients with septic shock. Intra-and inter-observer reproducibility are excellent. Although no relationship was found between LV GLS value and ICU mortality, further assessment is warranted in a larger prospective multicenter study.

was found between admitted and rejected patients regarding SpO 2 (p = 0.41), PaO 2 (p = 0.91), PCO 2 (p = 0.2), and oxygen-therapy (p = 0.18). All patients not admitted in the ICU improved their clinical condition and none of them died. Regarding patients' distribution about SpO 2 less than 92%, the ICU-group hold 17 (68%) patients while the rejected-group hold 9 (75%) patients (p = 1.0). Conversely, Chisquare analysis reported significant differences regarding dyspnea distribution (p = 0.03) as well as SpO 2 less than 85% (p < 0.001). Conclusion: Patients with COVID-19 interstitial pneumonia often presented tachypnea and desaturation, without dyspnea or severe neurological symptoms or any other organ damage. A conservative approach based on strict surveillance until the onset of dyspnea or desaturation with SpO 2 85% or even lower, before proceeding with ICU admission, resulted a good procedure to avoid ICU overload and to guarantee 'ICU refused' patients survival.

Rationale: Acute respiratory distress syndrome (ARDS) survivors frequently suffer from anxiety, depression or post-traumatic stress disorder (PTSD). COVID-19 pandemics has provoked an unprecedented strain on our health systems, especially on intensive care units with unknown consequences on patients' mental health. The aim of this pilot study is to assess the feasibility of an early psychological evaluation and support in patients with COVID-19 hospitalized in intensive care unit (ICU) and describe their mental health outcomes during a 6-month follow-up.

Psychological support was proposed to every COVID-19 survivor at invasive ventilation weaning or when conversation was feasible for patients receiving high-flow oxygen. Every patient was evaluated by a trained clinician psychologist during their hospitalization in ICU. Standardized evaluation occurred at day 7, week 6, 12 and 26 after ICU discharge with psychometric evaluation (HADS, PCL-5, ISI and SF-36 scales). Factors associated with insomnia, anxiety, depression and PTSD symptoms in follow-up were identified using linear mixed models. Results: Thirty-eight patients were included (82% of men, mean age of 59 (± 11)). Rationale: Having a family member hospitalized in the intensive care unit is a stressful event that can cause Post-traumatic stress disorder (PTSD), depression and anxiety. Many factors associated with PTSD were identified but these factors did not include reasons of intensive care admission. Aim: Prevalence and factors associated with post-traumatic stress disorder in family member of intensive care unit patients. Patients and methods: This is a prospective analytic study. We included all family members of ICU patients with a duration of stay more than 3 days during 2020. The Arabic version of the Post-Traumatic Checklist Scale (PCLS) was used to identify family member with PTSD. Two groups were individualized. Group 1: family member with PTSD (defined as those with a total score of 50 or higher). Group 2: family member who did not meet the criteria for PTSD (those who scored lower than 50 There were 33 cases of pneumonia followed by bloodstream infections (n = 18) and urinary tract infection (n = 2). A microbiological investigation was made in 25 cases. The most frequent bacterium among patients was Klebsiella pneumoniae (n = 10), followed by Enterococcus faecium (n = 6), Acinetobacter Baumanii (n = 4), Pseudomonas aeruginosa (n = 4) and Escherichia coli (n = 1). The development of a nosocomial infection extended ICU stay by 10 days. This complication was significantly associated with acute kidney failure occurrence (p < 10-3), septic shock (p < 10-3), invasive mechanical ventilation (p < 10-3) and mortality (p < 10-3).

Bacterial nosocomial infection is a common complication of ICU admission in patients with COVID-19 and ventilator associated pneumonia remains the most frequent. Our study noticed an association with a higher morbidity and mortality. [5, 11] . The NFI was diagnosed with a positive mannan antigenemia in 11 cases (with positive anti-mannan serology in 8 cases), a positive colonization index (CI) with a high candida score in 9 cases and positive blood cultures in 2 cases. The CI was achieved in 21 patients and was positive in 20 cases. The most frequently positive site was urinary (30%) and cutaneous (30%). The most frequently isolated candida was C. albicans (73.3%), C. krusei (23.3%) and C. glabrata (4%). Length of stay had a median of 18 days [14 -21] . The occurrence of NFI was significantly related to the presence of diabetes (p = 0.007), severe ARDS (p < 10 −3 ), nosocomial bacterial infection (p < 10 −3 ), vascular catheterization (p < 10 −3 ), urinary catheterization (p < 10 −3 ) and parenteral nutrition (p < 10 −3 ) also to lower serum albumin level less than 23 (p = 0.005 Results: DNAemia with EBV, CMV, and HHV-6 was detected in 28/34 (82%), 5/34 (15%), and 7/32 (22%) patients, respectively. EBV reactivation occurred early (median 4 days) after ICU admission and was associated with a longer ICU length-of-stay. CMV reactivation occured more latelely (median 12 days) after ICU admission, and required anti-CMV treatment in 3/5 (60%) patients. HHV-6 viremia was noticeable for a low viral load and a short duration. No association was found between ICU mortality (6/34, 18%) and EBV, CMV and HHV-6 reactivations. This was partly due to the small size of the cohort. Conclusion: Our study shows that EBV, CMV and HHV-6 reactivations are frequent in severe COVID-19. The identification of risk factors and the association with clinical outcome require larger studies. The relationship between herpesviruses reactivation and host immune response deserves further attention.

Rationale: Mid-regional proadrenomedullin (MR-proADM) is a peptide, an adipokine, generated by multiple tissues to stabilize the microcirculation and protect against endothelial permeability, both of which are widely acknowledged to play a significant role in the pathophysiological host response to sepsis. An elevated concentration of MR-proADM has been associated with both short-term mortality and complications in patients with sepsis and community-acquired pneumonia. Endothelial dysfunction plays an essential role in the pathophysiology of severe SARS-CoV-2 infection; therefore, we wonder if MR-proADM measured serially could be an informative prognostic biomarker in this disease. In our study we proved that a rate of PCT higher than 0.3 µg/L was significantly associated with mortality (74.7% versus 32.8%; p < 10-3; OR = 6 [2.9-12.3] and a higher use of invasive ventilatory assistance (69% versus 20.6%; p < 10-3: OR = 8.5 [4-18.3]). We also found that a rate of CRP higher than 120 mg/l was significantly associated with mortality (67% versus 35.7%; p < 10-3; OR = 3.7 [1.9-7]) and a higher use of invasive ventilatory assistance (58.8% versus 30.4%; p < 10-3: OR = 3.2 [1.6-6.35]). Conclusion: Inflammatory markers including C-reactive protein (CRP) and procalcitonin (PCT) have been identified as predictors of clinical severity and complications to provide reference for clinical treatment. More sensitive indicators able to reflect lung lesion changes and disease severity had to be explored. Compliance with ethics regulations: N/A. Rationale: Known for its low dose analgesic properties, ketamine is molecule of choice in procedural sedation in emergency rooms. Several routes are being tested. The objective of our study was to assess the analgesic property of intranasal ketamine in moderate-to-severe pain in the emergency department Patients and methods/materials and methods: It was a prospective study carried out in the emergency department during 1 year. We included patients over 18 years of age with moderate-to-severe acute pain with a visual analogue scale (VAS ≥ 5). We did not include patients with any of the following criteria: History of allergy or intolerance to ketamine, Structural or functional nasal occlusion. Ketamine was used intranasally at a dose of 1 mg/kg. Primary endpoint was obtaining a VAS ≤ 3 mm at 30 min from the administration of ketamine.

We included 60 patients with a sex ratio of 1.14. Rationale: Ketamine used in sub-dissociative doses has emerged as an alternative to traditional opioids for pain control in emergency department. The aim of our study was to evaluate analgesic efficacy and safety of intravenous (iv) ketamine in emergency department (ED).

This was a randomized, double-blind, 10-month prospective trial. Patients with moderate-to-severe acute pain, defined as a score on a numerical rating scale (NRS) of 6 or greater were randomized to receive either ketamine 30 mg iv or morphine 10 mg iv. Primary endpoint was pain reduction at 10 min. Informed consent was obtained. Results: We included 120 patients; 54 received ketamine and 66 morphine. Mean age was 44 ± 15 years in morphine group and 43 ± 14 years in ketamine group p = 0.7. Thirty-two patients (26.6%) visited the ED for a trauma. Thirty-six percent presented chest pain, 21% limb pain and 18% abdominal pain. Overall NRS was at 8.7 ± 1.4 with no difference between groups. At 10 min, the same number of patients in both groups achieved an NRS lower than 4 (p = 0.09). However, the mean NRS was significantly lower in the ketamine group (p = 0.008). More adverse effects were noted in the ketamine group (p < 0.0001). No significant changes in vital signs were observed and no serious adverse events occurred. Nevertheless, patients in the ketamine group reported an increase in minor adverse events 15 min after drug administration. Conclusion: Intravenous ketamine offers an analgesic efficacy comparable to that of intravenous morphine for short-term management of acute pain in the ED. Compliance with ethics regulations: Yes in clinical research. Rationale: Performing EEG is recommended to assess brain function and outcome of comatose patients. Background rhythm and associated abnormalities (discontinuous, unreactive patterns) are important parameters to identify for prognostication. The objective of the study was to assess feasibility and interpretation of a simplified EEG montage performed by intensivists for prognostication. Patients and methods/materials and methods: All consecutive patients admitted in the ICU from January to November 2019, for whom an EEG was requested for persistent unresponsiveness, were eligible. For each patient, a simplified (10 monopods) EEG montage was performed by one intensivist at bedside. The interpretation of EEG was performed by one intensivist and one neurophysiologist, on 3 specific patterns: (1) predominant background EEG frequency (Hz);

(2) presence of a continuous or discontinuous background, including burst suppression; (3) background reactivity. Data are presented as median (interquartile range) or numbers (percentage). Agreement between the neurophysiologist and the intensivist was made using Cohen's kappa coefficient or Pearson's correlation, as appropriate. Statistical analyses were performed with SAS ® Software. with predominant theta (39%) or delta (47%) activity. Continuous EEG background was observed in 28 (78%) cases, and preserved EEG reactivity to both nociceptive and auditory stimuli was observed in 4 (11%) cases. Agreements between the intensivist and the neurophysiologist are presented in the Table. Concerning background frequency and continuity, the correlation was satisfactory, whereas there were discrepancies for background reactivity analysis (Cohen's kappa 0.37 and 0.44, respectively). Compared to the neurophysiologist, the intensivist diagnosed preserved reactivity more frequently, which could be influenced by clinical reactivity at bedside during stimulation. Conclusion: A simplified EEG montage for prognostication of comatose patients in the ICU appeared technically feasible. Compared to physiologists' interpretation, identification of background frequency and continuity by intensivist was satisfactory, whereas discrepancies were observed for background reactivity. These preliminary findings deserve validation in an independent cohort. Compliance with ethics regulations: Yes in clinical research. Patients and methods/materials and methods: A retrospective observational study was performed over 10 years (2010-2020). All GBS presentations admitted to ICU were included. Clinico-epidemiological features, treatments, clinical course and outcomes were assessed. Results: We reviewed 43 GBS patients (58% male) with a mean age at 41 ± 15 years. Previous infection was identified in 72% of cases; and it was mainly secondary to flu-like syndromes (44%). The mean delay between symptoms onset and ICU hospitalization was 11 days. The major cause of hospitalization was acute respiratory failure (44%). The mean IGSII was at 16 and mean SOFA was at 2. Acute motor axonal neuropathy was the most common feature (42%) and acute inflammatory demyelinating polyradiculoneuropathy was found at electroneuromyography in 19% of cases. cerebrospinal fluid albumino-cytologic dissociation was present in 56%. Thirty percent received IVIg and 54% received TPE. Twenty-two patients (53%) needed mechanical ventilation with a mean delay of 12 days and a mean duration of 14 days. The major complication during ICU stay was pulmonary infection (42%), and pulmonary embolism was detected in 14% of cases. The mortality rate was at 21% in our population. The risk factors were higher SOFA score, infection and pulmonary embolism. Rationale: Organ transplantation is the only alternative for many patients with terminal organ failures. It has become essential for developed and mature health care systems. While the demand for organ transplants is increasing, the rate of transplants is still low. Our multiorgan donation coordination focused on the quality and security of the "organ donation process" in potential brain-dead organ donors. Patients and methods/materials and methods: We analyzed the organ donation process. We reviewed its steps and subsystems with the backward mapping. We identified potential failure modes of the procedure and their causes and effects and we recorded them in a specific Failure mode and effects analysis (FMEA) worksheet.

The specific failure mode and effects analysis (FMEA) worksheet with the backward mapping of the "organ donation management" process identified 7 process steps, 30 sub-processes and 80 failure modes. By weighting the items at the management level ( Fig. 1) , we identified 3 risks in red (not acceptable) and 18 risks in orange (acceptable to assess). For each of these failures, we have proposed actions for improvement. The interveners are essentially the organ donation coordination, the resuscitation department and the quality and risk assessment department. Discussion: The backward analysis of the risks allowed us: to analyze the current organization and operational modes; to identify risky situations in organ donation process; to propose actions to improve and secure these practices Conclusion: As part of the hospital certification on the one hand and in response to the biomedicine agency's audit report, we have been working on the organ donation process and risk management and have put in place corrective actions. A periodic assessment is Rationale: SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C) is frequently associated with shock. Endothelial involvement may be one of the underlying mechanisms. We sought to describe endothelial dysfunction during MIS-C with shock and then assess the relationship between the degree of endothelial involvement and the severity of shock. Patients and methods/materials and methods: This is an observational study conducted in a Pediatric Intensive Care Unit (PICU) in a tertiary hospital between April the 1st and May 31st, 2020. Patients aged less than 18 years with SARS-CoV-2-related MIS-C and shock, according to the Centers for Disease Control and Prevention criteria were included. Demographics, clinical, biological data including inflammatory and endothelial markers were collected. Endothelial markers were assayed in the first blood sample collected after PICU admission. Data were expressed as the median [interquartile range (IQR)] or the frequency (percentage). Correlations between the endothelial marker levels and shock severity were assessed by calculation of Spearman's coefficient. Results: Twenty-eight patients were included. The patients' age was 9 years [8-11] with a median Pediatric Logistic Organ dysfunction-2 score of 3 [2] [3] [4] . Sixteen children presented with cardiogenic shock and distributive shock, 10 presented with cardiogenic shock only and 2 children presented with distributive shock only. The median left ventricular ejection fraction, troponin and lactate levels were at 40% 

The weak correlation between the two variables could be due to many factors, one of which is a small dataset. The frequent use of vasoactive amines (epinephrin, milrinone) in post-operative cardiac surgery can modify the peripheral circulation and influence on the thermal gradient. The central temperature should also influence the thermal gradient. This weak correlation can also be due to the infrared technology itself like the Flir one camera lack of performance or other technical aspects. Conclusion: Thermography is potentially an additional tool in multimodal monitoring after cardiac surgery. A more significant correlation would probably observe with a larger dataset, after taking confounding factors into account and with a more reliable technique of thermal image acquisition. Compliance with ethics regulations: Yes in clinical research.

Correlation between O2ER and thermal gradient FC-220 Heart rate reduction with ivabradine in infants with tachycardia after open-heart surgery: a pilot study Yael Levy 2 , Julien Jegard 2 , Jean-Bernard Selly 2 , Bernard Kreitmann 2 , Nadir Tafer Rationale: Necrotizing enterocolitis (NEC) is a well-known complication in newborns. The main risk factors are prematurity and low birth weight. Congenital Heart Disease (CHD), especially those with duct dependent condition, also have an increased risk of NEC. The objective of this study was to identify risk factors for NEC in patient with ductdependent congenital heart disease. Patients and methods/materials and methods: This is a case-control, retrospective study in a pediatric intensive care unit. Newborns with duct-dependent CHD and NEC, defining the "CHD + NEC" group, were matched to 1:1 (on gestational age, birth weight and antenatal or postnatal diagnosis of heart disease and type of CHD) to those without NEC, a "CHD without NEC" group. Results: Twenty-three infants were included in each group. In univariate analysis, lower diastolic blood pressure (PAD) was a risk factor for NEC (26.1 ± 3.9 mmHg vs. 30.3 ± 5.8 mmHg, p = 0.008) while a more negative inflow balance, peritoneal dialysis and adrenaline-pumping were significantly associated with a decreased risk of developing NEC (respectively, p = 0.008, p = 0.002, p = 0.007, p = 0.017). In multivariate analysis, diastolic blood pressure (PAD) ≤ 30 mmHg was an independent risk factor of NEC (OR-8.70; 95% CI [1.46-53.50], p-0.019) (Fig. 1) .

In CHD + NEC group, mortality, lenght of intensive care unit stay and lenght of hospital stay were significantly higher (34.8% vs. 

Main feature of the COVID-19 outbreak is an acute respiratory failure linked with diffuse alveolar damages. However, there are reports of increased rates of acute kidney injury (AKI) ranging from 5% to 36% in hospitalized patients and rising up to 52.2% in ventilated ICU patients 1,2 . Mechanism, risk factors and outcome of AKI related to COVID-19 are not fully understood.

We conducted an observational study to assess risk factors of AKI in patients admitted in ICU for COVID-19. All patients admitted in our ICU with COVID-19 confirmed by positive SARS-CoV-2 RT-PCR or COVID-19 serology between March 1st 2020 and May 30th 2020 were included. We collected all clinical and biological data within the 14 first days following admission. Primary outcome was severe AKI defined by a KDIGO stage ≥ 2. Statistical analysis was carried out by using a multivariate time-dependent Cox cause-specific proportional hazard (CSH) model. Missing values of covariates in the multivariable model were handled by multiple imputations with chained equations. All tests were two-sided, with P values of 0.05 or less denoting statistical significance. Results: Seventy-seven patients were included in the study population ( Rationale: Infection with COVID-19 is primarily a respiratory illness, but other organs including the kidneys are often affected. However, the incidence of acute kidney injury (AKI) reported in COVID-19 patients is extremely variable and the renal complications of COVID-19

are not yet well explored. This study aimed to identify the incidence of AKI in patients with COVID-19 and to evaluate it's impact on patient outcomes.

We conducted a retrospective study including critically ill patients with confirmed SARS-CoV-2 infection in an intensive care unit during 4 months. AKI was defined according to the serum creatinine criteria in the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Results: A total of 178 patients were admitted during the study period. The mean age was 62 ± 12.8 years, and 132 (74.2%) of patients were male. Among these patients, 84 (47.2%) had hypertension, 76

Rationale: Acute kidney injury (AKI) has been reported as a severe complication of COVID-19 [1] . Few of studies have reported AKI stages.

We report the incidence, risk factors, severity, and prognosis of AKI in an observational study including 333 patients with severe SARS-CoV-2 infection in three ICUs between March 4th and November 30th, 2020. AKI was diagnosed and classified according to the KDIGO classification. We collected demographic data, comorbidities, exposition to nephrotoxic agents, need for supportive therapy and death 28 days after ICU admission. We compared baseline patient characteristics between patients with or without AKI. We excluded patients with end stage kidney-disease (n = 7), patients hospitalized for < 48 h (n = 8), patients with missing date (n = 2), and patients transferred to another ICUs (n = 42). Results: Among the 274 remaining patients, 117 (43%) presented AKI. The median time from ICU admission to highest AKI stage was 6 (IQR 2-13) days. Patients with AKI were distributed as follows: stage 1: 33%, stage 2: 21% and stage 3: 46%. A total of 33 patients required renal replacement therapy. By univariate analysis, age > 65 years, chronic hypertension, diabetes mellitus, chronic kidney disease, chronic use of ACEI or ARB, cardiovascular disease, mechanical ventilation, vasopressor therapy were predictors of AKI. Independent predictors, by multivariate analysis, included chronic kidney disease and mechanical ventilation. Mortality was significantly higher in AKI patients (58% vs 16% p < 0.001) compared to patient with normal renal function. Figure 1 shows that mortality increased along with AKI severity. Discussion: As expected, our results show that AKI is frequent in COVID-19 critically ill patients and confer a poor outcome. However, our study is one of the largest published to date reporting AKI stages specially in critically ill patients. The present results underline the need of mechanical ventilation support as a risk factor for the development of AKI. Recent evidence has established that kidney involvement is parallel to the severity of the underlying lung involvement [2] . Conclusion: Due to its high prevalence and severity, early detection of impaired renal function, careful use of nephrotoxic drugs and targeted treatment of these potential pathogenic mechanisms can help prevent AKI and improve the prognosis of patients severely infected with COVID-19. The pathophysiological mechanisms of severe AKI specially in Covid-19 patients with severe ARDS, e.g., detrimental mechanical ventilation strategies such as high PEEP levels, warrant further research. Rationale: Initial reports of COVID-19 focused on the severe acute respiratory syndrome seen in critically ill patients. However, it became apparent that many COVID-19 patients also displayed kidney abnormalities, primarily acute kidney injury (AKI). Incidence of AKI still poor documented in Tunisia. In this study, we report our experience with AKI in COVID-19 patients and asses its incidence, risk factors, and outcomes. Patients and methods/materials and methods: In this single-center, retrospective cohort study, we analyzed data of COVID-19 patients admitted to the ICU of a tertiary hospital, from March 23th 2020 to January 31st 2021. Demographics characteristics, comorbidities, clinical, paraclinical, therapeutics and outcomes were collected. Patients younger than 18 years or those with end stage kidney disease were excluded. AKI was defined according to KDIGO criteria. Results: 121 patients were enrolled, median age was 64 ± 12 years (IQR, 56-70), sex ratio = 1.5, Medians of SAPS II and APACHE II scores were, respectively, 26 ± 8 and 8 ± 3. Hypertension (48%) and diabetes (35%) were the most frequent underlying diseases. Fifty patients (41%) required invasive mechanical ventilation. Among 121 patients admitted with acute respiratory failure due to Covid-19, incidences of AKI reported on the first day of ICU admission was 19%. During hospitalization, 37 patients (30%) developed secondary AKI (10 kept their renal failure from admission). Hospital acquired AKI were classified on stage 1 of KDIGO classification in 19 cases (51%), stage 2 in 10 patients (27%) and stage 3 in 8 patients (22% Rationale: Acute kidney injury (AKI) is a clinical syndrome that complicates the course and worsens the prognosis of ICU patients. There are numerous potential causes of AKI, mainly related to a focal mismatch between oxygen delivery (due to impaired microcirculation) to the nephrons. The incidence, prognosis and determinants of AKI in ICU patients with COVID-19 remain unclear. The aim was to determine the incidence, the severity degree of AKI, the risk factors and prognosis during hypoxemic pneumonia related to COVID-19.

Retrospective comparative case/control study. All medical records of patients hospitalized in ICU (medical and surgical) for COVID-19 pneumonia (complicated or not with AKI) were analyzed. Results: Among 109 patients admitted in the 2 ICUs for COVID-19, 48 (44%) developed AKI during hospitalization: 33 were males (68%) and the median age was 69 years [61-77]. 11 (23%), 9 (19%) and 28 (58%) were classified as being at stage 1, 2 and 3, respectively. 8 patients (17%) received renal replacement therapy. AKI occurred within a median of 4 days [1] [2] [3] [4] [5] [6] [7] [8] [9] . Patients in the AKI group were older with an increased rate of white blood cells and CRP. Sepsis, nephrotoxic drug, vasopressors and invasive ventilation were more frequent in this group. Logistic regression showed that vasopressors use was an independent factor associated with AKI in COVID-19 patients (Table) . Renal recovery was identified among 3 patients with AKI (6.25%). Duration of ventilation and ICU stay were similar in AKI group and non-AKI group (6 [3-8] vs 3 [2] [3] [4] [5] [6] [7] [8] , p = 0.2 and 7 [5-10] vs 8 [4-15], p = 0.59). Mortality was significantly higher in AKI patients (85% vs 39.4%, p < 0.001) and AKI increased the death risk by 6 (p = 0.009). P/F ratio < 70 (at admission or during hospitalization with OR = 7.5 and p = 0.006), invasive ventilation (OR = 5.6, p = 0.017) and vasopressors use (OR = 16, p < 0.001) were also independent factors of mortality. Conclusion: The incidence of AKI among patients with critical illness of COVID-19 was important. Several factors were shown to contribute to its occurrence and vasopressors use was an independent factor. This complication was highly associated with mortality. Compliance with ethics regulations: Yes in clinical research. Rationale: High incidence of both AKI and post-AKI chronic kidney disease have been reported in patients with SARS-CoV-2 infection. Specific mechanisms as Fanconi syndrome have been, therefore, supposed but remain unproven. No study had compared AKI incidence between critically ill patients with viral pneumonitis related to SARS-CoV-2 from other viral pneumonitis. Patients and methods/materials and methods: Monocentric retrospective cohort study including 46 consecutive COVID patients in whom AKI incidence, characteristics and recovery were recorded. COVID patients were compared to an historical control group of patients admitted to viral pneumonia requiring respiratory support within the last 3 years. 53 controls were identified (with influenza virus in 74%). AKI definition was based on KDIGO creatinine criteria. Full renal recovery was defined as no AKI criteria (KDIGO < 1) among survivors. The risk of AKI occurrence during ICU stay was adjusted for patient's severity and virus type. Results: AKI occurred in 28 patients with COVID. Early AKI < 48 h (n = 14) was associated with more inflammation and rhabdomyolysis, while late AKI (n = 14) was associated with the severity of hemodynamic and respiratory failures. Proximal tubulopathy with complete criteria for a Fanconi syndrome was identified in one patient only. AKI was more frequent in COVID patients (61% vs 42%, p = 0.055) with KDIGO-3 (35% vs 8%, p = 0.001) and more renal replacement therapy (20% vs 0%, p = 0.001). Hospital mortality was similar between COVID-19 and no COVID-19 patients (22% vs 13%, p = 0.21). 17/18 COVID-19 and 15/18 non-COVID-19 survivors with AKI had full renal recovery with a mean follow-up of 63 ± 32 days. Characteristics of patients with and without AKI are indicated in the table. In multivariate logistic regression analysis, SARS-CoV-2 infection was not independently associated with AKI development (OR = 1.12, 95% CI 0.37-3.45, p = 0.84).

Conclusion: Compared to patients with viral pneumonitis from other virus, SARS-CoV-2 is not associated with a significant higher risk of AKI in critically ill patients. Despite a more severe form of AKI in COVID patients, the odds of recovery appear similar. Compliance with ethics regulations: Yes in clinical research. Rationale: Non-invasive ventilation (NIV) is the first choice of ventilatory modality for acute exacerbation of chronic obstructive pulmonary disease. Standard oxygen therapy (SO) (nasal cannulas and simple masks) is conventionally used during breaks off NIV. High-flow nasal therapy (HFNT) is known to wash out nasopharyngeal dead space and to provide a small positive end-expiratory pressure. The aim of the study is to compare SO vs HFNT during breaks off NIV in severe exacerbation of chronic respiratory failure (CRF).

It is a randomized controlled study performed between 2018 and 2019. Inclusion criteria: age > 18 years, acute NIV for an anticipated time > 12 h due to severe exacerbation of CRF. Exclusion criteria: usual contra-indications to NIV, inability to obtain consent and patient who underwent into tracheal intubation before the end of the first session of HFNT. Subjects were randomized (1:1) to receive SO or HFNT during breaks off NIV. The primary outcome was time to NIV weaning. Secondary outcomes included changes of respiratory rate (RR), and arterial blood gas (ABG) parameters before the second session of NIV (after the first session of SO or HFNT), on day 2, 3 and 4 of randomization. Rationale: To evaluate the ability of the oxygen reserve index (ORI) to predict the occurrence of mild hypoxemia (defined as SpO2 < 97%) during endotracheal intubation (ETI) of patients in the intensive care unit (ICU).

This observational single-center study included patients without hypoxemia (defined as SpO2/FiO2 > 214) who required ETI in the ICU. Patients were followed during preoxygenation and ETI then until hospital discharge and/or day 28. We recorded cases of mild hypoxemia, moderate (SpO2 < 90%) and severe (SpO2 < 80%) hypoxemia, moderate arterial hypotension (systolic arterial pressure < 90 mmHg), esophageal intubation, aspiration, cardiac arrest, and death. Results: Between September 2018 and July 2020, 56 patients were included prospectively and 51 patients were analyzed. Twenty patients had mild hypoxemia between the end of preoxygenation and the end of intubation; in 10 of these patients, the decrease in SpO2 below 97% was preceded by an ORI < 0.4, the median time difference being 81 s (interquartile range, 34-146). By multivariable analysis, a higher ORI (by 0.1 increase) value during preoxygenation was associated with absence of hypoxemia (odds ratio, 0.76; 95% confidence interval, 0.61;0.95; p = 0.0141).

The 81 s [34-146] median time between the ORI decrease below 0.4 and the SpO2 decrease below 97% during apnea may allow preventive action. A higher ORI value during preoxygenation was independently protective against hypoxemia. Whether these findings also apply to hypoxemic patients, and the clinical impact of a preoxygenation strategy based on ORI monitoring, remain to be evaluated prospectively.

Compliance with ethics regulations: Yes in clinical research. Rationale: Ventilatory management of patients with acute respiratory distress syndrome (ARDS) includes pulse oximetry (SpO 2 ) measurement. However, the accuracy of SpO 2 measurement in critically ill patients is still debated. We investigated in patients with ARDS monitored with next-generation pulse oximeter (i) the accuracy and precision of SpO 2 measurement and the different factors associated with it; (ii) the ability of SpO 2 measurement to track changes in arterial oxygen saturation (SaO 2 ) induced by a positive end-expiratory pressure (PEEP) trial and (iii) the ability of SpO 2 measurement to detect hypoxemia. Patients and methods/materials and methods: We prospectively included 55 consecutive patients with ARDS ventilated in pressure regulated volume control mode, in whom the attending physician decided to perform a PEEP trial. Simultaneous SpO 2 and SaO 2 measurements were performed at PEEP +5 and +15 cmH2O. SpO 2 and SaO 2 measurements were compared with Bland-Altman method and the bias was calculated as the mean difference between SpO 2 and SaO 2 measurements. The concordance rate between PEEP-trial induced changes in SpO 2 and SaO 2 was assessed with four-quadrant analysis and the inter-rater agreement kappa coefficient (κ). Results: All patients had pulmonary ARDS, 47% were patients with COVID-19 and 31% were black. Overall, SpO 2 and SaO 2 measurements were significantly correlated (r = 0.70; p < 0.0001). The bias was +1.1%, the precision 3.4% and the limits of agreement ranged from −5.6 to +7.9%. Ethnic group, COVID-19 status and PaO 2 /FiO 2 ratio were significantly associated with bias, with a poorer accuracy of SpO 2 measurement in black, COVID-19 and severe ARDS patients. Overall, PEEP trial-induced changes in SpO 2 were correlated to changes in SaO 2 (r = 0.65, p < 0.0001), changes in respiratory system compliance (r = 0.44, p = 0.0007), changes in PaO 2 /FiO 2 ratio (r = 0.35, p = 0.009) but not to changes in functional residual capacity (r = 0.09, p = 0.14).

The concordance rate between PEEP trial-induced changes in SpO 2 and SaO 2 was 84% and the κ coefficient was 0.60. Only COVID-19 status was independently associated with the concordance rate between PEEP trial-induced changes in SpO 2 and SaO 2 . The concordance rate between PEEP trial-induced changes in SpO 2 Rationale: Post-intubation tracheal stenosis (PITS) is a complication of ventilatory support by intubation and/or tracheotomy. Most often the diagnosis of PITS is easy in the presence of inspiratory high located dyspnea in a patient with a history of intubation or tracheotomy. Endoscopic and radiological investigations make it possible to study the characteristics of stenosis in order to adapt therapy. The treatment of choice remains surgical; it is based on tracheal resection-anastomosis which guarantees satisfactory and reliable results in the long term. Patients and methods/materials and methods: We reviewed retrospectively the medical records of 9 patients admitted to our ICU with PITS during February 2018 to February 2020. Ten of them were males with mean age 52 years old and seven females with mean age 61. In relatively stable patients, computed tomography and virtual tracheoscopy were used, followed by rigid (RB) or fiberoptic bronchoscopy. In emergency cases we used RB for diagnosis and treatment. All procedures in the operating room were done under general anesthesia. Results: In 7 patients PITS had a diameter of 5 to 6 mm and produced dyspnea. Four of 7 patients had soft PITS that were dilated with rigid dilators; in another three patients with hard stenosis, balloon dilation was used. Emergency tracheostomy was performed in one case and intubation with small endotracheal tube after partial dilation in one case. The average duration of intubation was 9 days, 2 patients received tracheotomy 10 days on average after intubation. Respiratory dyspnea in 8 (88%) patients was the main finding of tracheal stenosis, clinical examination found signs of respiratory distress in all patients. Endoscopy, performed under general anesthesia, showed a single tracheal stenosis in 7 patients, and the appearance was diaphragmatic in 55.5% of cases. The lesion averaged 32 mm from the glottal plane and the mean extent was 10 mm. The dilatation was performed in all patients resection tracheal anastomosis was performed in 5 patients (55%). Discussion: Laryngo-tracheal endoscopy is the essential part of exploration, to appreciate their complexity and to check the laryngeal mobility, but the radiological assessment is also an essential step in the management of tracheal stenosis. Endoscopic treatment plays an important role in the treatment of tracheal stenosis. In fact, endoscopy allows the practice of instrumental dilations.

Post-intubation tracheal stenosis should be considered in the differential diagnosis of any patient who has recently been intubated in an intensive care unit and who presents with exertional dyspnoea or monophonic wheeze. Compliance with ethics regulations: Yes in clinical research. Rationale: Protective ventilation is increasingly used in anesthesia and ICU, because many studies have shown its benefits on the lung and advocate for its generalization to all patients. It combines a reduction in the current volume and a positive end-of-expiration pressure (PEP). Few studies have been carried out in Algeria in this field. In the face of this revolution, we asked ourselves what was the practice of this concept in anesthesia and resuscitation at the CHU Sidi Bel Abbes (west of Algeria). Our objective was to evaluate the use of protective ventilation in the operating room and in ICU in our center. Patients and methods/materials and methods: We wanted to know the state of the practice of protective ventilation at the University Hospital Center of Sidi Bel Abbes during the month of December 2020. To this end we realized an observation grid and an audit. Initially, a collection of data was developed on the different ventilatory parameters in each operating unit and in the two ICUs. Secondarily, a questionnaire was sent to medical and paramedical professionals to collect their knowledge on protective ventilation. The model was designed according to the model used in the VENTILOP survey. Results: 70 health professionals were interviewed, including 10 senior anesthesiologists/intensivists, 40 residents in anesthesiology/intensive care and 20 medical auxiliaries in anesthesiology/intensive care. The participation rate was estimated at 71% which 50 professionals in total (10 anesthesiologists/intensivists, 30 residents in anesthesiology/intensive care and 10 auxiliaries in anesthesiology/intensive care). Most answering machines have control over the tidal volume setting. On the other hand, more than two-thirds do not control the PEP setting, for the rest of the parameters (FIO2, I/E setting, recruitment maneuvers) more than half need continuous training in order to control the setting of all the parameters. Conclusion: Despite the proven interest of protective mechanical ventilation in anesthesia and ICU, its use is not widespread in all services at our center. Half of the staff interviewed did not integrate it into their daily practice. Strict protocols must be applied to ban bad habits in mechanical ventilation teams and every 8 h by 17 (31%) of them. During the stay in the ICU the change of the cannula was guided by clinical observation (n = 34) or systematically every 5 days (n = 15). Thirteen practitioners disposed of multidisciplinary protocol of decannulation. Among the Tunisian intensivists that answered to our questionnaire, 53% were compliant to the recommendation. Conclusion: Tracheotomy practice is heterogeneous in Tunisian ICU and only 53% were compliant to the international recommendation. Rationale: Risk factors for a prolonged invasive mechanical ventilation greatly vary from one study to another. The aim of our study was to determine the risk factors for prolonged mechanical ventilation in an intensive care unit. Patients and methods/materials and methods: It was a retrospective, monocentric and descriptive study, conducted during the year 2018, from January to November in the intensive care unit of La Rabta University Hospital. Patients over 15 years of age, who required invasive mechanical ventilation for more than 48 h with a length of stay of at least 7 days were included. Prolonged mechanical ventilation was defined as 7 days of mechanical ventilation. Results: Fifty-eight patients were included during the study period. The average age was 44 (± 15.4) and the gender ratio was 1.3. The most frequent reason for admission was coma in 35 cases (60). The mean IGS II and APACHE II scores at admission were 33 (± 15.6) and 14 (± 6.6), respectively. The median duration of invasive mechanical ventilation was 10 days (3.75-14.75). The most frequent complications during the stay were shock (57%) and ventilator-associated pneumonia (52% Rationale: As the vaccination campaign has begun, we are still trying to determine best which patients benefit the most of an admission in intensive care and bring them the most adapted care. The goal of our study was to use an unsupervised clustering approach to determine clinical phenotypes among critically ill COVID-19 patients. Patients and methods/materials and methods: A retrospective observational multicentric cohort study from February 2020 to May 2021, taking place in Intensive Care Unit of several hospitals in the northern part of France, was conducted. Patients with proven SARS-CoV-2 infection diagnosed by PCR on fluid samples, meeting intensive care admission eligibility criteria, were included. Any patient who expressed disagreement in participating in the study was not included. The primary objective was to emphasize differences between clusters extracted by Machine Learning on a COVID-19 population. In a second time, we sought correlation between the patients' evolution, needs in terms of treatment and cluster appurtenances. At last, we wanted to discuss the relevance of these clusters by linking them to the pathophysiology of COVID-19. Results: Promising preliminary results were obtained with 44 patients from the Intensive Care Medicine Unit of Amiens University Hospital. Three clusters were obtained after hierarchical clustering on principal components (HCPC) (Fig. 1) , labelled inflammatory, mild respiratory and severe respiratory. Outcomes were different according to cluster appurtenance in terms of respiratory failure management, duration of stay and need of extracorporeal renal replacement (p < 0.05). There were no difference in terms of mortality (p = 0.74). These are preliminary results; inclusions are ongoing and we plan to include approximatively 200 patients. Discussion: As in former studies on subjects as sepsis shock [1] , machine learning helped us to confirm the intuition that different presentations of COVID-1 9exist by using a innovative tool. On the other hand, we did not observe a difference in mortality and no specific parameter was isolated as a strong marker of cluster appurtenance Conclusion: Using HCPC on our severe COVID-19 population allowed us to extract three clusters with independent phenotypes (inflammatory, severe respiratory, mild respiratory). More inclusions are needed to enhance our model, as inclusions are pursued.

of lung area, the presence of pulmonary embolism, and the absence of crazy-paving of chest CT was a protective factor (respective ORs: 18.7, 9.1, 9.4 and 0.33). The risk factors independently associated with mortality were a Charlson comorbidity index greater than 4, CT scan damage greater than 50%, NLR at day 1 greater than 7, and diabetes mellitus (respective ORs: 10.3, 4.9, 2.7, 2.8). A critical form risk score of COVID-19 was obtained from the multivariate model, which showed an AUC of 0.843 on the ROC curve. Conclusion: In our multicenter cohort study, the NLR was not the best tool to identify evolution to a critical from of COVID-19. Other risk factors identified by early chest CT were better to grade risk of progression to a critical form of COVID-19. and during hospitalization, ventilation modes, use of extra-corporeal membrane oxygenation, renal replacement therapy, treatments, complications and vital status at day 28. We performed an univariate analysis; the medians of the continuous variables were compared by the Wilcoxon test and the percentages of the categorical variables with their 95% confidence interval were compared by Fisher's exact test. Due to missing data, and in order to obtain an analysis of the least biased and most precise parameters, we performed a multivariate MICE (multivariate imputation by chained equations) analysis. Results: 212 patients with severe pneumonia were included, after confirmation of COVID-19 by RT-PCR (211 patients), with suggestive symptoms associated or not with a chest CT-scan (194 patients . PEEP, the plateau pressure and the driving pressure had a mean value, respectively, of 11.2 CmH2O ± 1.5, 28 CmH2O ± 3.7 and 16 CmH2O ± 4.1. During their hospitalisation, 12 patients presented a PB. It was revealed by a chest X-ray in 6 cases, by the chest computed tomography (CT) scan in 4 cases and by physical exam in 2 cases. It was a subcutaneous emphysema, a pneumomediastinum and a pneumothorax in, respectively, 6, 5 and 1 case. Median duration before the complication occurred was 6.5 days. 7 patients were under IV and 5 were under NIV at the time of diagnosis. A respiratory worsening occurred in 11 cases. 2 patients needed IV and we stopped NIV temporarily in 3 patients. Only one patient was treated with chest drain insertion: It was a bilateral tension pneumothorax complicated by a cardiopulmonary arrest that needed exsufflation and bilateral chest drain. In the Chest CT scan, lung damage superior to 75% of the parenchyma was identified as an independent risk factor of PB (OR: 8.22; 95% CI: 1.73-39.07; p = 0.008). PB was significantly associated to an extended duration of MV (p = 0.01), an extended duration of stay (p = 0.05) and an increased mortality (p = 0.01). Conclusion: PB may worsen prognosis in critically ill patients. It extends the MV duration, the length of stay and it increases mortality. Compliance with ethics regulations: Yes in clinical research. Rationale: Barotraumas are a known complication of mechanical ventilation. In SARS-CoV-2 infection, some studies showed that 10 to 20% of patients developed a pneumothorax, probably caused by a rupture of the alveolar wall. The aim of the study is to determine the clinical characteristics, risk factors and outcomes of patients with COVID-19 pneumonia complicated by a barotrauma. Patients and methods/materials and methods: This is a retrospective study. We included all patients admitted in the intensive care unit with a confirmed COVID-19 pneumonia. The diagnosis of COVID-19 was confirmed with reverse transcriptase PCR. The diagnosis of acute respiratory distress syndrome was based on Berlin criteria. All patients were ventilated with a tidal volume equal to 6 ml/kg and a driving pressure less than 14 cmH2O. We recorded: comorbidities, clinical parameters, laboratory, chest X-ray and CT scan findings, SAPSII score, driving pressure and PEEP. Results: A total of 114 patients with a mean age of 62 ± 12 years and with a mean SAPSII score 28 ± 12 was included. At admission, 24(21%) patients were on invasive mechanical ventilation, 6 patients were receiving non-invasive mechanical ventilation. The prevalence of barotrauma was 21% (pneumothorax 16 (14%) cases, subcutaneous emphysema 17(15%) patients and pneumomediastinum in 3 patients).

The traditional tracheostomy tube was performed in 16 patients. The mortality rate was 45%. The driving pressure and the plateau airway pressure were similar between patients with and without barotrauma. In multivariate analysis, the predictor factors of barotrauma were SAPSII score (OR: 1.2, 95%IC [1.02-1.58] p = 0.01) and the presence of diabetes (OR = 2.1, IC95% [1.20-2.32, p = 0.022). In patients with barotrauma, the mortality rate was 80% (19 patients). In multivariate analysis, the only predictive factor of mortality was barotrauma (RR = 6.9; 95%IC [1.9-18.9], p = 0.002). Conclusion: Patients with a COVID-19 pneumonia developed barotrauma in 1/5 cases. Patients with barotrauma had a high mortality rate. It's necessary to pay attention to diabetic patients with an elevated SAPSII score.

Intrathoracic Airway Closure Impacts CO2 Signal and Delivered Ventilation during Cardiopulmonary Resuscitation

New physiological insights in ventilation during cardiopulmonary resuscitation

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Weaning from mechanical ventilation

Feasibility of using point-of-care lung ultrasound for early triage of COVID-19 patients in the emergency room

Accuracy of Bedside Lung Ultrasound as a Rapid Triage Tool for Suspected Covid-19 Cases

Guidelines for nutrition support in critically ill patients

Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient

Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study

Diagnostic test accuracy of the BioFire ® FilmArray ® meningitis/encephalitis panel: a systematic review and meta-analysis

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

Early hypertension after vasopressor weaning during septic shock: associated factors and prognostic significance

Management of patients at risk of acute kidney injury

COVID-19 does not lead to a "typical" acute respiratory distress syndrome

Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology

RFE SFAR-SRLF Pneumonies associées aux soins de réanimation

Pneumonia in acute ischemic stroke patients requiring invasive ventilation

Bacterial epidemiology of early ventilator-acquired pneumonia (E-VAP) according of the previous antibiotic treatment (ATB+) or not

One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study

Compliance with ethics regulations: Yes in clinical research

Flow-chart of the 90 patients with systemic rheumatic disease requiring extracorporeal membrane oxygenation

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

Quality of Life and Lung Function in Survivors of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

The role of methemoglobin and carboxyhemoglobin in COVID-19: a review

Endogenous carbon monoxide production correlates weakly with severity of acute illness

Compliance with ethics regulations: Yes in clinical research

Continuous Positive Airway Pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: a retrospective c

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study

Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK

Capillary refill time exploration during septic shock

Compliance with ethics regulations: Yes in clinical research. Fig. 1 Bland-Altman plots

Left ventricular global longitudinal strain is independently associated with mortality in septic shock patients

Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients

COVID-19 pandemic: triage for intensive-care treatment under resource scarcity

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists

Prevalence of SpO2 distribution in patients at the Intensive Care consultation, stratified according to the outcome (ICU-admitted, improved without ICU)

WHO| Developing the World Health Organization Disability Assessment Schedule 2.0

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Reactivation of Multiple Viruses in Patients with Sepsis

Early herpes and TTV DNAemia in septic shock patients: a pilot study

Compliance with ethics regulations: Yes in clinical research

MR Pro-adrenomedullin as a prognostic factor for severe SARS-CoV2 pneumonia

Compliance with ethics regulations: Yes in clinical research

Bonnes pratiques relatives au prélèvement de tissus et de cellules du corps humain: système de management de la qualité; Approche par la gestion des risques

Outils de visite à destination des experts visiteurs: Guide thématique don d'organes et de tissus à visée thérapeutique

Endothelial dysfunction as a component of SARS-CoV-2-related multisystem inflammatory syndrome in children with shock

Charlyne Brakta 1 , Damien Bonnet 1 , François Angoulvant 1 , Julie Toubiana 1 , Maximilien Desvages 1

France Correspondence: Mehdi Oualha -mehdi.oualha@aphp.fr Annals of Intensive Care

The coagulopathy, endotheliopathy, and vasculitis of COVID-19

]) were significantly associated with AKI. In multivariate analysis, only prior CKD (OR = 19.36 [3.17-118.36]) was significantly associated with AKD. Conclusion: Our study suggests an independent effect of DXM in the risk of AKI in severe COVID-19 patients. This result needs to be confirmed in larger studies. It could suggest an important impact of inflammatory state in the pathogenesis of COVID-19-induced AKI. AKD is a period characterized by a highly inflammatory condition which seems to be the cornerstone of the risk of CKD development. Lack of effect of DXM in AKD incidence was probably due to a lack of power. Compliance with ethics regulations: Yes in clinical research. FC-226 Incidence and risk factor of AKI in severe COVID-19: a time-dependent competing risk analysis Antoine Marchiset

Acute kidney injury in patients hospitalized with COVID-19

5%) had chronic lung disease. 40% of patients suffered from obesity. Mean SAPSII score on ICU admission was 34 ± 14.9 and mean SOFA score was 5 ± 2.7. During hospitalization

Risk factors for AKI in COVID-19 in our study were hypertension (p = 0.01), diabetes (p < 0.001), a SOFA score > 5 (p < 0.001), SAPSII > 35 (p < 0.001), the use of diuretic drugs (p = 0.023) and the use of vasopressors

Conclusion: AKI is a common serious complication in critically ill patients and is associated with higher mortality, longer hospital stay and increases the need of ventilator support

Acute kidney injury in severe SARS-CoV-2 infection: a report of experience

Guillaume Louis -gus_louis@yahoo.fr Annals of Intensive Care 2021

Acute kidney injury in critically ill patients with COVID-19

Acute kidney injury in patients hospitalized with COVID-19

Compliance with ethics regulations: Yes in clinical research

Annales Françaises d' Anesthésie et de Réanimation

FC-237 Cardiac arrest as a cause of acute respiratory distress syndrome: respiratory mechanics, gas exchange and ventilator settings

François Beloncle -francois.beloncle@univ-angers.fr Annals of Intensive Care 2021

Lung-Transplantation for Severe post-Coronavirus Disease 2019 Respiratory Failure. Transplantation

Tracheotomy in the intensive care unit: guidelines from a french expert panel

Non-invasive ventilation vs. high-flow nasal oxygen after extubation of obese patients in ICU: a post hoc analysis of a randomised controlled trial

Chistophe Girault 7 , Laurence Dangers 8 , Alexandre Lautrette 9

Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUs

CT lung lesions as predictors of early death or ICU admission in COVID-19 patients

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Compliance with ethics regulations: Yes in clinical research

Prognostic contribution of respiratory mechanics and gas exchange in moderate-to-severe COVID-19 ARDS

Intensive care unit and Biosurgical research lab (Carpentier Foundation)

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases

Compliance with ethics regulations: Yes in clinical research. FC-258 Association between body mass index and pneumonia outcomes in critically ill patients with coronavirus disease-19: an international multicenter retrospective cohort study

Hasharon Hospital-Rabin Medical Center

Mercedes Jourdain -mercedes.jourdain@univ-lille.fr Annals of Intensive Care 2021

Adjusted mixed logistic regression model showed a significant relation between BMI and the need for IMV: odds ratio (OR) 1.27 (95% CI, 1.12-1.45) per 5 kg/m 2 in the whole cohort, and 1.65 (95%CI, 0.97-2.79) per 5 kg/m 2 in females under 50 years. Adjusted Cox proportional hazards regression model with random center effect showed a significant association between BMI and mortality, which was only increased in obesity class III (≥ 40 kg/m 2 ) (hazard ratio 1.68 (95% CI 1.06-2.64). Conclusion: We observed a linear association between BMI and the need for IMV, more pronounced in younger females, and a non-linear association between BMI and mortality risk in critically ill patients with COVID-19

Compliance with ethics regulations: Yes in clinical research

François Angoulvant-Invitation to national or international congresses: Pfizer. Pierre Asfar-Consultancy, Expert: Activité expertise pour la Banque Publique d'investissement, agence gouvernementale française. Bilal Badat-Other: Med2Lab -Air Liquide Medical Systems

Expert: Ex Clinical innovation engineer at Air Liquide Medical Systems -Invitation to national or international congresses: None -Patent or product inventor: None. Laurent Brochard-Patent or product inventor: General Electric (index

Expert: Gilead, Sanofi, Baxter -Invitation to national or international congresses: Gilead. Claire Carette-Consultancy, Expert: Astra Zeneca, Publicis Health

Sanofi -Invitation to national or international congresses: Astra Zeneca; boehringer Ingelheim; Novartis; Roche; Sanofi -Research support/Scientific studies: boehringer Ingelheim

Expert: Lungpacer -Invitation to national or international congresses: Lungpacer -Research support/Scientific studies: Lungpacer. Johan Dupuis-Consultancy, Expert: Asten Sante -Invitation to national or international congresses: no conflict of interest -Patent or product inventor: no conflict of interest -Research support/Scientific studies: no conflict of interest -Stock shareholder: no conflict of interest -Trainings, Teaching: no conflict of interest -Other: no conflict of interest. Guillaume Eberst-Research support/Scientific studies: Research support by Don Du Souffle for institutional support

Matthias Jacquet-Lagrèze-Patent or product inventor: Inventor and patent owner of a device that measures Capillary refill time -Stock shareholder: Co-founder and stock shareholder of DICARTECH a Medtech that develop a device to measure capillary refill time. Matthieu Jamme-Research support/Scientific studies : Open Health Institute

Expert: AstraZeneca, Chiesi. Arnaud Lesimple-Research support/Scientific studies: PhD student in the (Med2Lab) partially funded by Air Liquide Medical Systems. Charles-Edouard Luyt-Consultancy, Expert: Carmat, MSD, Biomérieux, ThermoFischer Brahms, Bayer Healthcare, Aerogen -Invitation to national or international congresses: Correvio -Patent or product inventor: NA -Research support/Scientific studies: Correvio, Bayer Healthcare -Stock shareholder: NA -Trainings, Teaching: NA -Other: NA. Tommaso Mauri-Consultancy, Expert: Fisher and paykel, drager, mindray, bbraun -Research support/Scientific studies: Drager, fisher and paykel. Eric Maury-Consultancy, Expert: non -Invitation to national or international congresses: non -Patent or product inventor

Jonathan Messika-Invitation to national or international congresses: Fisher & Paykel, CSLBehring. Christelle Meuris-Invitation to national or international congresses: 2018: contribution aux frais relatifs à une manifestation scientifique (Bard Benelux) 2019 Contribution aux frais relatifs à une manifestation scientifique (GSK, MSD Belgium). Jean-Paul Mira-Consultancy, Expert: Roche, AKPA, Fresenius -Invitation to national or international congresses: Roche, Fresenius. Xavier Monnet-Consultancy, Expert: Pulsion Medical Systems, Baxter -Trainings, Teaching: Pulsion Medical Systems. Olivier Moranne-Consultancy, Expert: yes Boehringer, Astellas, Astrazeneca, Bayer -Invitation to national or international congresses: yes from Sanofi, Freseinus, Infomed, Baxter, Vifor, Boehringer, compagny -Patent or product inventor: no -Research support/Scientific studies: no -Stock shareholder: no -Trainings, Teaching: no -Other: no. Gregoire Muller-Invitation to national or international congresses: Unrelated to the present work: Pfizer (travel reimbursement, registration fees

Mai-Anh Nay-Invitation to national or international congresses: Pfizer (Invitation to national congress) -Research support/ Scientific studies: Non-financial support from Fisher&Paykel outside the submitted work

JCR reports part-time salary for research activities from Air Liquide Medical Systems and Vygon and grants from Creative Air Liquide, outside this work. AM reports personal fees from Faron Pharmaceuticals, Air Liquid Medical Systems, Pfizer, Resmed and Draeger and grants and personal fees from Fisher and Paykel and Covidien, outside this work. -Research support/Scientific studies : Unrestricted grand, Fisher and Paykel -Other : AC reports a one-year research fellowship grant from Air Liquid Medical Systems

Eric Rondeau-Consultancy, Expert: Alexion Pharmaceuticals -Invitation to national or international congresses: yes -Patent or product inventor: no -Research support/Scientific studies: yes -Stock shareholder: no -Trainings, Teaching: no. Damien Roux-Consultancy, Expert: DR: Astellas (past) -Invitation to national or international congresses: Congrès Réanimation. Pauline Roux-Claudé-Consultancy, Expert: Sanofi, astra zeneca, novartis, GSK -Invitation to national or international congresses: sanofi, novartis, chiesi -Research support/Scientific studies: astra zeneca, GSK -Trainings, Teaching: astra zeneca, novartis, sanofi, GSK, chiesi / subvention du Don Du Souffle pour un soutien institutionnel. Emmanuel Samain-Research support/Scientific studies : This study was supported by a grant from Don du Souffle. All autors from the Chest Desease Departement have as conflict of interest a grant from Don du Souffle. Matthieu Schmidt-Consultancy, Expert: Getinge, Drager, Xenios, 3M. Florian Sigaud-Consultancy, Expert: Medical Consultant -World Health Organization

Bayer-Pharma -Invitation to national or international congresses: Merck -Patent or product inventor: none -Research support/Scientific studies: Thermofisher, Pfizer, Merck -Stock shareholder: none -Trainings, Teaching: none -Other: none. Renaud Tissier-Invitation to national or international congresses: Servier -Patent or product inventor: Patents on hypothermia and liquid ventilation -Research support/Scientific studies: Agence Nationale pour la Recherche, Fondation pour la Recherche Médicale, CREATIVE Fund -Stock shareholder: Co-founder of a company dedicated to liquid ventilation (Orixha) . Ibrahim Traore-Research support/Scientific studies : This study was supported by a grant from Don du Souffle

Expert: MSD, Correvio, INOTREM -Invitation to national or international congresses: NO -Patent or product inventor: No -Research support/Scientific studies: NO -Stock shareholder: NO -Trainings, Teaching: NO -Other: NO. Mohamad Zaidan-Consultancy, Expert: Consultant (Alnylam) -Invitation to national or international congresses: Congrès Européen (Otsuka) -Other: Repas (Alexion, Retrophin)

Houda Mayoufi, Sandie Mazerand, Aurélien Mazeraud, Nicolas Maziers, Fatema Mazour, Eric Meaudre, M'hamed Sami Mebazaa

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Rates of severe hypoxemia during intubation procedure in obese patients after preoxygenation with non-invasive ventilation (grey bar) and high-flow nasal cannula oxygen therapy (dark bar). Rationale: In spite being a common practice in intensive care unit (ICU), tracheotomy still a procedure that faces disparity. The divergence of views on its utility, indications, the appropriate timing, and its technique led us to conduct this study. The main aim of our study was to evaluate our practices. Patients and methods/materials and methods: It was a descriptive analysis of a questionnaire with 34 items, sent via Google Forms platform evaluating tracheotomy practice in Tunisian intense care unit. We have referred to the latest recommendation of the scientific society (Société de Réanimation de Langue Française SRLF and Société Française d'Anesthésie et de Réanimation SFAR) [1]. Results: Fifty-five intensivists had answered to the questionnaire, 47 (85%) were practicing in university-affiliated hospitals. The participation rate was 30%. Thirty-nine (17%) was the number of medical intensivists. An informed consent signed by the legal guardian before each tracheotomy was required by 44% of the intensivists. The percutaneous tracheotomy was performed by 21 (38%) of those who answered. Twelve intensivists had already a standardized procedure of percutaneous tracheotomy in their department. Twenty-two disposed of care protocols defining the management of the tracheotomy, its supervision and its maintenance. Thirteen of the clinicians preferred the percutaneous tracheotomy by unique progressive dilatation. Forty-six consider deflating the balloon once the patient was spontaneous ventilated. The pressure of the balloon was measured daily by 35 (63%) of

Rationale: The 2019 coronavirus disease (COVID-19) outbreak, caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-COV2) emerged in China and quickly spread throughout the whole world. We were interested in all the acute community pneumonia admitted during this period of the COVID 19 pandemic and which requires admission to intensive care. The aims of this study were to describe the epidemiological characteristics, to identify the predictive factors as well as the prognostic factors of COVID 19 pneumonia. Patients and methods/materials and methods: This is a prospective cohort study carried out in the Medical ICU at the Ibn Sina University Hospital in Rabat, from March to August 2020. All adults patients admitted for suspected or confirmed SARS-COV2 community-acquired pneumonia, requiring hospitalization in intensive care and having undergone a PCR test for SARS-COV2 were included in the study. Factors associated with mortality in confirmed SARS-COV2 infection were determined. Results: Of the 100 patients admitted to ICU during the study period 40 patients had positive SARS-CoV-2 (mean age of 65 ± 13 years, 63 males, 37 females). The mean Fine score was 112 ± 36. Five % of patients had septic shock at admission. Invasive mechanical ventilation was needed in 53% of the cases. The CORADS score was Rationale: The prognosis of patients with severe COVID-19 treated with invasive mechanical ventilation is poor. High-flow nasal oxygen therapy has been recommended to avoid intubation. Data about HFNO efficacy in patients with severe COVID-19 are still scarce. The ROXX score has been shown to predict HFNO failure outside of the COVID-19 setting. Some authors have recommended using it in COVID-19 patients. Patients and methods/materials and methods: We performed a retrospective bicentric study in the 18-bed and 20-bed ICUs in two non-teaching hospitals. All patients with COVID-19 treated with HFNO in the period February-May 2020 were included. Patients with do-not-intubate order on admission were not included. Criteria for intubation were not standardized. HFNO failure was defined as the need for intubation or hypoxic cardiac arrest. Data collected included: demographic, clinical, and biological usual variables on admission, symptoms duration, CT scan severity of disease, arterial blood gases, P/F ratio under HFNO, ROXX score. Data are displayed as median (IQR25%-75%) or numbers(percentage) Univariate analyses with non-parametrical tests were performed to identify predictors for HFNO failure. Results: Fifty-two patients were included (43 male/9 female, on admission: age 60 (56-64) years, SAPS II 33 (30-38), symptoms duration 10 (6-13 days)). After 2 h under HFNO, required FiO2 was 80% (60-100), P/F ratio was 95 (76-120) and ROXX score was 3.8 (2.8-5.1). HFNO was successful in 19 patients (37%). No hypoxic cardiac arrest occurred under HFNO. Thirty-three patients (63%) required intubation. Only 6 patients were treated with corticosteroids. Comparison between patients with HFNO success or failure using univariate analyses showed that the following admission variables were not significantly different between the two groups: sex, age, BMI, disease severity on CT scan, Fine score, arterial blood gas results, respiratory frequence, biological variables (CRP, LDH). On another hand, symptoms duration before ICU admission was significantly shorter in HFNO failure group than in success group (9 (0-21) versus 11 (5-25) days, p = 0.03) P/F ratio (p = 0.39) and ROXX (p = 0.8) score after 2 h under HFNO were not different between the two groups Conclusion: During the first COVID-19 phase, in our centers, HFNO allowed to avoid intubation in 37% of patients. A short duration of symptoms was predictive of HFNO failure, but not ROXX Score under HFNO.

Compliance with ethics regulations: Yes in clinical research. Rationale: Capillary refill time (CRT) is a simple and relevant clinical sign to assess peripheral perfusion. It may be used as a diagnostic or prognostic tool and to guide resuscitation (1) . However, it is susceptible to numerous factors as patient age, cutaneous temperature, ambience light and intensity or duration of the pressure applied. Dicartech company (Davézieux, France) is developing a fully automatized portable CRT measurement device. We aimed to evaluate the diagnostic performance of this first-generation prototype to detect a vascular occlusion test (VOT) on healthy volunteers. Patients and methods/materials and methods: DiCART ™ device is composed of a piston which is applied on the skin with a calibrated pressure. After withdrawal of the piston, a video of the skin recolouration is recorded in stable light condition. Finally, a mathematical algorithm determines CRT (CRT DiCART ) from the video. Manual CRT (CRT CLIN ) was measured as previously described (2) . CRT determined by investigators after videos reviewing was named CRTVIDEO. CRT was measured three times by method before and after three different VOT: "arterial VOT" (pneumatic tourniquet 50 mmHg above systolic arterial pressure); "venous VOT" (30 mmHg) and "control VOT". VOT were performed successively in a randomized order, alternatively by one and the other limb. Investigator assessing CRT was blinded from VOT type. The whole protocol was first carried out on the upper limb and then on the lower limb. Statistical analysis: ROC curves were constructed to evaluate diagnostic performance to detect VOT. Agreement between CRT measurements methods was assessed by Bland-Altman method with calculation of percentage of error. Results: 20 healthy volunteers were included. Five participants were excluded because of prototype dysfunction. CRT CLIN had an ROC AUC of 1.00 (95%CI: 1.00; 1.00), CRT VIDEO 0.96 (95%CI: 0.88; 1.00) and CRT DiCART 0.92 (95%CI: 0.79; 1.00) to detect arterial VOT on the upper limb. Results were not reproducible at the lower limb. CRT did not detect venous VOT with ROC AUC > 0.75. Precision of CRT CLIN and CRT VIDEO was significantly higher than CRT DiCART (0.18 and 0.20 vs 0.28 p < 0.05). For 3 measures average, Bland-Altman plots are reported in Fig. 1 . The percentage of error was 76% between CRT CLIN and CRT VIDEO and 87% between CRT CLIN and CRT DiCART . Conclusion: The prototype developed by DICARTECH was accurate to detect an experimental arterial ischemia. However, precision was lower than with the manual method, and the agreement was not acceptable. Those results give leads to improve the mechanics and the algorithm of future devices. Rationale: Hospitalization in an intensive care unit (ICU) is stressful for patients' relatives. The objectives of this monocenter prospective study were to assess their psychological distress during the unique lockdown context and to search for some risk factors. Patients and methods: The closest referents of adults admitted to ICU for COVID-19 pneumonia in March and April 2020 were consecutively included. Psychologists conducted the interviews by phone, one (M1) and three (M3) months following ICU discharge. Relatives completed the Hospital Anxiety and Depression scale (cutoff defined as ≥ 11/21 for anxiety and depression in the HADS-A and HADS-D subscales, respectively) and the Impact of Event Scale-Revised (IES-R: cutoff defined as defined as > 36/88 for post-traumatic stress disorder (PTSD)). Their psychological history, the co-existence of concomitant other stressful private events, and the mean of communication with ICU teams were noted. Relatives were divided into 2 groups according to patient's status at ICU discharge: Deceased Group and Alive Group. [2-7.5] , p = 0.244. Proportion of relatives with depression and PTSD tended to decrease at M3 (28.6% for both conditions) compared to M1 (respectively, 31.2 and 37.5%) in the Deceased Group. At the opposite in the Alive Group, proportion of relatives with depression and PTSD tended to increase at M3 (respectively, 15.8 and 36.8%), compared to M1 (respectively, 4.8 and 28.6%). Videoconferencing (vs phone call alone) or concomitant stressful events did not influence any scores. Relatives with a history of anxiety and/or depression had higher HADS-A scores at M1 (p = 0.001) and at M3 (p = 0.002), The same was observed for IES-R at M1 (p = 0.02). Conclusion: Psychological distress was observed in relatives of ICU survivors, as in relatives of deceased patients. A history of mental health disorders seemed to be a risk factor for anxiety and PTSD in relatives who experienced the ICU stay of their loved ones. Videoconferencing did not impact relatives' psychological burden. Compliance with ethics regulations: Yes in clinical research. Rationale: During the COVID-19 pandemic, strict and standard admission criteria to intensive care units (ICU) were needed. In our COVID-19 center we implemented standard criteria for ICU admission, a low-PEEP strategy and others associated features, like aggressive thromboembolism management. Primary outcome of this study was to analyze the mortality rate in patients evaluated for admission to the ICU comparing patients admitted vs patients not accepted and regularly followed in the medicine department; secondary outcome was a comparison of clinical and biological data between the two groups. Patients and methods: A retrospective analysis was conducted on all consecutive patients with acute respiratory distress syndrome due to COVID-19 pneumonia who underwent to ICU consultation from March 16th to April 12th, 2020. SpO 2 below 85% and/or dyspnea were admission criteria; exclusion criteria were DNR (do not resuscitate) orders. Results: Thirty-six patients were consulted by the intensivist; 23 (64%) patients were admitted to the ICU; 13 (36%) were monitored and followed on Internal Medicine ward. Global Rationale: Patients' satisfaction is an important indicator for measuring quality of health care. The aim of our study was to assess determinants and level of patients' perception for the intensive care unit (ICU) to create policies for improving health care system Patients and methods: This study was performed in a 10-bed tertiary ICU. It was a prospective study enrolled between 1st July and 31st December 2020. We developed a local questionnaire that consisted of 34 questions in six domains (scientific level and origin of all patients, medical staff availability and quality of health care, pain management, hospital stay and discharge conditions). Answering possibilities ranged from 1 (very satisfied) to 5 (not concerned). All consecutive competent adult patients discharged after a stay in the Unit of over 24 h, and who agreed to participate in the project were enrolled; they were interviewed by phone or face to face. Patients with serious physical or mental pathologies, that could make the comprehension and completion of the questionnaire difficult, were excluded. Results: During the study period 90 patients were enrolled (56% of all admission). Mean age was 52 ± 15 years [19-94] and sex ratio was 2.33. Majority of patients were admitted from the emergency room (47.8%) and 37.8% were admitted from the COVID unit. median (interquartile) length of hospital stay was 9 (5-15) days and all cases mortality rate was 37%. 63% of patients said they were very satisfied with quality of ICU care, and 32% satisfied. Patients were very satisfied of their relationships with medical staff (87.8%) and paramedical staff (81.1%). 83.3% of cases were satisfied about pain management. Hospital conditions as rooms cleanliness and comfort was very satisfactory in more than 70%. While satisfaction about hospital meals provided is less than 50%. 97.8% of patients recommended the intensive care unit to their entourage and they agree to return to intensive care unit if their state of health requires it in 93.3% of cases. There is no significant association between satisfaction level and patient characteristics, nor with the length of their stay. Conclusion: Our study showed a good overall satisfaction. She revealed some shortcomings to be corrected quickly to ensure better patient care and install good practices. Compliance with ethics regulations: Yes in clinical research.

What happens after a research project has been funded? Assessment of the scientific output following the award of a grant by the French Intensive Care Society Bertrand Hermann 1 , Jean-Francois Llitjos 11 , Saber Davide Barbar 12 , Gwenaelle Jacq 6 , Laurent Poiroux 2 , Guillaume Decormeille 9 , Lamia Ouanes Besbes 10 , Toufik Kamel 7 Rationale: Clinical and experimental research is costly and funding is key to the successfully conduct of academic projects. The French Intensive Care Society (FICS) offers several grants aimed at promoting high quality research in the field of intensive care. However, the scientific output following the award of a grant is not always known. We sought to determine the scientific productivity of grantholders funded by the FICS. Patients and methods/materials and methods: The details of grant recipients and funded projects were obtained from a prospective database managed by the FICS. We contacted each grantholder through an online survey form (Google form) to collect data on the advancement of the funded project. Scientific output was defined as publication in a peer reviewed journal and/or abstract presentation in an international congress. Univariate and multivariate analyses were performed to investigate factors associated with scientific output. Results: Between 2007 and 2019, the FICS awarded 104 grants to 95 recipients for a total amount of 1 572 500 euros. Recipients were mostly men (67%) of 34 [31-37] years of age. Most grants were awarded to recipients affiliated to public hospitals (94%) and universities (89%). Both clinical (58%) and experimental (48%) research projects were funded. Out of 86 (83%) recipients who answered the online survey form, 69 (80%) declared having produced scientific results, either through publication in a peer reviewed journal (54 (63%)) and/or through an abstract presentation in an international congress (52 (60%)). The majority of papers were published in high impact peer-reviewed journals (54% and 30% published, respectively, in the top 10% and top 25% journals within a discipline according to their impact factor). In a multivariate analysis, recipients affiliated to a university were more likely to achieve scientific valorization (12.0 Rationale: Catheter-related infection is a common complication in the intensive care unit. It increases the morbidity and mortality of patients in intensive care. The usefulness of systematically culturing all central arterial and venous catheters in intensive care settings is a controversial topic. The aim of this study was to assess the value of the systematic culture of all arterial and central venous catheters in intensive care as well as its impact on patient management.

This study was prospective, descriptive and cross-sectional, from January 1, 2020 to June 30, 2020, including 86 catheters placed in patients hospitalized in a Tunisian medical intensive care unit Results: This research covered a period of 6 months. It consisted of the study of 86 catheters in 18 patients. The mean age of the patients was 52.83 years with a minimum of 17 years and a maximum of 73 years. There was no significant difference in terms of the rate of suspected infection linked to the catheter, whether or not the catheter was placed during a night shift. In febrile patients, defervescence following a catheter ablation for a suspected catheter-related infection is significant compared to a defervescence following a routine catheter ablation. The majority of changes in antibiotic therapy after a catheter removal were due to suspected catheter-related infection. There was no significant difference in the positivity of catheter tip cultures between systematically ablated catheters and those ablated due to suspected catheter-related infection. The positivity of the central blood culture of the ablated catheter following a suspected catheterrelated infection compared to that of a systematically ablated catheter was significant. Conclusion: These results were against the systematic catheter tip culture. It also generates an additional cost and an increase in the workload. Indeed, in the majority of cases where the catheters were systematically ablated, even when the samples of the latter came back positive, the management of the patients remained unchanged. These results were in line with those found in the literature. Rationale: Acute renal failure is a frequent complication in resuscitation, mostly observed in septic conditions. Despite numerous technical innovations, mortality remains significant. The aim of this work is to study the incidence of acute renal failure in postoperative sepsis, its various epidemiological aspects as well as to evaluate the predictors of mortality of acute renal failure in postoperative sepsis. Patients and methods/materials and methods: We conducted a two-and-a-half year descriptive and analytical retrospective study (between January 2018 and June 2020) on 70 cases of acute renal failure in post-operative sepsis, hospitalized at the P33 surgical emergency resuscitation department of IBN ROCHD University Hospital in Casablanca. Adult patients with normal pre-operative renal function who developed a complicated septic condition of acute renal failure were included in our study. The parameters studied are demographic, clinical, para-clinical, therapeutic and evolutionary data. Statistical analysis was carried out using the SPSS software, the evaluation of prognostic factors used univariate and multivariate analysis. Results: The incidence of acute renal failure in our work was 9.15%. The average age of patients was 58 ± 14 years with a sex ratio of 2.5. The most common risk factors were: field-related factors (male gender, diabetes, chronic high blood pressure, smoking, nephrotoxic drugs) related to initial surgery (emergency surgery, intra-abdominal surgery site). Clinical signs were dominated by tachycardia (55.71%) polypnea (30%) hypotension (31.42%) consciousness disorder (20%), fever (24.28%), oligo-anuria (24.28%), 75.71% of the patients had septic shock and 24.28% severe sepsis, hemodynamic, hepatocellular and hematological failure were the most common. 54% of our patients were Class 3, 11.43% Stage 2 and 34.28% Stage 1 of KDIGO (Kidney Disease Improving Global Outcomes) the organic nature of acute renal failure was the majority with more than 85.71%, 21.42% of patients benefited from extracorporeal purification. The mortality rate was 81.43%, the prognostic factors emerged in multivariate analysis are: the history of high blood pressure, the history of diabetes, the presence of consciousness disorder, and arterial hypotension, hyperkalemia, the time of onset of acute renal failure greater than 48H Conclusion: The occurrence of acute renal failure in sepsis in the midst of surgical resuscitation is a critical stage with a very pejorative prognostic significance. A better knowledge of its risk and prognostic factors is fundamental for a more effective management. Compliance with ethics regulations: N/A. Rationale: Recent studies reported an increased risk of ventilator associated pneumoniae (VAP) in case of COVID-19 that may be not fully explained by ventilation time. Previous studies reported that corticosteroids now recommended in COVID pneumonia may increase risk of VAP. We reported the epidemiology of VAP occurring in COVID-19 patients admitted in intensive-care unit (ICU) with acute respiratory distress syndrome (ARDS) without glucocorticosteroids nor immunomodulatory drugs. Patients and methods/materials and methods: We conducted a retrospective monocentric cohort study comparing the COVID group, including all consecutive adult patients admitted in the ICU with COVID-19-related ARDS between 15 March to 31 April 2020, with a historical control group, including all consecutive patients admitted with all cause ARDS between 1st January to 31 December 2019. Exclusion criteria for both groups were: ICU stay of less than 24 h, admission from another hospital after 48 h of mechanical ventilation, corticosteroids or experimental drugs received during intensive-care hospitalization. The primary endpoint was the density of VAP. Secondary endpoints were ventilation time to VAP occurrence, number of VAP episodes, type and resistance of bacteria evidenced by microbiological samples. Rationale: Intensity of anxiety at admission in intensive care unit (ICU) is associated with subsequent deterioration. The primary aim of this study was to assess the additive value of stressful fears and feelings to predict new organ failure within the first 7 days after ICU admission, after adjustment on critical illness severity and anxiety defined as a State-Trait Anxiety Inventory (STAI) ≥ 40. Patients and methods/materials and methods: We conducted a prospective three-center cohort study of non-comatose patients without delirium or invasive mechanical ventilation. A twelve-item questionnaire was developed to assess stressful fears and feelings. Severity of illness was assessed using SAPS-II and SOFA scores. Intensity of chronic and acute anxiety was assessed with the 'Trait' and 'State' forms of the STAI. Patients were followed up for 7 days. Rationale: Adult patients with hematological malignancies are at risk of neurological complications. The primary objective of this study was to characterize neurological complications leading to ICU admission in this population. Patients and methods/materials and methods: Single-center retrospective study including 57 patients (66 admissions) admitted to the ICU between January the 1st 2009 and December 31st 2018 for a neurological complication. Results: The population was mostly composed of patients with non-Hodgkin lymphomas (35%) and acute myeloblastic leukemia (33%), 35% had stem cell allografts. The causes of neurological deterioration were: 45% cerebrovascular complications (mainly stroke and subdural hematoma), 36% encephalopathies (primarily toxic), 11% infections and 9% tumoral invasion. ICU mortality was 17%. The median SOFA score upon ICU admission was 4.7 and SAPS II 37. Twelve percent of admissions required mechanical ventilation, 10% vasopressors, and 4% extrarenal epuration. Hospital mortality was 35%, survival of the 39 patients alive after hospitalization was 74% at 6 months and 62% at 1 year. In multivariate analysis, the factors associated with hospital mortality were age (OR: 1.09; 95% CI: 1.02-1.16) and SOFA score (OR: 2.05; 95% CI: 1.41-2.97). Conclusion: Vascular complications and encephalopathies should be searched for in case of neurological deterioration leading to ICU admission in patients with hematological malignancies. Age and SOFA score are associated with higher hospital mortality risk. Compliance with ethics regulations: Yes in clinical research.

Correlations between endothelial markers (angiopoietin-2, sEselectin, and vWF:Ag) or inflammatory markers (CRP and IL-6) and the vasoactive inotropic score (VIS) or the lactate level Rationale: The postoperative period of cardiac surgery is a crucial moment during which low cardiac output can occur. The assessment of hemodynamic status of critically ill children is challenging and the clinician's estimate of cardiac output is often unreliable. Extremity heat is often used to evaluate peripheral perfusion but remains a very subjective sign. A high thermal gradient between core and peripheral temperature has been correlated with increased systemic vascular resistance and decreased cardiac output, but the results are controversial. The aim of this study is to assess the relationship between thermal gradient, obtained by thermography pictures, and oxygen extraction levels in children in post-operative cardiac surgery. Patients and methods/materials and methods: Children admitted in a single pediatric intensive care unit after a cardiac surgery were included, after obtaining parental consent. Photos of patients with external cooling system, extensive skin disease and extracorporeal support were excluded as this could change the thermal gradient. Infrared images of the patients were taken using the FLIR OnePro camera within 24 h after surgery. The core temperatures (extracted from the internal epicanthus) and toes temperatures were extracted. Temperature gradient between core and extremities (thermal gradient) was calculated and compared to the simultaneous oxygen extraction ratio (O 2 ER: the ratio between arterial and mixed venous oxygen saturations). The correlation was established by the Spearman correlation coefficient. Results: 29 patients of 5 (0-15) months-old were included in the study. One to three thermal images per patient were analyzed for a total of 66 photos. Our patients had cardiopathies that are frequently described in pediatrics. The thermal gradient median was 3. Rationale: The acute respiratory distress syndrome (ARDS) is a rapid progressive acute hypoxemic respiratory failure resulting from an alteration of the alveolar-capillary barrier by direct or indirect pulmonary aggression. The management of this rare and serious pathology in children is largely based on adult studies. There is a lack of pediatric evidence. Furthermore, few data are focusing on severe ARDS. The main objective of this study was to analyze epidemiology and treatments used for severe ARDS in children. The secondary outcome was to determine factors associated with mortality. Patients and methods/materials and methods: We led a retrospective bicentric study, in two pediatric intensive care units (PICU). Inclusion criteria were children between 28 days and 18 years old hospitalized in PICU and having presented severe ARDS define as index oxygenation (OI) ≥ 16 or PaO2/FiO2 < 100 when OI was not available. Period of inclusion was going from 2003 to 2018. Results: 148 children were included in the study, corresponding to a prevalence of 0.99%, stable over studied years. Etiologies were dominated by infections (55%). There was a stable prevalence of mortality with thirty-two percent over time despite a change in treatment practices. Multivariate analysis identified several factors independently associated with mortality: high weight (OR 1. Conclusion: This study is the largest French retrospective cohort on children's ARDS. We identified independent factors associated with mortality never described before in children, which are likely to be indicative of the initial severity of the clinical presentation. They could help clinicians for a better management and a more accurate parental information. These results require confirmation by prospective data. Compliance with ethics regulations: Yes in clinical research. Rationale: Acute respiratory distress in infants is a frequent and highrisk emergency in daily practice. It requires urgent analysis to assess the severity, to determine the aetiology and to start adequate treatment immediately. Our purpose is to evaluate the incidence, etiologies, management and evolution in ICU. Patients and methods/materials and methods: Our work is based on a prospective descriptive study of 122 cases of respiratory distress in infants at the pediatric intensive care unit during 1 year from July 1st 2018 to June 30th 2019. We included all infants over 28 days of age and under 24 months with dyspnea with or not signs of struggle. All infants with bronchopneumopathy without dyspnea were excluded. Results: The incidence was 7.26%. The average age was 8 months with a range of . The sex ratio was 1.39. The diagnosis was guided by patient medical history, physical examination and chest X-ray. A chest X-ray was requested in all patients with pathological results in 83.6% of cases. The etiologies were mainly represented by viral bronchiolitis (25.6%), congenital heart disease (15.6%), whooping cough (10.7%), foreign body inhalation (9.0%) and acute severe asthma (6.6%). All infants received symptomatic and etiological treatment. Despite appropriate treatment, the mortality represented 15.7%. Conclusion: Acute respiratory distress in infants is due to many causes and viral bronchiolitis remain the most frequent one. The diagnosis is clinical and guided by chest X-ray and should not delay the treatment. Rationale: Since the first wave of COVID-19, the management of patients with severe COVID-19 in intensive care units (ICU) has changed with the widespread use of dexamethasone (DXM). We have reported a high incidence of acute kidney injury (AKI) in severe COVID-19 patients. As lung injury, specific SARS-CoV-2 inflammatory process was previously suggested in AKI pathogenesis susceptible to be improved by DXM. We have reported a chronic kidney disease (CKD) incidence of 15%, 3 months after COVID-19-induced AKI. All of these suffered from acute kidney disease (AKD) before CKD highlighting the impact of this inflammatory period. Patients and methods/materials and methods: Aim of this report was to evaluate clinical effect of DXM in the kidney involvement in severe COVID-19 patients. We carried out a prospective study in a medical ICU from March to December, 2020. All patients admitted for a severe COVID-19 were included. DXM was exclusively used during the second wave (6 mg/day, for 10 days). Patients treated by DXM who developed AKI before or in the first 24 h after corticosteroid administration were excluded from the analysis. Results: 126 patients were enrolled. 21/126 patients (17%) were excluded because of AKI prior or in the first 24 h to DXM administration. DXM administration was used in all patients in the second wave and in none of the first wave patients. In the 105 patients included, median age was 63 ± 11 years, 64/105 (61%) suffered from Rationale: Specific respiratory mechanics alterations of patients ventilated after a cardiac arrest have never been systemically assessed. This study aimed at assessing respiratory mechanics, gas exchange and ventilator settings of patients with or without ARDS after non-traumatic cardiac arrest (post CA-ARDS and post CA-non ARDS). Rationale: In some patients with late refractory ARDS (LR-ARDS) on maximal support by ECMO, considering switch from "ECMO to recovery" to bridge to lung transplantation (LTx) could be an option (1). We report our preliminary experience in such strategy. Patients and methods/materials and methods: Between 2016 and 2020 patients with LR-ARDS on ECMO to recovery strategy failure referred to our center for LTx evaluation were reviewed. Patients with pre-existing lung disease or other severe comorbidities before ARDS onset were not considered for evaluation. In all cases, lung damage irreversibility was established by multidisciplinary staff. Results are expressed in median [min;max]. This study was approved by ethic local committee. Results: 13 patients (4 women; 9 men) aged of 56 years [20;63] were included. The etiologies were SARS-CoV-2 ARDS (9), toxic (2), anti-MDA5 interstitial pneumonia (1), and unknown (1). Only 6 patients were transferred to our center. Only those data were analyzed. Among 6 patients, 4 were transplanted and 2 died before LTx. ECMO . Every induction protocol included basiliximab and post-operative immunosuppression was as usual. 2 patients were informed of and accepted LTx surgery and 2 could not. Though, patients graft acceptance and treatment adhesion were good in all cases. Relatives were systematically extensively informed of risks and benefits, and accepted the strategy. All patients were listed in high emergency program after expert panel acceptation. Conclusion: In our experience, LTx seems to be a reasonable option in irreversible LR-ARDS under maximal support therapy in very selected patients in an expert center with a specific task force. Incidence of such young potentially eligible patient is increased due to the current COVID-19 pandemic. As further evaluations are needed, we propose to create a national registry to evaluate this new strategy. Rationale: Current practices regarding tracheostomy in patients treated with extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome are unknown. We aim to assess the prevalence and the impact of the timing of the tracheostomy (i.e. during or after ECMO decannulation) on related complications, sedative, and analgesic use. Patients and methods/materials and methods: International, multicenter, retrospective study in four large volume ECMO centers during a 9-year period. Results: Of the 1,168 patients treated with ECMO for severe ARDS (age 48 ± 16 years, 76% male, SAPS II score 51 ± 18) during the enrollment period, 353 (30%) and 177 (15%) were tracheostomized during ECMO or after ECMO decannulation, respectively. The incidence and the severity of early tracheostomy complications were uncommon and similar for the two groups, whereas local bleeding or oozing after 24 h was four times more frequent when the tracheostomy was performed during ECMO (25 vs 7%, p < 0.01). Cumulative sedative consumption decreased more rapidly after the procedure for patients tracheostomized after ECMO decannulation with sedative doses almost negligible 48-72 h after the tracheostomy when performed after ECMO decannulation (p < 0.01). A significant increase of the RASS was observed within 72 h after the tracheostomy in the "after ECMO" group whereas it was unchanged in the "during-ECMO" group. Conclusion: Contrary to the patients undertaking tracheostomy after ECMO withdrawal, tracheostomy during ECMO was not associated with a prompt decrease of the sedation and analgesic levels and an increase of the RASS. This finding and a higher local bleeding risk during the days following the procedure reinforce the need for a caseby-case discussion of the balance between risks and benefits when performed during ECMO. Compliance with ethics regulations: Yes in clinical research. Rationale: Non-invasive ventilation (NIV) is a supportive therapy that may improve mortality in acute respiratory failure. Currently, it belongs to the therapeutic arsenal used during weaning of patients from mechanical ventilation. Nevertheless, NIV application modalities in post-extubation are not accurately codified. The aim of this study was to describe post-extubation NIV use in intensive care unit clinical practice and to identify factors associated with failure. Patients and methods/materials and methods: Retrospective study carried out in respiratory medical intensive care unit of Abderrahmen Mami teaching hospital between January 2017 and December 2018. It included patients who required more than 48 h of invasive mechanical ventilation and who received NIV after extubation. NIV application modalities were recorded and predictive NIV failure (death under NIV or re-intubation within 72 h after extubation) factors were identified. Results: During study period, 60 patients were included with mean age of 56 ± 18 years, sex ratio of 3.6 and COPD history in 43% patients. Extubation was scheduled in 48 patients (80%) and unplanned in 12 (20%). Post-extubation NIV was: preventive (n = 36; 60%), therapeutical (n = 5; 8%) and systematic (n = 19; 32%). Pressure support was the most frequently adopted mode (93%) with a mean inspiratory pressure support level of 12.9 ± 2.9 cmH2O and the mean positive expiratory pressure of 6.2 ± 1.7 cmH2O. NIV was started meanly 3.6 h after extubation and discontinuously applied in 70% of cases with a mean rhythm of one session every 4 h. The mean whole duration of NIV was 2.87 days [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . NIV rate failure was 20%, mean length of stay was 18 days and overall mortality was of 25%. Multivariate analysis identified two independent predictors of NIV failure: Age > 69 years (OR = 6.13, 95% CI [1.03-36.5], p = 0.046) and duration of NIV at day 1 > 9 h (OR = 10.18, 95% CI [1.65-62.59], p = 0.012). Conclusion: Non-invasive ventilation is an effective technique to avoid re-intubation. Age over 69 years and need to NIV for more than 9 h during the first day are significantly associated to NIV failure after extubation. Compliance with ethics regulations: Yes in clinical research.

In intensive care units (ICUs), the use of non-invasive ventilation (NIV) immediately after extubation may prevent reintubation in patients at high-risk of extubation failure. Prophylactic use of NIV after extubation has been poorly assessed in obese patients. We hypothesized that NIV may be particularly effective in obese patients by decreasing the risk of reintubation compared with high-flow nasal oxygen. Patients and methods/materials and methods: Post hoc subgroup analysis focusing on obese patients included in a multicenter, randomised, controlled trial comparing NIV alternating with high-flow nasal oxygen versus high-flow nasal oxygen alone within the first 48 h after extubation. The main outcome was reintubation rates within the 7 days following extubation according to oxygenation strategy. Results: Among 628 patients extubated in 30 ICUs, 206 (33%) had obesity including 112 patients (54%) treated with NIV and 94 (46%) treated with high-flow nasal oxygen alone. The reintubation rate at day 7 was 6% (7 of 112 patients) with NIV and 18% (17 of 94 patients) with high-flow nasal oxygen alone (difference − 12%; 95% CI, − 21 to − 3; p = 0.008). Whereas the reintubation rate was exactly the same in non-obese patients treated with high-flow nasal oxygen (18%, 37 of 201 patients; difference 0.3% compared with obese patients; 95% CI, − 10% to 9%; p = 0.92 using log-rank test), the reintubation rate in patients treated with NIV was significantly lower in obese (6%, 7 of 112 patients) than in non-obese patients (15%, 33 of 221 patients, difference, − 9%; 95% CI, − 15 to − 1; p = 0.02 using log-rank test). Conclusion: Prophylactic NIV alternating with high-flow nasal oxygen immediately after extubation of obese patients significantly decreased the rate of reintubation as compared with high-flow nasal oxygen alone. NIV was particularly effective in obese patients with reintubation rates significantly lower than in non-obese patients treated with NIV. Compliance with ethics regulations: Yes in clinical research.

High-flow oxygen during spontaneous breathing trial for patients at high risk for weaning failure: a pilot randomized controlled trial Guillaume Fossat 1 , Mai-Anh Nay 1 , Sophie Jacquier 2 , Dalila Benzekri 1 , Armelle Mathonnet 1 , Anne Bretagnol 1 , Marie Skarzynski 1 , Gregoire Muller 1 , Toufik Kamel 1 , Francois Barbier 1 , Nicolas Bercault 1 , Isabelle Runge 1 , Emmanuelle Desmalles 1 , Thierry Boulain 1 1 CHR ORLEANS, Orleans, France; 2 chu tours, Tours, France Correspondence: Guillaume Fossat -guillaume.fossat@chr-orleans.fr Annals of Intensive Care 2021, 11(Suppl 1):FC-243 Rationale: T-piece spontaneous breathing trial (SBT) is commonly performed as the final step of mechanical ventilation (MV) weaning to assess whether a patient is eligible for extubation. However, T-piece SBT appears as a highly demanding ventilation strategy that may lead to delayed weaning and extubation failures when compared to Pressure Support SBT. High-flow oxygen (HFO) therapy could be usefully implemented during SBT, as in hypoxemic respiratory failure it reduces the work of breathing, maintains a low level of positive end-expiratory pressure, exerts a wash-out effect on the anatomical dead-space, and has no hemodynamic side-effect. This study aimed to investigate whether HFO SBT would accelerate MV weaning while not increasing the rate of re-intubation when compared to standard T-piece SBT in patients at risk for extubation failure. Patients and methods/materials and methods: In this single-ICU pilot randomized controlled trial, patients under MV for > 24 h who had chronic pulmonary and/or cardiac disease and in whom an SBT was ordered, were randomly allocated (1:1) to T-piece SBT or HFO SBT using a connecting device attached to the endotracheal tube. Primary outcome measures were (1) the rate of extubation within 7 days after the first SBT and (2) the rate of re-intubation within 7 days after extubation. Secondary outcome measures were (1) the rate of trial success and (2) arterial partial pressure of oxygen (PaO2) at the end of first SBT. Rationale: Weaning failure of cardiac origin can be diagnosed by the elevation of the left ventricular (LV) filling pressure. This hydrostatic pulmonary edema is associated with hemoconcentration du to hypooncotic fluid movement from the vascular compartment to the interstitium. The aim of this study was to search for a correlation between the protidemia and the hemoglobin elevation during the weaning test and the presence of LV filling pressure elevation. Patients and methods/materials and methods: This prospective observational study was conducted during 24 months (between January 2018 and January 2020). Every patient with weaning failure was included. The variation of the biological and ultrasound criteria between the periods before and after the ventilator weaning was analysed. Results: We included 60 patients which failed during the first weaning test. 20 patients (33%) had an elevation of the LV filling pressure during the second weaning test with E/A > 0.95 and E/Ea > 8.5 at the end of the test period and within these 20 patients, 12 (60%) failed this second weaning test. When compared to the 40 patients who didn't present a pulmonary edema, these 12 patients required additional delay for the weaning: 2.5 + 3.7 days versus 0.75 + 2.4 days (P = 0.023). the unique predictive factor associated with the occurrence of pulmonary edema was positive body weight difference between the admission in the ICU and the inclusion in the study (4.6 + 5.6 versus 3.5 + 7.3, p = 0.004). The was no significant variation of the hemoglobin and protidemia during the weaning for the patients who presented a pulmonary edema. Conclusion: During this study we did not find a correlation between the hemoglobin or the protidemia variation during the weaning period and the ultrasound criteria of th LV filling pressure elevation. The difference of body weight between the admission in the ICU and the inclusion, which reflect a positive fluid balance, was the unique factor associated with weaning failure of cardiac origin. Its control could allow a more frequent weaning success and the diminution of the morbidity and mortality due to the diminution of the mechanical ventilation duration Compliance with ethics regulations: Yes in clinical research.

Retrospective comparative cohort study including all patients hospitalized in ICU for COVID-19. Two groups were studied according to the presence or not of ULD. We collected data of demographics, clinical presentation, laboratory results, cardiac ultrasound and CT scan findings, treatments and outcomes. The primary outcomes were the use of mechanical ventilation (MV), ICU length of stay (LOS) and death. Results: 143 patients were included of which 102 were males (ULD group, n = 31 versus no ULD group, n = 112). ULD corresponded to sleep apnea (SA, n = 8), chronic obstructive pulmonary disease (COPD, n = 7), asthma (n = 6), diffuse interstitial lung disease (ILD, n = 6) and mixed disorder in 4 cases (asthma/SA, n = 2 and COPD/SA, n = 2). Home oxygen or ventilation was required in 3 cases. The ULD group was more likely exposed to tobacco (45% vs 15%, p = 0.001) and have more history of bacterial pneumonia (22.5% vs 3%, p = 0.001). No difference was showed in the clinical presentation (cough, dyspnea, struggle signs, respiratory rate, digestive signs, myalgia, etc.). Severity scores and CURB-65 were similar. For laboratory results, only LDH (552 vs 402 IU/L, p = 0.035) and AST (60 vs 38 IU/L, p = 0.016) differed and it were higher in no ULD group. A CT scan involvement greater than 50% was more observed in no ULD group (47% vs 15%, p = 0.011). The follow-up of blood gas, compliance and driving pressure did not reveal any differences between the 2 groups. The 2 groups developed similarly ARDS, thrombo-embolic events and septic shock. Requirement of MV not differed (51% vs 44%, p = 0.41) as well as the duration of MV (6,6 vs 6,5 days, p = 0.9), the ICU-LOS (9.1 vs 10, p = 0.4) and the death rate (51.6% vs 55%, p = 0.68). Conclusion: Unexpectedly, we did not find any major difference (regarding the clinical presentation, severity scores at admission and CURB-65, and the entire disease's course: ARDS, MV requirement and mortality) between critical COVID-19 patients with ULD versus without ULD. The differences were showed with LDH and AST levels and CT scan lesions which were most marked with patients without ULD. Rationale: COVID-19 is associated with a variety of complications. Rapid deterioration to acute respiratory distress syndrome (ARDS) occurs in about 10-15% of patients who develop dyspnea. Early identification of indicators for ARDS facilitated the access to the ICU. The improvement of acknowledgment in the field of COVID-19 reported that in addition to the metabolic co-morbidities; some biological indices occurred frequently in severe COVID-19 patients. We aimed to assess the utility of the most well-known disturbed laboratory parameters in COVID-19 to predict progression to stage 3-ARDS requiring mechanical ventilation (MV).

We performed an analytical retrospective cohort study. Primary outcome: progression to the stage 3 (or severe) ARDS. After determining the cut-offs using the ROC curves and Youden's indices, we selected the followings indices: neutrophil-to-lymphocyte ratio (NLR), D-dimers, C-reactive protein (CRP), fibrinogen, ferritinemia, prothrombin time (PT) and LDH. Rationale: While the COVID-19 pandemic is still ongoing, there is a need to identify risk factors for the need for unconventional oxygen therapy in the context of limited medical resources. Neutrophil-tolymphocyte ratio (NLR) has been identified as a marker correlated with COVID-19 severity and outcome. Patients and methods/materials and methods: In a retrospective multicenter cohort study, we analyzed medical charts of patients with a severe pulmonary form of COVID-19 documented by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) in 5 different hospitals. We used a multivariate model including clinical, biological variables including the NLR and chest CT variables to assess the risk factors for developing a critical form of COVID-19, in-hospital mortality, and ICU mortality. Our primary judgement criterion was the association between the NLR and evolution to a critical form of COVID-19. Results: Of the 149 cases identified, 51% developed a critical form, 36.2% were admitted to ICU, 32.2% required mechanical ventilation, and 22.8% died. NLR was associated to evolution to a critical form of COVID-19 in univariate analysis but not in multivariate analysis. The risk factors independently associated with critical COVID-19 were a SOFA score at day 1 greater than 2, chest CT lesions exceeding 50% Annals of Intensive Care 2021, 11(Suppl 1):FC-250Rationale: SARS-CoV-2 acute respiratory distress syndrome (ARDS) pathophysiology and its differences with ARDS of other etiologies remain unclear. A few studies described respiratory mechanics and gas exchange in COVID-19 moderate-to-severe ARDS, mainly in the first 24 h. The aim of our study is to describe the prognostic contribution of respiratory mechanics and gas exchange in the first 48 h after ARDS onset and its evolution at day 7. Patients and methods/materials and methods: Between March 1th and May 30th 2020, we identified all patients with positive SARS-CoV-2 PCR and moderate-to-severe ARDS hospitalized in our ICU within 48 h of ARDS onset and for whom respiratory mechanics data were collected. All patients were ventilated on a GE Carescape R860 with a metabolic module. Respiratory mechanics including dead space fraction (Vd/Vt) and gas exchange parameters were collected in the first 48 h of ARDS onset and at day 7 ± 24 h. Results: Among 103 patients admitted in our unit, 48 patients met the inclusion criteria. At day 7, only 32 patients were analyzed (died before day 7 n = 7, alive and transferred in other unit/hospital n = 9). In the first 48 h, Survivors had a significantly lower driving pressure than deceased patients (8,5 (8;10,75) vs 10,5 (9;11,75), p = 0.042). At day 7, survivors had a significantly lower driving pressure (10(9;13) vs 14(13;18), p = 0.027) and a significantly higher respiratory system compliance (42(36;55) vs 31(26-36) p = 0.002). Moreover, the evolution of physiological dead space, end-expiratory lung volume and ventilatory ratio between the first 48 h and day 7 was significantly different. Conclusion: In this monocentric retrospective study, higher driving pressure seems to be associated with ICU mortality in the first 48 h and at day 7. During ICU stay, dead space parameters also have opposite trend between survivors and deceased patients. Rationale: The COVID-19 led to a global health disturbance. Since the lesions due to this infectious disease with respiratory tropism are specific, the chest CT scan was of great help in the diagnosis. The objectives of our study were to describe the CT scan abnormalities in COVID 19 positive patients and to seek a correlation between the extent of lesions and the clinical severity of patients. Patients and methods/materials and methods: This was a prospective and analytical descriptive study carried out in the intensive care unit of Abderahmen Mami Hospital from March 2020 to October 2020. We included all COVID-19 positive patients who have undergone chest CT scan. Results: During study period, 60 COVID-19 patients were admitted, 41 were included. Mean age was 61 years ± 14 (28-90 years) and sex ratio was 1.64. The clinical severity scores IGS II and APACHE II scores were, respectively, 24 ± 12 and 7.64 ± 4. Eighteen patients (40%) had hypertension and 14 (31%) had diabetes. At admission, 20 patients (44%) had an ARDS, light in 6 cases (13%), moderate in 9 (20%) and severe in 5 (11%). For scanning data, frosted glass images were present in 34 patients (75%), condensations in 28 patients (62%), bronchiectases in 16 cases (35%) and one case of crazy paving. Pulmonary embolism was noted in 5 patients (11%) and reticular images in 3 patients (6%). The images were bilateral and peripheral in 100% of Ann. Intensive Care 2021, 11(Suppl 1):97 cases. The extent of scanning lesions was less than 50% in 11 patients (25%), between 50 and 75% in 16 patients (37%) and greater than 75% in 5 patients (11%). Described lesions were without significant difference between patients with the ARDS and those without as well for frosted glass images (P = 0.28), condensation (p = 0.22) and bronchiectases (p = 0.74)). However, a scanning extent of less than 50% was significantly more common in patients without ARDS (p = 0.026). Furthermore, a scanning range greater than 50% was significantly associated with mortality (p = 0.026). No correlation was found between the severity of the ARDS and the extent of the lesions. Conclusion: Chest CT scan is a reliable diagnostic tool. The extent of more than 50% of CT lesions was not correlated with clinical severity. A larger sample study is required. Compliance with ethics regulations: Yes in clinical research. Many COVID-19 patients in Intensive Care Unit (ICU) show typical and uncommon chest computed tomography (CT scan) features. We report the spectrum of chest CT imaging findings in COVID-19 infected patients in ICU. Patients and methods/materials and methods: Retrospective descriptive study comprising 82 COVID-19 patients with respiratory symptoms hospitalized from March 2020 to January 2021 in ICU. Data of initial chest CT were retrospectively collected. Prevalence, distribution, extent and type of lung findings were recorded. Results: 82 patients were hospitalized in ICU for COVID-19 infection between March 2020 and January 2021: 48 males (58.6%) and 34 females (41.4%) aged between 34 and 82 years with mean age of 63 years. A total of 80 chest CT scan were evaluated. We observed lung parenchymal abnormalities in 79 cases with incidental chest findings in 5 cases. In only one case, we noted isolated vascular abnormality (bilateral pulmonary embolism).Among the patients with abnormal CT finding, bilateral 68 (85%), multilobar 55 (68.7%) lung involvement with a predominant peripheral 63 (78.75%) and posterior distribution were commonly observed. With regards to the type of opacity, ground glass opacity (GGO) was the dominant abnormality found in all 72 (90%) cases. Pure GGO was observed in 42 (52.5%), GGO with crazy paving pattern was seen in 8 (10%) and GGO mixed with consolidation was noted in 22 (27.5%). Uncommon finding were: pleural effusion 11 (13.75%), pericardial effusion 5 (6.25%). Pulmonary embolism was seen in 5 (6.25%) cases on initial CT. Severity score of parenchymal involvement was at least a grade 2 (25-50% of parenchymal involvement) in 70 (87.5%) cases. Conclusion: COVID-19 critically ill patients tend to manifest typical imaging features on chest initial CT scan. The most common chest imaging finding was bilateral, peripheral and predominantly basal ground glass opacities. Despite of some atypical images, these typical findings can help in the diagnosis and triaging before PCR diagnosis. Lung damage is often severe and severity score of parenchymal involvement is correlated to clinical severity. Compliance with ethics regulations: N/A.

High incidence of thromboembolic events in anticoagulated COVID-19 patients Khaoula Ben Ismail, Boudour Ben Dhia, Najla Ben Slimene, Hedia Ben Ahmed, Moez Kaddour, Takoua Merhabene Hopital regional de Zaghouan, Zaghouan, TUNISIA Correspondence: Khaoula Ben Ismail -khaoula87@hotmail.fr Annals of Intensive Care 2021, 11(Suppl 1):FC-253 Rationale: Coagulopathy is a common abnormality in patients with COVID-19. It may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia and diffuse intravascular coagulation. It has been associated with multiple direct and indirect cardiovascular complications. We aim to evaluate incidence and outcome of cardiovascular complications (CVC) and thromboembolic events (TEE) in anticoagulated COVID-19 patients. Patients and methods/materials and methods: We performed this retrospective cohort study in COVID-19 patients hospitalized in our ICU between 24th March 2020 and 31st January 2021 to assess the incidence and the composite outcome of symptomatic CVC and TEE in all COVID-19 patients admitted to the ICU. Pulmonary embolism was systematically searched in patients with persistent hypoxemia or secondary respiratory deterioration. Results: 126 patients were enrolled. Mean age was 62 ± 12 years [34-92] with a sex ratio 1.5. 47% of patients were over 65 years. Seventynine patients (65.3%) were obese (IMC ≥ 30 kg/m 2 ) and 30.6% were smokers. Mean SAPS II, Charlson and APACHE II scores were 25.9 ± 8 [6-50]; 2.8 ± 1 [0-7]; 7.7 ± 3 [1-27], respectively. Comorbidities were present in 66.9% of cases; it was mainly cardiovascular (60.3%) and diabetes (35.5%). All patients were treated with therapeutic anticoagulation. Twenty-eight patients developed TEE and/or CVC in our study (incidence of 23%).This group was significantly older (66.9 ± 10 vs 61.3 ± 12.8 years, P = 0.038). Thromboembolic events occurred in most cases in COVID-19 patients treated with preventive anticoagulation (76.9%), this complication occured at of day 5 ± 4 of hospitalization. PE was the most frequent thrombotic complication (n = 8, 28.6%).It was classified at high risk of mortally in 50% of cases (n = 4), intermediate and low risk in 25% (n = 2) of cases each one. Two patients have developed acute limb ischemia: the first was in the hand complicating implement of radial arterial line and the other was in the lower limb complicated with rhabdomyolysis and multiorgan failure. Only one patient have presented cerebrovascular accident complicating non-ST elevation acute coronary syndrome On the other hand, COVID-19 infection has been associated with multiple CVC including: acute myocardial injury in 4.9% of cases (ST +n=5 and ST −n = 1), myocarditis in 0.8% of cases and arrhythmias in 6.6% of cases. Treatment of pulmonary embolism with high risk was thrombolysis with success in 50%. In comparison of total patients, those who developed CVC ou VEE have higher mortality (60.7% in vs 48%, P = 0.038) Conclusion: Incidence of CVC in COVID-19 infections in patients who were treated with therapeutic anticoagulation is remarkable. Our findings reinforce the recommendation to strictly apply pharmacological thrombosis curative in all COVID-19 patients admitted to the ICU. Compliance with ethics regulations: Yes in clinical research.

Characteristics and mortality prognostic factors of patients with severe COVID-19 pneumonia admitted in an intensive care unit of a tertiary general hospital Marie Baron 1 , Luis Ensenyat-Martin 1 , François-Xavier Laborne 1 , Karim Chergui 1 , Pierrick Cronier 1 , Sabina Djouhri 1 , Nicolas Maziers 1 , DanielleOur objective was to analyze the evolution of patients who presented with refractory ARDS requiring venous-venous ECMO (VV ECMO) during the COVID-19 pandemic. Patients and methods/materials and methods: Single-center French retrospective study. All patients admitted for ARDS COVID-19 and treated with ECMO VV were analyzed. The ethics committee of Paris University Hospitals approved this study (CEERB Paris Nord. IRB 00006477). Results: Between March and April 2020, 83 patients were hospitalized for SARS-CoV-2 pneumonia. Thirteen patients required VV ECMO for severe refractory ARDS despite prone position, use of neuro-muscular blockers, and inhaled nitric oxide. At the time of ECMO implantation, the median duration of mechanical ventilation (MV) was 6 days and the median PaO2/FiO2 ratio was 59 mmHg. The median tidal volume was 5.25 ml/kg with a median positive end-expiratory pressure (PEEP) of 12 cmH2O. The median plateau pressure was 32 cmH2O with a driving pressure of 20 cmH20. All patients were hypercapnic (median PaCO2 65 mmHg). Seven major adverse events occurred in 4 patients, including 3 major hemorrhages requiring massive transfusion, 2 cannula infections with Enterococcus faecalis bacteremia, and 2 circuit changes (device thrombosis or circuit-related thrombocytopenia). All 13 patients were weaned from ECMO after a median of 13 days. Two patients died under MV: a 41-year-old man, Jehovah's Witness (information obtained after implantation), with deglobulization < 5 g/ dL (bleeding and hemolysis under ECMO) without any possibility of transfusion leading to early explantation; the second patient died of major right ventricular failure with probable pulmonary embolism 7 days after ECMO explant. After 3 months, the 11 other patients were discharged from the ICU with a median length of stay of 34 days and a median duration of MV of 29 days. Conclusion: Despite the retrospective nature of the study and the small number of patients, these results are very encouraging and contrast with previous studies. The rigorous selection of patients, in consultation with a reference center, could explain this difference. ECMO should be considered as a lifesaving therapy in selected patients who develop severe refractory COVID-19-related ARDS despite optimal conventional treatment.